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Community engagement in HIV vaccine research is a complex phenomenon and is articulated 
as a crucial part of HIV vaccine research. In spite of this, there is a dearth of literature that 
focusses on community engagement in HIV vaccine research. While there is much social 
science literature that focusses on the operational and ethical aspects of HIV vaccine 
research, there is little research that explores the process of community engagement. In order 
to contribute to understanding community engagement in context, the purpose of my research 
was to document and explore the dynamics of the current practice of community engagement 
at an HIV prevention research centre, Research Centre X in the Western Cape, South Africa. 
Located within a community mobilization approach, the research used the conceptual 
framework of the symbolic, relational and material contexts as the lens for exploring 
experiences of research participation and the dynamics of the current community engagement 
process at Research Centre X.  
The study applied a qualitative approach to address the research question and used focus 
group discussions and key informant interviews to access the perspectives of three key 
stakeholders who form part of the community engagement process at Research Centre X. 
Research participants were selected using a purposive sampling technique and included 
current HIV vaccine trial participants, CAB members who represent the interest of 
community members in the community engagement process and staff members at Research 
Centre X who implement community engagement activities. The data were analysed using 
the thematic analysis approach outlined by Braun and Clarke (2006). Ethical approval for the 
conduct of the study was provided by Ethics Review Committees at Stellenbosch University 
and the University of Cape Town.  
In the symbolic context, the findings highlight fear and avoidance of HIV/AIDS and 
HIV/AIDS stigma in the research setting. HVT participants reported that myths, beliefs and 
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rumours about the HIV vaccine research being conducted at Research Centre X circulate, 
inhibiting attempts to promote participation in the research and community engagement 
activities at Research Centre X. In the relational context, the findings reveal that community 
outreach workers engage in a narrow set of practices in their community engagement 
activities, generating a set of relational resources to support their activities. Their activities 
focus primarily on “spreading the word”, in other words disseminating HIV vaccine research 
information in the community setting with a view to meeting participant recruitment targets 
set by researchers and trial sponsors. The relational context of community engagement in 
HIV vaccine research at Research Centre X, therefore, offers limited roles for community and 
CAB members in the process. The material context of community engagement in HIV 
vaccine research is one that highlights contradictory perspectives on the extent to which it 
promotes empowerment among HVT participants and CAB members.  
My research findings highlight the complexities that accompany efforts to promote 
community engagement in HIV vaccine research in resource-poor settings and generates 
recommendations for transforming the HVT context and reframing community engagement 
process in the research setting.  
  




Gemeenskapsbetrokkenheid by MIV-entstofnavorsing is ’n komplekse saak wat ’n kritieke 
deel vorm van MIV-entstofnavorsing. Ten spyte hiervan is daar ’n gebrek aan navorsing wat 
fokus op gemeenskapsbetrokkenheid by MIV-entstofnavorsing. Daar is heelwat sosiaal-
wetenskaplike literatuur wat fokus op die bedryfs- en etiese aspekte van MIV-
entstofnavorsing, maar daar is baie min wat die proses van gemeenskapsbetrokkenheid 
ondersoek. Ten einde gemeenskapsbetrokkenheid binne so ’n konteks te verstaan, was die 
doel van hierdie navorsing om die dinamiek van die huidige praktyk van 
gemeenskapsbetrokkenheid by ’n MIV-voorkomingsnavorsingsentrum, Navorsingsentrum X 
in die Wes-Kaap, Suid-Afrika, te ondersoek en te dokumenteer.  Die navorsing is 
geposisioneer binne ’n gemeenskapsmobiliseringsbenadering en het die konsepsuele 
raamwerk van die simboliese, relasionele en materiële kontekste gebruik as die lens waardeur 
die ervaring van navorsingsbetrokkenheid en die dinamiek van die huidige 
gemeenskapsbetrokkenheidproses by Navorsingsentrum X ondersoek is.  
Ek het van ’n kwalitatiewe benadering gebruik gemaak om die navorsingsvraag te 
beantwoord en het fokusgroepe gehou en onderhoude gevoer met sleutel informante om die 
perspektiewe van drie sleutelrolspelers wat deel vorm van die gemeenskapsbetrokkenheid by 
Navorsingsentrum X, te ondersoek. Navorsingsdeelnemers is deur middel van ’n doelgerigte 
steekproefnemingstegniek geïdentifiseer en het huidige MIV-enstofproefdeelnemers, GAR-
lede (Gemeenskapsadviesraad) wat die belange van die gemeenskapslede verteenwoordig in 
die gemeenskapsbetrokkenheidproses, en personeel by Navorsingsentrum X wat die 
gemeenskapsbetrokkenheidaktiwiteite implementeer, ingesluit. Die studiedata is geanaliseer 
met behulp van ’n tematiese analisebenadering soos uiteengesit deur Braun en Clarke (2006). 
Die navorsingsetiekkomitees van die Universiteit van Stellenbosch en die Universiteit van 
Kaapstad het die navorsing goedgekeur.  
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In die simboliese konteks wys die bevindinge dat daar vrese en vermyding van MIV/Vigs en 
MIV/Vigs-stigma binne die navorsingsomgewing is. MIV-entstofproefdeelnemers het 
aangedui dat mites, oortuigings en gerugte oor die MIV-entstofnavorsing by 
Navorsingsentrum X die rondte doen, en dit verhinder die bevordering van deelname in die 
navorsing en gemeenskapsbetrokkenheidsaktiwiteite by Navorsingsentrum X. In die 
relasionele konteks toon die bevindinge dat gemeenskapsuitreikwerkers gebruik maak van ’n 
baie nou stel praktyke as deel van hulle gemeenskapsbetrokkenheidaktiwiteite en hulle 
sodoende ’n stel relasionele hulpbronne bymekaarmaak om hulle aktiwiteite te ondersteun. 
Hulle aktiwiteite fokus primêr daarop om die “woord te versprei”, dit wil sê om inligting oor 
MIV-entstofnavorsing in die gemeenskap bekend te maak om so die 
deelnemerwerwingsteikens wat die navorsings en proefborge stel, te bereik. Die relasionele 
konteks van gemeenskapsbetrokkenheid by MIV-entstofnavorsing by Navorsingsentrum X 
bied dus beperkte geleentheid vir die gemeenskap en gemeenskapsadviesraadslede om 
betrokke te wees. Die materiële konteks van gemeenskapsbetrokkenheid by MIV-
entstofnavorsing beklemtoon die teenstrydige perspektiewe oor die mate waartoe die 
navorsing die MIV-entstofnavorsingsdeelnemers en gemeenskapsadviesraadslede bemagtig.  
Die navorsingsbevindinge belig die kompleksiteit van die pogings om 
gemeenskapsbetrokkenheid by MIV-entstofnavorsing te bevorder in hulpbron-arme 
omgewings en gee aanbevelings vir die transformasie van die MIV-entstofnavorsingskonteks 
en vir die herinkleding van gemeenskapsbetrokkenheidprosesse binne die 
navorsingsomgewing.   
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Chapter 1: Introduction 
The impact of the Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency 
Syndrome (AIDS) pandemic globally has been well documented. In Sub-Saharan Africa, 
HIV/AIDS is the main cause of death, and in South Africa, the location for the present study, 
an HIV prevalence of 12.2% was recorded in 2012 (Merson, O’Malley, Serwadda, & Apisuk, 
2008; Shisana et al., 2014). The pandemic has been described as a socially patterned disease 
(Farmer, 1992). It follows deprivation and its impact is felt most acutely by poor, 
marginalized and vulnerable communities, amplifying the socio-economic and other 
challenges that threaten the well-being of these communities (Merson et al., 2008).   
A broad range of HIV prevention strategies have been adopted to stem the tide of HIV 
infections. These strategies have included knowledge, education and awareness-raising 
efforts, a wide range of interventions to encourage those at risk of HIV infection to change 
high-risk behavioural practices and structural interventions that have attempted to address the 
structural drivers of the pandemic (Padian et al., 2011). Biomedical interventions such as 
medical male circumcision have also shown some promise in reducing the risk of HIV 
acquisition in men (Kurth, Celum, Baeten, Vermund, & Wasserheit, 2011; Padian et al., 
2011). Despite substantial investment, these HIV prevention approaches have had limited 
impact on reducing HIV prevalence and incidence to date (Coates, Richter, & Caceres, 2008; 
Kalichman, 2008).   
The development of biomedical HIV prevention technologies, such as vaccines and 
microbicides, is another category of HIV prevention research that many believe may hold 
hope for reducing the spread of the HI-virus. MacQueen (2011) points out that biomedical 
HIV prevention strategies are an important and growing part of HIV prevention agendas. 
Biomedical HIV prevention technologies offer the potential of conferring life-long immunity 
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and reduction in susceptibility to HIV infection in populations where HIV risk is high 
(Kalichman, 2008). This research focusses on the process of community engagement in one 
such biomedical HIV prevention technology, namely clinical research to develop a safe and 
efficacious HIV vaccine.  
In South Africa, efforts to develop a safe and efficacious HIV vaccine have been 
underway since the 1990s. HIV vaccine clinical trials (HVTs) are currently being conducted 
in communities where HIV risk is high, with community members being targeted for their 
participation in the research process. From the perspective of clinical researchers, funders and 
vaccine advocates, local communities are regarded as crucial stakeholders in the HIV vaccine 
research enterprise (Wakefield, 2005). Communities, therefore, occupy a central role in the 
HIV vaccine research enterprise. This central role is promoted through an emphasis on 
collaboration, partnership and participation of communities in the research as key factors for 
ensuring the successful conduct of HVTs (UNAIDS-AVAC, 2011). Without the buy-in, 
support and mobilization of the communities in which HIV vaccine trials are being 
conducted, any effort to develop an effective HIV vaccine is unlikely to succeed (Fuchs, 
Sobieszczyck, Hammer & Buchbinder, 2010; Lau, Stansbury, Gust & Kafaar, 2009).  
The HIV vaccine research enterprise is made up of a collective of multiple 
stakeholders, such as clinical trial site staff, biomedical scientists, trial sponsors, 
pharmaceutical companies and local communities. At the global level, those involved in the 
HIV vaccine enterprise form part of global assemblages represented by networks of power 
and knowledge that influence the way in which stakeholders make sense of their own realities 
(Ong & Collier, 2005). They are part of the global AIDS industry: their micro-stories and 
relationships play themselves out at the intersection between scientific experimentation, lay 
person involvement in science, and the complex social and contextual factors that fuel the 
HIV/AIDS pandemic (Ong & Collier, 2005; Lau, Swann & Singh, 2011).    
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At the local level, HVTs are conducted, due to scientific necessity, in communities 
where HIV prevalence and risk of HIV infection are high (Lesch, Kafaar & Kagee, 2009). As 
highlighted above, the community settings in which these trials are conducted are 
characterized by complex socio-political and economic climates; histories of exploitation, 
and assaults on human dignity and human rights; all of which raise concerns about power 
imbalances between researchers and community members who participate in their research 
(MacQueen, 2011; Petryna, 2009). The location of clinical trials in such community contexts 
also raises concerns about the rights of communities of vulnerable individuals who are asked 
to participate in clinical research (Petryna, 2006). Emanuel, Wendler, Killen and Grady 
(2004) point out that research conducted in developing countries carries with it a greater risk 
of exploiting marginalized and vulnerable groups. The increased potential for exploitation is 
due to structural inequalities that characterize such local communities that may include a lack 
of access to resources that promote health and well-being, cultural and language differences 
between researchers and local communities and low levels of education and scientific literacy 
of local communities. The social context in which HIV vaccine research is conducted is, 
therefore, complex, involving interactions between diverse stakeholders with different 
perspectives, agendas, hopes, beliefs and levels of access to resources and power in the 
clinical trial process (MacQueen, 2011; Petryna, 2009). Researchers working in this area are 
challenged to balance the scientific goal of developing a safe and efficacious HIV vaccine 
with the need to build community capacity and leave communities better off as a result of 
their participation in HVTs and related research (Swartz & Kagee, 2006).  
Much social science research has been conducted to examine the social dimensions of 
HIV vaccine research. Research on the social dimensions of HIV vaccine research has been 
conducted in various HVT settings, targeting a range of high HIV risk populations. The body 
of research generated has predominantly focussed on understanding the factors associated 
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with willingness to participate (WTP) in HIV vaccine research (e.g., Asiki et al., 2013; Lesch, 
Kafaar, Kagee, & Swartz, 2006); examining knowledge about HIV/AIDS and HIV vaccines 
as the basis for WTP and improving informed consent processes (e.g., Kiwanuka et al., 2004; 
Lindegger et al., 2006); documenting the social harms experienced by community members 
who participate in HIV vaccine research (e.g., Allen & Lau, 2008; Nyblade, Singh, Ashburn, 
Brady, & Olenja., 2011); and examining community engagement in HIV vaccine research 
(e.g., Morin, Maiorana, Koester, Sheon, & Richards, 2003). These studies have focussed on 
identifying and describing the factors that impact HIV vaccine trial recruitment. Findings 
from these studies serve as the basis for adjustments to trial protocols to ensure that sufficient 
numbers of community members are recruited into trials to test candidate HIV vaccines. The 
available social science literature on HIV vaccine research has, therefore, tended to focus on 
the operational aspects of clinical trial implementation, framing the social issues that relate to 
lay community members’ participation in clinical trials as ethical issues (MacQueen, 2011).  
In spite of the recognition that achieving success in the HIV vaccine enterprise rests 
on community support, buy-in, partnership, collaboration and the participation of all 
stakeholder groups (Newman et al., 2015), the issue of community engagement in HIV 
vaccine research has received scant attention. Various authors call for the active participation 
of local communities in HIV vaccine research and point to investment in community 
engagement and recruitment as the key to achieving scientific goals (Frew, Archibald, 
Hixson, & del Rio, 2011; Lau, Swann & Singh et al., 2011; Newman, 2006). However, the 
complex local community environments in which clinical trials are conducted, the social 
processes and networks of relationships that operate in these contexts and the dynamics of 
community engagement in communities targeted for HIV vaccine trial participation, have not 
been prioritized as a research focus. Newman (2006) points out that much is invested in the 
biomedical, scientific and operational aspects of HIV vaccine development; yet crucial 
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processes of community engagement, upon which the successful development of a safe and 
efficacious HIV vaccine rests, tend to be approached in an ad hoc manner, and activities are 
left to trial and error approaches in the local community contexts in which they are 
conducted.   
Given the central role that local communities occupy in the HIV vaccine research 
enterprise, the dynamic features of the local social contexts in which such research is 
conducted, and the call to develop a “science of community engagement” (Newman, 2006, 
p.302), the purpose of this research was to examine community engagement as it is currently 
being practised at an HIV vaccine research centre, Research Centre X, in the Western Cape 
South Africa. The research examined the local community context of community engagement 
in HIV vaccine research (Slevin, Ukpong, & Heise, 2008) in one resource-poor community 
where the risk of HIV infection is high. My examination of community engagement and the 
dynamics of research participation at Research Centre X incorporates the perspectives of 
three key stakeholders who are involved in community engagement activities in this setting. 
The three key stakeholders involved are the community members who participate in the HIV 
vaccine research being conducted at Research Centre X, the community advisory board 
(CAB) members who represent the community and liaise and consult with research centre 
staff, and members of the Community Outreach Team at Research Centre X.   
Newman and colleagues (2015) argue that stakeholder engagement in HIV vaccine 
research is an ethical and scientific imperative. Writing from an international development 
perspective, Morgan (2001) further highlights the fact that community participation serves as 
an empowerment tool through which communities may take responsibility for and work to 
resolve threats to their well-being and development. Campbell and Murray (2004) echo this 
sentiment and support the notion that participation in interventions shape opportunities for 
health and well-being. In a context where HIV/AIDS risk is high and the local community 
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context presents numerous threats to participants’ well-being, this multiple perspective 
examination of community engagement in HIV vaccine research also aimed to investigate the 
potential that HIV vaccine research participation has as a vehicle for building community 
capacity, providing immediate benefits to those who participate in the research and leaving 
communities better off by virtue of their involvement in the research. 
I present an outline of the chapters in my dissertation below:  
Chapter 2 places the research in context by drawing on selected literature relating to 
HIV/AIDS prevention approaches and interventions, social science research on HIV vaccines 
and community engagement in scientific research.  
Chapter 3 positions this research on community engagement in HIV vaccine research in 
context. This chapter starts with my reflexive analysis in which I document the personal 
context that informs my research. In the remaining parts of this chapter, I discuss my 
perspective on what constitutes successful HIV vaccine research, meaningful participation in 
such research, and the role of community engagement in promoting both these aspects; and 
finally, I explain my use of the key concepts that form the conceptual foundation of my 
research.  
Chapter 4 outlines the rationale for the research and the research aims. I present the 
theoretical framework for the study, namely the community health psychology (CHP) 
paradigm. I also introduce the reader to the community mobilization approach with its three 
key contextual dimensions that I will use as the lens for interpreting and presenting the 
research findings.     
Chapter 5 outlines the procedure followed in the execution of the research. This chapter 
describes the research setting, outline the aims of the research and the qualitative research 
design used to address the research aims. The chapter also outlines the sampling, data 
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collection and data analysis procedures that I adopted, and the steps to ensure the ethical 
conduct of the research.  
Chapter 6 presents the findings of the research on the current practice of community 
engagement in the research studies conducted at Research Centre X. I integrate the discussion 
with the presentation of the findings and present the discussion in three parts. I use the three 
key dimensions of context, namely the symbolic, relational and material contexts, as outlined 
in Campbell and Cornish’s (2010, 2011) community mobilization approach, to describe the 
context and approaches that frame HVT participation and the implementation of community 
engagement processes at Research Centre X.  
Chapter 7 draws on key ideas on successful HIV vaccine research outlined in Chapter 3 to 
frame the conclusions on the current practice of community engagement at Research Centre 
X. In this chapter, I provide recommendations for creating an enabling environment for 
community engagement that generates immediate, direct benefit for both the local community 
and the HIV vaccine enterprise at Research Centre X. The chapter concludes with a 
discussion of the limitations and strengths of the research.   
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Chapter 2: Overview of the Literature 
 
2.1. HIV Prevention in Context 
2.1.1. Impact of the HIV pandemic in South Africa. 
In spite of large scale investment in HIV prevention, the number of new HIV infections 
continues to grow. Most new infections occur in generalized epidemics among heterosexuals 
in a few countries in southern and eastern Africa, including South Africa (Potts et al., 2008; 
Shelton, 2007). The HIV/AIDS pandemic has had a devastating impact on the South African 
population. A 2012 population-based survey recorded an HIV prevalence of 12.2% among 
the South African population (6.4 million HIV infected South Africans) (Shisana et al., 
2014). In addition, in 2012, a South African survey recorded 469 000 new HIV infections 
(Shisana et al., 2014).  
It is estimated that 15.9% of South Africans between the ages of 15-49 years are HIV 
infected (StatsSA, 2013), with females recording a significantly higher HIV prevalence than 
men (Ramjee & Daniels, 2013; Shisana et al., 2014). Groups at highest risk of becoming 
infected with the HI-virus in the South African population include Black African females in 
the 20-34 age range (31.6%) and Black African males in the 25-49 age range (Shisana et al., 
2014). These groups represent two high HIV risk groups who are targeted for their 
participation in biomedical HIV prevention research, including HIV vaccines.  
2.1.2. HIV/AIDS risk in social context. 
There is a strong link between HIV/AIDS and social inequality. It has been described as a 
socially patterned disease (Farmer, 1992) and follows the trend of most epidemics of deadly 
infectious diseases in that those at risk of becoming infected with the virus are the poorest, 
most vulnerable and marginalized members in a society (Merson et al., 2008). Warren (2005) 
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highlights the fact that the HIV/AIDS pandemic undermines local and global change, growth 
and development, and deepens the conditions of inequality that impact those living in 
poverty-stricken environments. HIV risk and vulnerability is, therefore, located within a 
complex web of social, economic, political and environmental conditions.  
In South Africa, the main routes for HIV transmission are heterosexual sex and 
mother-to-child transmission. Risk factors that contribute to the spread of the virus include 
behavioural, biological and structural risk factors. Behavioural risk factors include factors 
such as intergenerational sex, multiple concurrent partners, low condom use and excessive 
use of alcohol (Department of Health [DOH], 2012; Shisana et al., 2014). Biological risk 
factors, such as low rates of male circumcision and women’s increased risk of tissue injury 
during intercourse, also contribute to HIV risk (DOH, 2012; Ramjee & Daniels, 2013). 
Structural risk factors that contribute to HIV risk include high levels of poverty, low levels of 
education, health literacy and access to resources, HIV/AIDS-related stigma and 
discrimination, gender inequalities, mobility and migration (Harrison, Sullivan, Hoffman, 
Dolezal & Morrell, 2006; Kagee et al., 2011; MacQueen, 2011; Merson et al., 2008; Parker, 
Easton & Klein, 2000).  
In South Africa, delayed governmental responses and lack of political will to deal 
with HIV/AIDS has had an impact on the spread of the virus (Merson et al., 2008). AIDS 
denialism by prominent political leaders perpetuated conflicting messages and 
misunderstandings about HIV/AIDS (Kalichman, 2014; Rubincam, 2014). AIDS denialism 
has resulted in communities questioning the causes and transmission of HIV/AIDS and 
rejecting scientific evidence with respect to the prevention, diagnosis and treatment of 
HIV/AIDS (Kalichman, 2014; Nattrass, 2007; Rubincam, 2014). In addition, in Sub-Saharan 
Africa, alternative belief systems rooted in African traditional beliefs and explanations for 
HIV/AIDS that centre around racial themes and genocide also influences lay understandings 
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of the disease (Bogart, Kalichman, & Simbayi, 2008; Eriksson, Lindmark, Axemo, Haddad, 
& Ahlberg, 2013; McNeill, 2009). The most recent South African National Prevalence, 
Incidence and Behaviour Survey shows that knowledge of HIV transmission and prevention 
among South Africans is low, with only 26.8% of participants surveyed having accurate 
knowledge about the sexual transmission and prevention of HIV (Shisana et al., 2014).  
The features of individual behaviours and social contexts that drive HIV risk outlined 
above act as barriers to HIV prevention, contributing to the continued high HIV prevalence 
and incidence among high HIV risk groups in South Africa. These features also create the 
local community contexts in which HIV prevention interventions are implemented. 
Contextual factors create conflicting messages about HIV/AIDS and produce environments 
that inhibit the adoption of HIV health-protective behavioural practices. HIV prevention 
interventions that aim to reduce the spread of the HI-virus in settings where the risk of 
infection is high, must, therefore, consider these contextual challenges to HIV prevention.  
2.1.3. Sketching HIV prevention approaches. 
The HIV/AIDS pandemic plays itself out in complex and challenging environments. 
Intervention strategies that target HIV/AIDS prevention, treatment and care must be tailored 
to address the specific risk factors that act as barriers to HIV infection in any given context. 
Such intervention strategies must also consider the local realities and complexities that may 
affect HIV/AIDS interventions. The HIV prevention approaches that have been implemented 
to date include various strategies that range in focus from the individual to the community 
context as the target for change. These approaches have focussed on a range of different 
areas, namely traditional health education approaches, behaviour change approaches that 
draw on social cognition models, structural interventions targeting features of the social 
environment that fuel HIV risk and scientific research that focusses on developing biomedical 
HIV prevention technologies, such as HIV vaccines.  
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2.1.3.1. Behaviour change interventions. 
HIV prevention approaches in this category focus on the individual as the locus of change. 
Strategies that adopt individual level behaviour change approaches frame HIV/AIDS as a 
public health problem and emphasize interventions such as increasing knowledge about 
HIV/AIDS and promoting the adoption of safer sexual practices (Coates et al., 2008; Merson 
et al., 2008). These interventions are commonly grounded in social cognitive theories and are 
based on two key assumptions. First, they may assume that people engage in high-risk 
behaviours related to HIV due to a lack of knowledge about the virus, risk factors associated 
with HIV transmission and protective factors associated with reducing the risk of infection 
(Campbell & Cornish, 2010). Second, they may assume that interventions based on social 
cognitive models provide sufficient insight into how people assess their vulnerability to HIV 
infection and the costs and benefits associated with adopting health-protective behaviours as 
the basis for making rational choices in high-risk sexual encounters (Campbell & Cornish, 
2010; Roberts & Matthews, 2012). While there is evidence that behaviour change 
interventions have been effective in some settings, researchers point out that they have not 
fulfilled their promise of reducing the spread of the HI-virus (Coates et al., 2008; Kalichman, 
2008; Padian et al., 2011).  
Coates et al. (2008) point out that, when implemented on their own, behavioural HIV 
prevention interventions are necessary, but not sufficient to reduce the spread of HIV. Their 
limited success relates in part to the fact that they do not consider how social contexts 
characterized by a range of risks to HI-infection, enable or inhibit people from adopting and 
maintaining health protective behavioural practices (Campbell & Cornish, 2010). Effective 
HIV prevention must, therefore, be embedded in a nuanced understanding of the barriers to 
HIV prevention and base its strategies on an in-depth understanding of the socio-cultural 
context, life histories, beliefs, knowledge systems and understandings of HIV/AIDS that 
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constitute the local community contexts in which HIV prevention interventions are 
implemented (Roberts & Matthews, 2012).  
2.1.3.2. Structural and community mobilization interventions. 
According to Roberts and Matthews (2012), structural HIV prevention interventions 
challenge the notion that individuals are primarily responsible for becoming HIV infected. 
Structural interventions shift the target for intervention from the individual to the social 
context by intervening to address the social conditions that contribute to HIV infection. Such 
prevention interventions focus on the social, economic, political and environmental factors 
that increase vulnerability to HIV infection, for example gender inequalities, high levels of 
poverty (Gupta, Parkhurst, Ogden, Aggleton, & Mahal,2008; Merson et al., 2008; Roberts & 
Matthews, 2012). They seek to address and disrupt the root causes or structures that may 
impact individual risk and increase vulnerability to HIV infection (Gupta et al., 2008). 
Structural interventions take a bottom-up perspective and support the development of local 
innovation, increasing individual agency and power over the factors that contribute to HIV 
infection. Structural interventions offer individuals who may wish to make behavioural 
changes the possibility of adopting health-protective behaviours in contexts where such 
choices are constrained (Roberts & Matthews, 2012).  
Merson et al. (2008) argue that HIV prevention is fundamentally about transforming 
environments and structures. HIV prevention interventions that adopt a structural approach 
implement policies and programmes that aim to transform the environments in which people 
live. They implement community processes that act as catalysts for social and political 
change and reduce the vulnerability of individuals in high HIV risk settings (Gupta et al., 
2008). Structural interventions may use community mobilization approaches to achieve social 
change, incorporating strategies such as activism, education and awareness-raising, 
community mobilization and behaviour change into programmes that aim to reduce for 
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example gender-based inequalities or to shift social norms that impact the spread of HIV 
(Gupta et al., 2008; Merson et al., 2008; Piot, Bartos, Larson, Zewdie, & Mane, 2008). In 
spite of some successes, the structural intervention approach has been considered as too 
diffuse to warrant its use in the broader HIV prevention arena (Gupta et al., 2008). Critics of 
this approach argue that, with its focus on linking HIV risk to distal factors that are beyond 
the control of programme staff, it is hard to assess the impact of structural interventions to 
build an evidence base to support its use (Gupta et al., 2008).  
There is, however, some evidence for the utility of the structural intervention 
approach in building health-enabling social contexts (Campbell, 2003) that support people in 
adopting HIV-protective behavioural practices. In South Africa, a structural intervention 
approach was used to build AIDS competence in Entabeni, an isolated rural community with 
a high HIV prevalence (Campbell, Nair, & Maimane, 2007). A key strategy used in this 
intervention was working with local community members to identify obstacles to effective 
HIV/AIDS management in their community. The intervention also focussed on developing 
strategies that community members could use to support one another and that would make 
them more effective in accessing help and support from external groups. Another example of 
a structural HIV prevention intervention in the South African context is the Intervention with 
Microfinance for AIDS and Gender Equality (IMAGE) project that aimed to reduce gender-
based HIV vulnerabilities through a microfinance intervention (Pronynk, Hargreaves, & 
Morduch, 2007). This intervention enabled women to pursue small enterprises as a 
mechanism through which they could become financially independent. It also created 
opportunities for women to discuss and mobilize local action against intimate partner 
violence (Pronynk et al., 2007). While both these interventions used an empowerment 
approach to address the social drivers of HIV risk in the communities in which they were 
implemented, they had variable levels of success. In Entabeni, for example, the success of the 
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intervention was influenced by difficulties in building bridging partnerships between the local 
community and outside support agencies that would ensure access to resources and the 
sustainability of the community response to HIV/AIDS. In the IMAGE project, researchers 
believed that their intervention showed clear evidence of success from reports of a reduction 
in intimate partner violence due to women’s increased levels of agency in their intimate 
relationships (Kim et al., 2009).  
2.1.3.3. Biomedical HIV prevention technologies. 
The appeal of biomedical approaches to HIV prevention is their ability to offer immunity, 
permanent reductions in susceptibility and diminished infectiousness (Gwandure & 
Mayekiso, 2012). The most successful biomedical intervention for HIV prevention to date 
has been the use of Antiretroviral Therapy (ART) to prevent mother-to-child transmission of 
HIV (Kalichman, 2008; Merson et al., 2008). Building on this success, this area of HIV 
prevention strategies includes studies to develop microbicides and an HIV vaccine and 
studies that aim to reduce HIV infection susceptibility through strategies such as medical 
male circumcision and Pre-Exposure Prophylaxis (PrEP) for discordant couples (Gwandure 
& Mayekiso, 2012; Kurth et al., 2011; Padian et al. 2011). The effectiveness of medical male 
circumcision in reducing the risk of HIV acquisition in men has been shown in clinical 
research (Padian et al., 2011; Potts et al., 2008). While the development of a safe and 
efficacious HIV vaccine is a long-term endeavour, historically vaccines have been shown to 
be the best way to stop a virus (Bernstein, 2008). 
For biomedical HIV prevention interventions to be implemented, they have to be 
tested first for safety and efficacy and ultimately for effectiveness. Randomized clinical trials 
to test candidate products in community settings where HIV risk is high constitute the 
fundamental building blocks of research into such interventions. For ethical reasons, such 
trials have to incorporate a range of interventions that may reduce HIV risk in addition to 
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testing the efficacy of biomedical interventions. For example, while the end-point of a safe 
and efficacious HIV vaccine may be a long way off, clinical research to test candidate 
vaccines include features of other HIV prevention approaches, such as VCT services, sexual 
risk counselling, HIV/AIDS education and quality healthcare and screening services (Asiki et 
al., 2013; IAVI, 2009; Lesch et al., 2006; Newman et al., 2006; Ruzagira et al., 2009; Sahay 
et al., 2005, Smit et al., 2005; Voytek, Jones, & Metzger, 2011). HVTs also include 
community engagement as a key strategy for promoting the participation of community 
members in the research (UNAIDS-AVAC [United Nations Program on HIV/AIDS-AIDS 
Vaccine Advocacy Coalition], 2011). In high HIV risk, resource-poor settings, these trials 
offer community members who are targeted for their research participation with easy access 
to HIV prevention resources that enable them to stay HIV-free.  
2.1.3.4. Reframing HIV prevention – biomedical approaches in context. 
According to Piot et al. (2008), the HIV prevention arena has to come to terms with 
complexity. The available HIV prevention interventions have had a limited impact on 
stemming the tide of the epidemic due to their individualistic focus and the fact that those 
interventions that have sought to intervene at the level of the social context have been beset 
with difficulties. The dynamics of processes of social change and the constantly evolving 
social contexts in communities where HIV preventions interventions are implemented, create 
complex problems for researchers working towards the goal of preventing the spread HIV 
(Friedman et al., 2005). For such interventions to be effective, therefore, they must be 
embedded in an understanding of the social, economic, political and cultural factors that 
affect HIV transmission and influence responses to the threat of HIV in communities. 
Therefore, in-depth insight into the socio-cultural context, beliefs, knowledge systems and 
understanding of HIV/AIDS in the local communities in which HIV prevention interventions 
are implemented, is crucial.  
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Various authors have called for a renewed and revitalized movement for HIV 
prevention (Coates et al., 2008; Padian et al., 2011; Kurth et al., 2011). Reframing HIV 
prevention by adopting combination approaches that target multiple levels such as the 
individual, family, peer and community networks, and including both HIV infected and HIV 
negative individuals are considered to be crucial in reducing the spread of the virus (Coates et 
al., 2008; Kurth et al., 2011). Reframed HIV prevention approaches have a number of key 
features. First, reframed HIV prevention approaches leverage the successes of both biological 
and social interventions (Roberts & Matthews, 2012) and are based on in-depth knowledge of 
the dynamics of the epidemic in specific settings (Kurth et al., 2011). They create health-
enabling social contexts (Campbell, 2003) for HIV prevention by tailoring interventions to 
address the local realities that influence the spread of the virus, so that they enable individuals 
living in high-risk settings to adopt health protective behavioural practices. Second, reframed 
HIV prevention approaches move beyond a focus on stemming the tide of the disease to 
focussing on building community capacity. In high HIV risk settings, they build local skills 
and competencies, strengthening both individuals and the systems that they are part of, 
including families, groups and local communities. Finally, reframed HIV prevention 
approaches use participatory approaches and promote the participation of all relevant 
stakeholders as a crucial component in all phases of the intervention process (Friedman et al., 
2005).  
2.1.4. A key frontier in biomedical HIV Prevention – The development of an HIV 
vaccine. 
As stated above, HIV prevention requires a range of intervention strategies that target the 
multiple levels of risk factors that contribute to HIV risk (Kurth et al., 2011; Merson et al., 
2008). Biomedical HIV prevention interventions, such as HIV vaccines, form an integral part 
of interventions to prevent the spread of the HI-virus (Padian et al., 2011). As an HIV 
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prevention strategy, it is hoped that an HIV vaccine will form part of an integrated approach 
to HIV prevention that could potentially be combined with other partially protective 
biomedical strategies, such as male circumcision and behavioural, educational and structural 
HIV prevention strategies (Coates et al., 2008; Fuchs et al., 2010; Padian et al., 2011). 
Elements of a range of HIV prevention approaches are embedded in HIV vaccine research 
studies. Community members who participate in HVTs in high HIV risk settings have access 
to information and education about HIV/AIDS, VCT services, sexual risk monitoring and 
HIV vaccines and scientific research over the course of their involvement in the clinical 
research process.  
Across all levels of the HIV vaccine enterprise, the involvement of communities in 
which HIV prevalence is high in the research process is emphasized as crucial to the 
successful development of a safe and efficacious HIV vaccine (Lau, Swann & Singh, 2011; 
Wakefield, 2005). From the perspective of researchers and funders, communities form an 
integral part of the HIV vaccine enterprise, mediating their access to the dynamics of the 
local community context, providing input into study-related aspects to improve study 
recruitment, retention of participants and to ensure the ethical conduct of research in the local 
community context. The role of the local communities in which HIV vaccine research takes 
place is, therefore, clearly articulated and focussed on the ethical and operational aspects to 
ensure successful trial implementation. It is not clear, however, what direct benefits 
communities will derive from their involvement in the process. In spite of the substantial 
investment of resources into scientific experimentation to test candidate HIV vaccines in 
resource-poor, high HIV risk community contexts, the implicit assumption on which this 
research is based is that the development of a safe and efficacious HIV vaccine presents 
sufficient benefit to community stakeholders. This assumption requires disruption. Given the 
multiple risks to health and well-being that characterize the social contexts in which HVTs 
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take place, researchers and funders must work harder to integrate community capacity 
building agendas into clinical research, maximizing the utility of the available resources to 
generate short-term, mutual benefit for all stakeholders involved. Such integration reframes 
HVTs as a social good, advancing the agenda of the HIV vaccine enterprise and leaving local 
communities who host HVTs better off by virtue of their involvement in the process.  
2.1.4.1. HIV vaccines as HIV prevention. 
Vaccines are a powerful and effective public health tool (AVAC, 2013; Leach & Fairhead, 
2007). The evidence for the success of vaccines in halting deadly epidemics is well 
documented. For example, the development of vaccines that target polio, tetanus and measles 
have been instrumental in lowering the rates of these diseases worldwide (Arevshatian et al., 
2007). The timeline for developing vaccines, however, is lengthy, and attempts to develop an 
HIV vaccine have been ongoing since the early 1980s (Day & Kublin, 2014). Thirty years 
later, scientists have yet to achieve the goal of developing a vaccine that will prime the 
immune system to recognize and attack the HI-virus when it enters the body (AVAC, 2013; 
Kahn, 2005). In spite of the slow progress in developing an HIV vaccine, stakeholders in the 
HIV vaccine research enterprise continue to believe that a safe and efficacious HIV vaccine is 
within reach, and that such a vaccine offers the best chance of reversing and ultimately 
ending the HIV pandemic (AVAC, 2013; Kahn, 2005; Warren, 2005).  
Developing an HIV vaccine is a long-term endeavour that incorporates activities at 
many different levels. It includes animal laboratory studies, preparatory studies in 
communities that will be targeted for HVT participation, and randomized clinical trials to test 
the safety and efficacy of the candidate vaccines among target populations at risk of HIV 
infection (Day & Kublin, 2014; Manhart & Holmes, 2005). Clinical trials to test candidate 
preventive HIV vaccines in humans typically involve three phases. With each phase of the 
clinical trial process, larger numbers of volunteers are enrolled and different aspects related to 
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developing a safe and efficacious HIV vaccine are considered (Collins, 2005). In Phase I 
clinical trials, 40 to 120 volunteers at low risk of HIV infection are recruited to participate in 
trials that aim to test if the vaccine is safe in humans (South African AIDS Vaccine Initiative 
[SAAVI], n.d.). Phase I trials last between 12 and 18 months. Phase II clinical trials enrol 
hundreds of participants with both high and low levels of risk for HIV infection (SAAVI, 
n.d.). These trials focus on testing the safety of the vaccine in a larger group of volunteers, 
with the main focus on assessing the ability of the vaccine to trigger an immune response in 
research participants who participate in Phase II clinical trials. Phase IIb, or proof or concept 
trials may follow Phase II trials and aim to generate preliminary evidence of efficacy in 
shorter, smaller and less costly trials (SAAVI, n.d.). The evidence generated by these trials 
assist researchers in deciding whether to test the candidate vaccine in a Phase III trial. Phase 
III trials are the final phase in the process of testing a candidate HIV vaccine and focus on 
efficacy, in other words assessing whether the vaccine being tested protects people against 
HIV infection (Collins, 2005; SAAVI, n.d). Phase III trials enrol several thousand volunteers 
who are at high risk of HIV infection and may take five to six years to complete (Collins, 
2005; SAAVI, n.d.).  
Mitchell Warren, an AIDS vaccine advocate and Executive Director of the AIDS 
Vaccine Advocacy Coalition (AVAC), believes that the pursuit of an HIV vaccine must not 
influence immediate responses to the HIV pandemic (Warren, 2005). He suggests that while 
HIV vaccine development is a long-term and ongoing endeavour, this goal must be pursued 
alongside the range of currently available HIV prevention strategies. Prevention, testing, 
treatment and trials must, therefore, occur simultaneously (Warren, 2005). HIV vaccine trials 
are conducted in communities where the risk of HIV infection is high and target HIV 
negative community members for their participation in the research (Lesch et al., 2009). As 
mentioned above, current HIV prevention strategies such as HIV/AIDS and HIV vaccine 
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education and awareness-raising, VCT, sexual risk counselling and monitoring, are key 
components of HIV vaccine research and are offered to community members who participate 
in HIV vaccine trials to test candidate HIV vaccines (Asiki et al., 2013; AVAC, 2009; IAVI, 
2009; Kirby, Laris, & Rolleri, 2007; Lesch et al., 2006; Newman et al., 2006; Ruzagira et al., 
2009; Sahay et al., 2005, Smit et al., 2005; Voytek et al., 2011). Therefore, while clinical 
trials to test candidate HIV vaccines are framed as scientific experiments, they also 
incorporate HIV prevention intervention components that may assist participants in 
remaining HIV-free over the course of the clinical trial.  
2.1.4.2. Making sense of the ‘social’ in HIV vaccine research. 
Given that Phase III clinical trials to test candidate HIV vaccines require large numbers of 
volunteers at high risk to participate in the clinical trial process. Mirroring HIV prevention 
research, the target populations for HIV vaccine research are groups that are at high risk of 
HIV infection globally (Smit et al., 2005; Voytek et al., 2011). These target populations 
represent marginalized and vulnerable groups and include men who have sex with men 
(MSM), injecting drug users (IDUs), sex workers, and heterosexual men and women in sub-
Saharan Africa (AVAC, 2013; Smit et al., 2005). In Sub-Saharan Africa, the HIV prevalence 
is highest in heterosexual men and women. HIV vaccine research in this setting has, 
therefore, focussed primarily on these sub-groups (Smit et al., 2005).  
In HVTs, the goal of developing a safe and efficacious HIV vaccine moves out of the 
laboratory and is transplanted into local community contexts in which the research takes 
place. HVTs bring the scientific process of experimentation into local community contexts in 
search of large numbers of volunteers at high risk of HIV infection to participate in clinical 
research. Given the pragmatic objective of enrolling large numbers of HIV negative 
volunteers at high risk of HIV infection (Ruzagira et al., 2009; Voytek et al., 2011), HIV 
vaccine research is conducted in communities characterized by socio-economic challenges, 
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which include poor living conditions, high rates of poverty, unemployment, high rates of 
violence, HIV/AIDS stigma, and lack of access to resources that promote health and well-
being and confer protection against HIV risk (AVAC, 2013; Smit et al., 2005; Voytek et al., 
2011). These characteristics represent the lived realities of individuals who reside in these 
communities and these realities increase their vulnerability to HIV infection and other poor 
health outcomes (AVAC, 2013; Smit et al., 2005; Voytek et al., 2011). HIV vaccine research 
is, therefore, conducted at the confluence of key issues relating to its associations with a 
highly stigmatized disease, such as HIV/AIDS; the dynamics of community members’ 
research participation in resource poor contexts; and concerns about the exploitation and 
harm of vulnerable populations being targeted for their participation in and support of HIV 
vaccine research (MacQueen, 2011). Engaging with and understanding the dynamic features 
of participants, their social networks and the community contexts in which HVTs are being 
conducted, is crucial for the successful conduct of HIV vaccine research.  
HIV vaccine trials require long-term retention of participants and place many 
demands on trial participants (Smit et al., 2006). Community members who opt to participate 
in such trials are required to test for HIV and to submit to various screening procedures to 
assess their eligibility to participate in HIV vaccine trials. Once potential participants meet 
the criteria for trial inclusion, they are required to make multiple visits to the HVT research 
centres, test for HIV antibodies at each visit, subject themselves to questions about the most 
intimate and personal aspects of their sexual behaviours, have blood drawn, participate in 
educational sessions about HIV/AIDS and HIV vaccines, and adopt or maintain safe sexual 
practices (Highleyman, 2005).  
HIV vaccine research involves multiple stakeholders in the search for a safe and 
efficacious HIV vaccine. Collaboration and partnership between global and local 
stakeholders is presented as the crucial foundation of the HIV vaccine research enterprise 
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(Lau, Swann & Singh, 2011). Stakeholders involved in the HIV vaccine research enterprise 
include biomedical scientists from multiple scientific disciplinary groups, clinical trial 
scientists, clinical trial site staff, global not-for-profit organizations and clinical trial networks 
that support and advocate for the conduct of HIV vaccine research globally, pharmaceutical 
companies that fund HIV vaccine science and clinical trials (MacQueen, 2011; Newman et 
al., 2015; UNAIDS-AVAC, 2011), behavioural and social scientists, individual participants, 
local communities in which HIV vaccine research is conducted and their Community 
Advisory Boards (CABs) (Lau, Swann & Singh et al., 2011; MacQueen, 2011).  
While all stakeholders involved in the HIV vaccine research enterprise share a 
common goal, for instance a safe and efficacious HIV vaccine, each of these parties enter the 
HIV vaccine enterprise with their own vision for the vaccine development process 
(Wakefield, 2005). The HIV vaccine enterprise is, therefore, made up of a network of 
complex partnerships (MacQueen, 2011) as each stakeholder group brings their own needs, 
values, agendas and desired outcomes to the process. In addition, each stakeholder group has 
differential access to resources, power and control over the HIV vaccine development process 
(MacQueen, 2011; Petryna, 2009). These differences underpin the relationships between 
stakeholders, shaping and influencing the HIV vaccine development process. Promoting 
common understanding and goals in the HIV vaccine development process as the foundation 
for building collaborative partnerships among individuals and groups with varying needs, 
presents a challenge to researchers. This challenge has spawned a substantial body of social 
science research that aims to examine the social and human dimensions of HIV vaccine 
research. Such social science research is framed as ethical and scientific (MacQueen, 2011) 
and as a consequence of this framing, the priority areas promoted for social science research 
on HIV vaccines are those that will inform the operational aspects of trial conduct and trial-
related activities (MacQueen, 2011; Lau, Swann & Singh et al., 2011; Newman et al., 2015). 
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As stated above, a substantial amount of social science research has been conducted to 
explore the various socio-behavioural dimensions considered to be crucial to the successful 
implementation of HVTs. These research studies have been conducted in the context of 
community preparedness and HVTs to understand the settings and populations in which trials 
are being conducted, and research aimed at generating solutions to ethical problems and 
challenges encountered when conducting research in local communities, such as how to deal 
with informed consent in various settings. It also endeavoured to address pragmatic 
operational concerns of trial site researchers, like how to promote the participation of large 
numbers of individuals in HVTs and retain them over the lifespan of the trial (Lau, Swann & 
Singh et al., 2011; Ruzagira et al., 2009). Other areas of focus have included documenting the 
social impact of trials on participants (Allen & Lau, 2008; Fuchs et al., 2007), monitoring the 
sexual risk behaviours of trial participants (Bartholow et al., 2005; Gray et al., 2013) and 
examining the acceptability and uptake of future HIV vaccines in various populations (e.g., 
Newman et al., 2009; Sayles, MacPhail, Newman, & Cunningham, 2009). Given that this 
research explores community engagement as a vehicle for promoting the participation of 
community members in HIV vaccine research, I focus my discussion of the available social 
science research on HIV vaccines on two key areas relevant to this focus, namely 
understanding participation in HIV vaccine trials and guidance for promoting community 
engagement in HIV vaccine research.  
2.1.4.3. Understanding participation in HIV vaccine trials. 
 The largest proportion of social science studies on HVTs focus on the factors that 
influence willingness to participate in HIV vaccine research (WTP). The purpose of these 
studies is to identify barriers and facilitators to participation in HVT research that can be 
addressed through intervention to increase the numbers of community members willing to 
participate in HIV vaccine research. Studies on WTP focus on three key areas. First, 
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documenting WTP by describing factors that influence it in various high HIV risk 
populations, and across various setting in which HVTs are conducted. This area of research 
has generated a substantial body of evidence on factors that influence WTP in HVTs among 
various high HIV risk target groups, for instance African American women (e.g., Voytek et 
al., 2011) and ethnic minority communities in the United States of America (USA) (Newman 
et al., 2006); sexually transmitted infection (STI) and reproductive tract infection clinic 
attendees in India (Sahay et al., 2005); heterosexual adults and adolescents in South Africa 
(e.g., Gray et al., 2013; Jaspan et al., 2011; Lesch et al., 2006; Smit et al., 2006); heterosexual 
adults from a community-based cohort in Uganda (e.g., Ruzagira et al., 2009) and fishing 
communities in Uganda (e.g., Asiki et al., 2013); and participants at two HIV vaccine 
research centres in Kenya (Nyblade et al., 2011). Consolidating the findings from these 
studies, there are number of reviews that have drawn together evidence on barriers and 
facilitators to HVT participation across a range of different HVT settings (e.g., Dhalla & 
Poole, 2011; Mills et al. 2004; Rosenblatt & Dorsen, 2011; Smit et al., 2005).  
The second key area relates to studies that have examined the role of knowledge of 
HIV/AIDS and HIV vaccines on WTP in Uganda (Kiwanuka et al., 2004) and the USA 
(Lally et al., 2014). Contributing to this area, Lindegger et al. (2006) explored the 
effectiveness of assessing understanding of HIV vaccine research using four different 
measures. These studies examine the impact of knowledge on WTP as both an operational 
and ethical imperative to assess “good enough understanding for trial participation” (p. 562, 
Lindegger et al., 2006), among other things, as the basis of informed decision-making about 
trial participation. The final area of social science research on HVTs that explores issues 
relating to WTP examines the social impact of research participation on HVT participants in 
the local community settings where such research is conducted (e.g., Allen & Lau, 2008; 
Newman et al., 2011). These studies focus on identifying the social harms that HVT 
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participants may experience by virtue of trial participation with a view to developing 
mechanisms of support.  
The social science research on HIV vaccines, as has been highlighted above, is 
limited in its focus on generating findings that can be utilized to improve the operational and 
ethical aspect of clinical trials. While framed as socio-behavioural research using social 
science methods, this body of research may be viewed as operational research in its emphasis 
on generating findings that may inform clinical trial implementation. In addition, while 
studies on the socio-behavioural aspects of HIV vaccine research have used both quantitative 
and qualitative methods to document the factors that inhibit or facilitate the participation in 
HVTs, they have failed to harness the potential of the latter. Findings from these studies are 
presented in a manner that compares findings across various populations and settings, 
highlighting similarities and documenting differences as new and unique findings. They fail 
to move beyond this tendency to describe and compare to explore in-depth the dynamics of 
local communities that host clinical trials, the networks of relationships that influence WTP 
and other key trial-related activities, and the experiences of those who participate in HIV 
vaccine research in local communities.  
To conclude, the available social science literature on HIV vaccine research is limited 
in its ability to inform an in-depth exploration of the dynamics of HVT participation and 
community engagement processes. It is, however, important to document the salient findings 
of this research as it forms the starting point for my examination of community engagement 
in HIV vaccine research at the local community level. In presenting findings on the factors 
that influence WTP in HIV vaccine research from the available literature, I draw on the 
framework outlined, by my colleagues and I, in previous research examining the enablers and 
inhibitors to participation in HIV vaccine trials among HVT site community members at 
three potential SAAVI HIV vaccine trial sites (Lesch et al., 2006). Following this framework, 
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I discuss the enablers and inhibitors to HIV vaccine trial participation identified at three 
levels, namely the individual and family level, the community level, and the societal level.  
2.1.4.4. Inhibitors to HIV vaccine trial participation. 
2.1.4.4.1. Individual level and family level. 
Participants’ concerns about personal or individual risks associated with HIV vaccine trial 
participation have been found to be the most prevalent inhibitor to HIV vaccine trial 
participation. Individual level inhibitors to HVT participation include self-perception of HIV 
risk, concerns about trial-related procedures, fears relating to the safety of the candidate 
vaccines being tested and side effects associated with receipt of candidate vaccines, fears of 
becoming infected with the HI-virus, fears of being assumed to be HIV infected, and 
pragmatic obstacles that may accompany HVT participation.  
Participants’ assessment of their own risk for becoming infected with the HI-virus has 
been shown to act as an inhibitor to HVT participation in a number of studies. In Newman et 
al.’s (2006) study in the USA, Latina women reported their belief that Latino men would not 
participate in HIV vaccine trials due to their low perceived risk of HIV infection. They 
reported that “men ignore the problem” (p. 214). In Uganda, Ruzagira et al. (2009) reported 
similar findings with respect to the relationship between low perceived HIV risk behaviour 
and WTP in HIV vaccine research.  
Concerns about trial methodology and trial-related procedures have also been cited as 
an inhibitor to WTP in HIV vaccine trials (Mills et al., 2004). Participants in various studies 
report fears of being randomized to the placebo arm of the trial, indicating that they would 
participate if they were assured that they would be receiving the candidate vaccine being 
tested (Newman et al., 2006; Ruzagira et al., 2009). Additional trial procedures such as the 
frequent and largevolume blood draws (Asiki et al., 2013; Jaspan et al., 2006; Ruzagira et al., 
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2009), aversion to needles, receiving injections and suspicions about the use of disposable 
syringes (Newman et al., 2006; Sahay et al., 2005; Voytek et al., 2011) and fears of HIV 
testing (Lesch et al., 2006) have also been reported to act as inhibitors to HVT participation. 
Participants in Uganda and Kenya also reported concerns about the requirement that they 
should delay pregnancy if they were to participate in an HIV vaccine clinical trial (Asiki et 
al., 2013; Ruzagira et al., 2009).  
Participants’ vaccine-related fears act as an inhibitor to HIV vaccine trial 
participation. This category of fears relates to their concerns about the safety and efficacy of 
the candidate vaccine being tested (Asiki et al., 2013; Dhalla & Poole, 2011; Ruzagira et al., 
2013; Sahay et al. 2005; Smit et al., 2005). Participants’ fear of experiencing potential 
adverse reactions and unknown side-effects are included as inhibitors to HVT participation in 
this category (Dhalla & Poole, 2011; Mills et al., 2004; Sahay et al., 2005; Smit et al., 2005). 
Potential side effects cited relate to the fears of physical harm and experiencing physical side 
effects, such as losing hair or damage to organs (Newman et al., 2006; Ruzagira et al., 2009), 
and fear of becoming infected with the HI-virus through receipt of the candidate vaccine 
(Lesch et al., 2006; Newman et al., 2006). Vaccine-induced seropositivity (VISP) has also 
been highlighted as an inhibitor to HIV vaccine trial participation (Dhalla & Poole, 2011; 
Newman et al., 2006). In this regard, participants in Newman et al.’s (2006) study reported 
that they would experience testing HIV infected as emotionally challenging. Behavioural 
disinhibition (Mills et al., 2004), and other unforeseen short- and long-term reactions that 
may have a significant impact on their future health and well-being have also been cited as 
feared side effects of HVT participation (Dhalla & Poole, 2011; Voytek et al., 2011).  
The final category of inhibitors to HVT participation at the individual/family level 
relates to pragmatic obstacles that participants encounter through their participation in HVTs. 
Participants in various studies mentioned concerns about the disruption and inconvenience 
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that HVT participation may cause in their daily lives in terms of time required, distances that 
they would have to travel to HVT sites, the logistics of trials and study demands, transport 
challenges and the monetary costs associated with HVT site visits (Asiki et al., 2013; Dhalla 
& Poole, 2011; Lesch et al., 2006; Newman et al., 2006; Voytek et al., 2011). In addition, 
participants also mentioned the personal limitations that HVT participation would impose on 
them as inhibitors to participation. In particular, issues such as relocation to other 
communities and the difficulties that this would pose for regular trial site visits; restrictions 
on travel and immigration; and other contingencies such as illness, being imprisoned and lack 
of a support network to assist with family and caregiving responsibilities, were cited as 
inhibitors to HVT participation (Dhalla & Poole, 2011; Jaspan et al., 2011; Newman et al., 
2006; Sahay et al., 2005). 
2.1.4.4.2. Community level. 
Inhibitors to HVT participation at the community level include mistrust of institutional 
stakeholders involved in HIV vaccine research, including researchers, research-related 
procedures, and fears of experiencing HVT-related discrimination or social harms.  
Mistrust of institutional stakeholders including researchers, governments, government 
sponsored research, research-related procedures and pharmaceutical companies, has been 
highlighted as an inhibitor to HVT participation across different settings in which HVTs are 
being conducted (Lesch et al., 2006; Mills et al., 2004; Newman et al., 2006). Participants 
express concerns that researchers would exploit Black communities, expose participants to 
risk by testing untested vaccines and medicines in communities, and experiment on 
participants without their consent (Lesch et al., 2006; Newman et al., 2006). They also 
express scepticism and concerns about whether candidate vaccines may cause HIV infection 
in trial participations. Participants mention historical incidences of abuse of vulnerable Black 
communities, such as the Philadelphia prison experiments (Voytek et al., 2011) and fatalities 
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in previous medical research (Lesch et. al, 2006). As an extension of the notion of 
exploitation, community members also report concerns about being treated like guinea pigs 
by HVT researchers (Allen & Lau, 2008; Mills et al., 2004; Newman et al., 2006; Voytek et 
al., 2011), articulating these concerns as concerns about being treated like a “lab rat”, “test 
dummy” and “research monkey” (p. 6132, Voytek et al., 2011).  
The primary community level barrier to HVT participation relates to HVT-related 
discrimination. HIV/AIDS is highly stigmatized in the communities in which HVTs are 
conducted. In these communities, HIV infected individuals and those associated with them 
are avoided by others. Potential HVT participants, therefore, express concerns about being 
stigmatized, discriminated against and avoided by virtue of their HVT participation because 
of its association with HIV/AIDS (Lesch et al., 2006; Mills et al., 2004; Nyblade et al., 2011; 
Smit et al., 2005). This discrimination may impact the daily lives of participants and their 
interactions with their partners, families, neighbours and the wider community. In Kenya, 
research participants reported fears of being subjected to gossip, finger pointing, and 
experiencing physical and social isolation (Nyblade et al., 2011). Research participants report 
that HVT participation may lead to them being stigmatized in their communities and may 
cause conflict and negative reactions in their spousal, family and peer relationships (Allen & 
Lau, 2008; Dhalla & Poole, 2011; Lesch et al., 2006; Newman et al., 2006). Related to the 
fear of being discriminated against by virtue of HVT participation, participants also fear 
disclosure of their involvement in HIV/AIDS-related research (Nyblade et al., 2011).  
In terms of the assumption that research volunteers are HIV infected, participants in 
Kenya report that their friends, family and community members may assume that 
participating in an HIV vaccine trial serves as confirmation of a positive HIV status (Nyblade 
et al., 2011). This finding is echoed across other HVT settings, where study volunteers have 
reported that fears of being mistakenly presumed to be HIV infected by virtue of HVT 
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participation, and being stigmatized and discriminated against for this reason, acts as an 
inhibitor to participation (Lesch et al., 2006; Mills et al., 2004; Sahay et al., 2005). 
Participants in Nyblade et al.’s (2011) study further report that the presumption of HIV 
infection is related to community members’ misperception that HVT participants are injected 
with the HI-virus. Being presumed as being HIV infected by virtue of HVT participation may 
impact participants’ relationships with others, as others may fear contracting HIV through 
contact with the HVT participant and avoid sexual contact with him/her (Dhalla & Poole, 
2011; Mills et al., 2004). The stigma and discrimination reported to exist in various HVT 
settings is perceived to be largely a result of community members’ lack of knowledge about 
HIV/AIDS and HIV vaccines (Lesch et al., 2006; Sahay et al. 2005).  
2.1.4.4.3. Societal level. 
At the societal level, patriarchal systems that structure relations in many HVT settings have 
been identified as an inhibitor to HVT participation. Women in Sahay et al.’s (2005) Indian 
study reported their belief that men should be offered the vaccine first and that men should 
make decisions about HVT participation on behalf of their spouses. This finding is mirrored 
in Asiki et al.’s (2013) study in Uganda where participants reported that community or 
religious leaders and spouses, particularly husbands, should be consulted before decisions 
about HVT participation are made. In South Africa, female participants reported that they 
would need to obtain permission from their boyfriends or husbands before agreeing to 
participate in HVTs (Lesch et al., 2006). Participants in this study also supported the role of 
the family in decision-making about HVT participation, reporting that they would have to 
convince their families to accept their decision to participate in such research (Lesch et al., 
2006).  
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2.1.4.5. Enablers to HIV vaccine trial participation. 
2.1.4.5.1. Individual level and family level. 
At the individual level, altruism has consistently been identified as an enabler to HVT 
participation. Motives such as contributing to ending the HIV/AIDS pandemic and 
participating in HVTs to help others, has been cited by participants in USA, India, Uganda 
and South Africa as enablers to their participation in HVTs (Asiki et al., 2013; Jaspan et al., 
2006; Lesch et al., 2006; Newman et al., 2006, 2012; Sahay et al., 2005; Voytek et al., 2011).  
The need for protection from becoming infected with the HI-virus has also been cited 
as an enabler for HVT participation in HVT settings where the risk of infection is high. 
Participants cite benefits such as improved quality of life, gaining extra protection from HIV 
infection and opportunities to live a better life as promoting their WTP in HVTs (Asiki et al., 
2013; Lesch et al., 2006; Newman et al., 2006, 2012; Ruzagira et al., 2009).  
Access to the incentives associated with HVT participation has also been identified as 
an enabler to WTP. Research participants across a range of studies identified financial 
compensation as an enabler to WTP (Lesch et al., 2006; Newman et al., 2006; Sahay et al., 
2005; Voytek et al., 2011). In some settings, the financial incentive paid to research 
participants was viewed as an alternative to other income generating activities in 
impoverished neighbourhoods. Therefore, for participants in these studies, the financial 
compensation become salient, coercing them into participation and overshadowing the 
scientific issues related to HVTs (Lesch et al., 2006; Voytek et al., 2011). Access to other 
material benefits associated with HVTs have also been identified as enablers. These material 
benefits include receiving free, quality medical care at HVT clinics, access to confidential 
HIV counselling and testing services, and receiving medical and life insurance (Asiki et al., 
2013; Lesch et al., 2006; Newman et al., 2006; Ruzagira et al., 2009; Sahay et al., 2005, Smit 
et al., 2005). The opportunity to access health and HIV/ AIDS information and education and 
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having supportive persons to talk to is also associated with reported WTP (Asiki et al., 2013; 
Voytek et al., 2011).  
Self-perception of risk acts as an enabler to WTP at the individual level. Jaspan et al. 
(2006) found that adolescents who reported being sexually active indicated higher levels of 
WTP than those who are not sexually active. In addition, participants in Voytek et al.’s 
(2011) study reported that HVT participation would prompt them to change current risk 
behaviours that increase their susceptibility to HIV infection.  
Awareness of current HIV vaccine development efforts and knowledge of HIV 
vaccines have also been found to promote WTP (Kiwanuka et al., 2004; Sahay et al., 2005; 
Smit et al., 2005). However, the link between knowledge about HIV/AIDS and HIV vaccines 
and WTP has not been consistent across studies examining this relationship. Evidence 
suggests that increasing levels of information and education may in fact reduce WTP (Smit et 
al., 2005).  
Finally, at the family level, positive family reactions towards HVT participation has 
been cited as a factor that may enhance the likelihood of trial participation. Participants point 
out, however, that support from their families would depend on the level of HIV vaccine 
research information that their families have access to (Lesch et al., 2006).  
2.1.4.5.2. Community level. 
At the community level, the high salience of the HIV/AIDS pandemic in communities where 
HVTs are being conducted acts as an enabler to WTP. In South Africa, participants point out 
that HIV/AIDS is highly visible in their communities, among friends and families who are 
HIV infected (Lesch et al., 2006). In addition, they highlight that offering different levels of 
participation in HVTs by involving HIV infected community members as advocates for HVT 
participation, would increase the likelihood that people would participate in the research 
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(Lesch et al., 2006). The visibility of prominent community members’ involvement in HVTs 
would also serve as an enabler to WTP. Finally, in India, Sahay and colleagues (2005) found 
that participants who understand their own stake in the HIV vaccine development process 
would be more likely to participate in such research.  
2.1.5. Community engagement in HIV vaccine research: Science, citizens and 
HIV/AIDS. 
This research focusses on the process of community engagement that promotes the 
participation of local communities in HVTs conducted in resource-poor environments. My 
examination focusses on the current community engagement practices at one HIV vaccine 
research centre in the Western Cape, Research Centre X. As outlined above, HVTs take place 
in complex social environments where levels of poverty, unemployment, violence, and 
HIV/AIDS are high; and access to resources that promote health and well-being are low 
(Lesch, Singh, Kafaar, Swartz & Menezes, 2013). When HIV vaccine research moves into 
such local community contexts, it brings with it a range of resources beneficial to 
communities. Community members’ participation in HIV vaccine research mediates their 
access to these resources as it provides the context in which all trial-related activities take 
place, including HIV/AIDS and HIV vaccine education and awareness-raising, trial 
recruitment, and community consultation and representation. HIV vaccine research involves 
multiple stakeholders with differing interests, needs, priorities and viewpoints. Therefore, 
while securing the buy-in, support and participation of communities in HVTs through the 
community engagement process is emphasized as a key ethical, scientific and operational 
imperative (Frew et al., 2011). At the coalface of clinical trial implementation, achieving 
authentic, meaningful community engagement that is mutually beneficial, is challenging.  
  




2.1.5.1. Challenges to community engagement in HIV vaccine research. 
Promoting the participation of local communities in HIV vaccine research is a complex 
example of relatively higher risk involvement of communities in clinical trials. The higher 
level of risk associated with HVT participation results from the various risk factors that fuel 
HIV risk in the contexts in which HVTs are conducted. These risk factors increase the 
vulnerability of local community members to co-option and exploitation within the HVT 
process. Community engagement, the mechanism by which local communities are involved 
in the research process, is conducted against the backdrop of such complexities, presenting 
researchers with the challenge of developing strategies to overcome these challenges through 
their community engagement processes.  
Firstly, HIV vaccine research is conducted in communities where concerns about 
ethical violations and the exploitation of vulnerable communities are salient (Freimuth, 
Cole& Kirby, 2001; MacQueen, 2011). Public mistrust of scientists and researchers has been 
well documented as a consequence of the chequered history of the clinical trial enterprise 
(Emanuel et al., 2004). The most prominent of these clinical trials is the now infamous 
Tuskegee Syphilis clinical trial conducted to study the natural progression of untreated 
syphilis among rural African American men in the USA. The men who participated in this 
study were told that they were being treated for “bad blood” and, while they received free 
healthcare, meals and burial insurance, their diagnosis was never shared with them. In 
addition, they did not receive treatment for their disease after it was shown that penicillin is 
effective in treating the disease (Brandt, 1978). Another prominent case that of Henrietta 
Lacks: a poor, Black tobacco farmer, whose cells were taken without her knowledge and 
consent, after she presented for cancer treatment at Johns Hopkins Hospital in Baltimore 
during the early 1950’s. Her immortal cell line became known as HELA and has been 
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instrumental in developing some of the most important medical interventions available to 
date, including the polio vaccine, gene mapping and in vitro fertilization. In spite of Henrietta 
Lacks’ substantial contribution to biomedical innovation, her family were unaware that her 
cells had been taken and continued to live in impoverished conditions, unable to afford health 
insurance (Skloot, 2010).  
In Africa, controversies over the use of placebo in clinical trials to test the efficacy of 
short-course azido thymidinetreatment (AZT) to prevent perinatal HIV transmission, 
contributes to these debates about ethical violations in research among vulnerable, high risk 
populations (Petryna, 2009). The development of biomedical HIV prevention technologies, 
events such as the Ushercell microbicide controversy (Honey, 2007) and the halted 
STEP/Phambili HIV vaccine trial (Fuchs et al., 2010; Ruzagira et al., 2009) has sharply 
brought into focus the challenges encountered when involving communities in the 
experimental process. The phase IIb Phambili trial (a companion to the STEP trial) conducted 
among heterosexual adults across five HIV vaccine trial sites in South Africa, was halted 
after interim results from the STEP trial in the USA and Australia among 801 of a targeted 
3000 participants, showed that the vaccine probably did not confer protection against HIV 
infection, but was associated with possible increased risk of HIV acquisition (Fuchs et al., 
2010; IAVI, 2007; Lau, Stansbury, Gust, & Kafaar, 2009). While principal investigators at 
the sites where Phambili was conducted emphasized that volunteers’ safety was never in 
jeopardy, the halting and subsequent unbinding of volunteers in the trial has been considered 
controversial and has raised concerns about the research among community members 
(Newman et al., 2015). Lau and colleagues (2009) highlight the fact that such events may 
contribute to fear of HVT participation by community members. Alerting researchers to the 
fact that the manner in which they manage and communicate early trial cessations with 
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communities is crucial to establishing and maintaining trust with communities (Newman et 
al., 2015). 
Clinical trials are, therefore, embedded in histories of racism and social inequalities 
that gives rise to images of powerful scientists practising deception and compromising the 
safety of poor, vulnerable, Black communities in which the research is being conducted 
(Newman et al., 2015). Clinical trials that are perceived to violate participants’ rights and 
cause harm take place in global and local spheres. Their impact filters into local community 
members’ understandings and stories about clinical trials and clinical researchers’ co-option, 
trickery and exploitation of vulnerable communities. Overcoming the legacy of these stories 
that form the basis of mistrust of science, research and the clinical research process, 
represents a substantial barrier to researchers seeking to involve communities in HIV vaccine 
research (MacQueen, 2011).  
Secondly, the HIV vaccine development process is part of a global enterprise and 
involves the active participation of a broad range of stakeholder groups. Each of these groups 
have their own specific interests in and perspectives on clinical research that may diverge 
from each other (Baylies 2004; Kafaar et al., 2007, Lindegger et al., 2006). When viewed 
from the perspective of researchers and funders, clinical trials are experimental processes. 
From the perspective of individuals and communities who participate in clinical trials, these 
trials may be deeply personal experiences that may have a potentially enduring impact on 
their lives and their health. Such trials may also represent a means to access resources and 
strengthen the health of their communities (Wills & Tyeku, 2000). The differing notions of 
participation inherent in these perspectives present researchers with the challenge of creating 
partnerships with local communities and educating them about the scientific research process 
to facilitate informed participation in the research process.  
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The potentially diverging perspectives between researchers, individuals and 
community stakeholders are further affected by expectations that those who implement 
clinical trials in resource-poor communities should display a commitment to promoting the 
social good of communities and leave them better off as a result of their involvement in the 
clinical trial process (Petryna, 2009; Swartz & Kagee, 2006). Clinical trials draw on public 
resources, redistribute public health resources and are viewed by community members in 
contexts of poverty as having the potential to leave them better off (Petryna, 2009). Trial 
participation may, however, be accompanied by a substantial personal risk for participants 
due to the reported social stigma and other costs that HVT participants face, as highlighted 
above (Baylies, 2004; Buchbinder et al., 2004; Lesch et al., 2006; McCluskey, Alexander, 
Larkin, Murgula, & Wakefield, 2005; Milford, Barsdorf, & Kafaar, 2007). Therefore, on an 
individual level, limited benefits will necessarily accrue to those who participate in the 
clinical trials to test biomedical interventions. Balancing the individual good with the social 
good must, therefore, be a priority for clinical researchers (Kafaar et al., 2007).  
A third challenge in the HIV vaccine research process is the task of building public 
understanding of science by educating communities about HIV vaccine research. According 
to Lindegger et al. (2006), potential participants in HIV vaccine trials must understand a 
number of HIV vaccine and clinical trial methodological components before enrolling to 
participate in an HIV vaccine trial. Educating community members about these aspects of 
trial participation presents a significant challenge to researchers working in the field. There is 
at present limited research that indicates HVT participants’ levels of understanding of the key 
aspects of clinical trials and the scientific process (Lau, Swann & Singh et al., 2011). In 
addition, researchers in this area do not have any indication of what baseline levels of 
knowledge about science, research and HIV/AIDS exist in trial site communities upon which 
HIV vaccine education can be scaffolded.  
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Fourthly, HIV vaccine design is complex. A preventive vaccine does not have 
therapeutic value, but is designed to have a prophylactic effect. In addition, developing an 
HIV vaccine is complex from an immunological point of view: researchers have to consider 
issues such as side effects associated with receipt of a candidate vaccine (Buchbinder et al., 
2004) and the possibility that participants may become immune to future vaccines (Kerns, 
1997). Considering the challenges associated with local community members’ involvement in 
HIV vaccine research, the assumption that trial participation promotes community 
empowerment must, therefore, be interrogated as it does not take into account the 
complexities that accompany community members’ involvement in HIV vaccine research in 
resource-poor, high HIV risk local community contexts (Swartz & Kagee, 2006).  
2.1.5.2. Frameworks for promoting community engagement in clinical 
research. 
The challenges to promoting the participation of local communities in HIV vaccine research 
highlighted above raise central questions about how researchers may intervene to address 
these challenges through community engagement processes that maximize community 
involvement in the HIV vaccine enterprise. Community engagement is a key component of 
HIV vaccine research and rests on the development of community-researcher partnerships to 
support the successful implementation of scientific research in community settings (Emanuel 
et al., 2004; UNAIDS-AVAC, 2011).  
This section outlines a few key contributions that underpin efforts to build 
community-researcher partnerships that expand the role of local community members in the 
process and through which all stakeholders involved in the process may derive mutual benefit 
through their involvement in the research.  
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The issue of public participation in science has received increased attention, 
particularly in pursuit of ensuring a fully informed research participant population that 
derives maximal benefit from the results of the research process (Leach, Scoones, & Wynne, 
2005). The scientific literature increasingly recognizes that research participants have much 
to contribute to the research enterprise. Acknowledging the contribution of research 
participants, researchers have suggested that communities in which research is being 
conducted can become co-owners of the research process through their involvement in the 
scientific process (Green & Mercer, 2001; UNAIDS, 2007). Promoting the role of local 
communities as co-owners of the research process rests on expanding their role and levels of 
involvement over the lifecycle of the research. From the co-ownership perspective, therefore, 
the role of the local community in research studies moves community members away from 
the role of subjects or consumers of research to one in which they are partners in the process, 
engaging in dynamic interactions with researchers throughout the lifecycle of the research.  
Calls for participant-centred scientific research build on the notion of local 
community members as co-owners of the research process (Aungst, Haas, Ommaya, & 
Green, 2003; Green & Mercer, 2001; UNAIDS-AVAC, 2011). Participant-centred scientific 
research adopts participatory research frameworks. In this context, participatory research 
frameworks are defined as the “systematic inquiry, with the collaboration of those affected by 
the issue being studied, for purposes of education and taking action or affecting change” 
(Green & Mercer, 2001, p. 1927). The local community members who participate in 
participant-centred scientific research includes all stakeholders who will use or benefit from 
the research findings and may include researchers, practitioners, agencies, their constituents 
and clients, and community residents (Green & Mercer, 2001). In terms of assessing whether 
participant-centred scientific research is truly participatory, Green and Mercer (2001) define 
the upper and lower bounds of participation as ranging from maximum to minimal 
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participation. At the lower bounds of participation, minimal participation denotes stakeholder 
involvement at the start of the study to assist in formulating the research questions; and at its 
end, to provide input into the interpretation and application of study findings. Maximum 
participation represents the upper bounds of participation and describes a situation in which 
all stakeholders are actively involved throughout all study stages.  
Other perspectives on scientific research that is participatory in nature and reframes 
the role of lay persons in the scientific process come from Callon (1999) and Nowotny, Scott 
and Gibbons (2001). Nowotny et al. (2001) argue that due to the socially embedded nature of 
scientific research, new spaces must be created for lay persons or non-scientists to be 
involved in the scientific process. Therefore, by creating new spaces for lay person 
involvement in science, the role of lay persons in the research is reframed as participants, 
rather than subjects, resulting in the production of more socially robust forms of knowledge 
through engagement in public spaces open to democratic forms of reasoning and decision-
making (Nowotny et al., 2001). Callon (1999) supports the notion of the co-creation of 
knowledge and considers the role of non-specialists/persons in knowledge production as 
crucial. He calls for a democratic process of knowledge co-production between scientists and 
non-scientists/lay people. For Callon (1999), the production of scientific knowledge involves 
a dynamic and constant process of interaction between lay persons and scientists, resulting in 
collective learning and the collective production and dissemination of knowledge and know-
how. While these ideas about participant-centred science, the use of participatory research 
frameworks and the democratic process of knowledge co-production between lay persons and 
scientist offer a useful starting point for reframing the role of local communities in the 
research process, they do not provide insight into the mechanisms by which the processes 
may be achieved. In addition, they do not provide clear guidelines or a conceptual framework 
that those working to engage local communities in the research process in this manner can 
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utilize to drive such processes of dynamic interaction and ongoing engagement between 
researchers and local communities that is mutually beneficial.  
Finally, community-based participatory research (CBPR) has much to offer in making 
communities active participants in the research process and generating research that will 
ultimately benefit them (Aungst et al., 2003; Minkler & Wallerstein, 2008). Such CBPR 
approaches view community participation as a social process based on the development of a 
democratic system in which members of the affected community are actively involved in 
decision-making, implementing the clinical trial, sharing responsibility for their own health 
problems and needs, and sharing the benefits of the trial (Frolich, 2007). The CBPR 
framework, therefore, offers one potential framework for implementing a co-production of 
knowledge process between researchers and communities, the democratization of the 
research process (Callon, 1999). Lau, Swann and Singh et al. (2011) support the use of CBPR 
frameworks for engaging and educating communities who are targeted for HIV vaccine 
participation, pointing out that CBPR techniques may facilitate the collection of important 
demographic and behavioural data and may also allow researchers to sharpen their focus 
when intervening to promote HVT participation.  
2.2. Promoting Community Engagement in HIV vaccine trials 
Building relationships with communities in which HIV vaccine research is being 
conducted and involving them in the research through community engagement processes, has 
been highlighted as crucial to finding a safe and efficacious HIV vaccine and for the 
dissemination of a future vaccine (Frew et al., 2008). From the perspective of HIV vaccine 
researchers and funders, promoting the participation of local communities in HIV vaccine 
research is, therefore, an ethical, scientific and pragmatic imperative for researchers 
conducting HVTs in communities (Newman et al., 2015). When compared to the literature on 
WTP and trial recruitment in HVT contexts, the issue of community engagement has not 
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been prioritized as a focus area for investigation in empirical research on the social and 
behavioural aspects of HVTs. This dearth of research on community engagement is 
incongruent with the emphasis on the crucial role that local communities are purported to 
play in the HIV vaccine research process.  
The available literature that directly addresses community engagement is reported in 
the form of concept papers and meeting reports (e.g., Lau, Swann & Singh, 2011; Lesch et 
al., 2013), research articles that report on multiple stakeholders’ perspectives on community 
engagement activities (e.g., Newman et al., 2015; Upton, 2011). There are also suggestions 
for meaningful community engagement that ensue from the findings of research articles that 
focus on understanding WTP and factors that impact trial implementation (e.g., Voytek et al., 
2011). There are also various sets of guidelines developed by organizations that fund and 
oversee the implementation of biomedical HIV prevention trials, for example the HIV 
Vaccine Trials Network (HVTN), SAAVI, UNAIDS, and AVAC. These guidelines outline 
systematic ways for engaging communities in biomedical HIV prevention trials. The most 
prominent of these sets of guidelines is the guidelines for the UNAIDS-AVAC Good 
Participatory Practice for Biomedical HIV Prevention Trials (GPP) (2011). It was designed to 
provide normative guidance on community engagement that regulates participatory practices 
in the same way as operational documents, such as the Good Clinical Practices Guidelines 
regulates operational aspects of trial implementation (HIV/AIDS Network Coordination 
[HANC], 2014).  
The available guidelines for community engagement and other literature in this area 
focusses on describing community engagement practices and developing guidelines that 
advise clinical trial staff on how to ensure the involvement of communities in the research 
process. In this way researchers can guarantee that their ethical and scientific objectives are 
met. Researchers seeking to conduct community engagement activities in the context of their 
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biomedical prevention trials, therefore, have access to a burgeoning body of literature that 
explores crucial components of successful trial implementation. This section examines the 
available literature that informs researchers’ attempts at “doing” community engagement in 
biomedical HIV prevention trials to explore key ideas about community engagement 
circulating in this area.  
Across the literature, community engagement is conceptualized as an ongoing process 
of multidirectional communication that enables sustained, collaborative partnerships between 
all stakeholders who are likely to participate in the research, to be affected by it or to 
influence its conduct (Frew et al., 2008; HPTN, n.d.; UNAIDS, 2007; UNAIDS-AVAC, 
2011). Community engagement processes involve a range of stakeholders, such as trial 
funders, sponsors and implementers, trial participants, their families and partners, local 
organizations, service providers and other community groups within the geographical area 
that constitutes the clinical trial location (Forbes, Sylla, & Yassky, 2008; UNAIDS-AVAC, 
2011). These stakeholder groups collaborate on all aspects of the trial, including design, 
development, implementation, monitoring and the distribution of the results of HIV 
prevention trials (UNAIDS-AVAC, 2011). The features of community engagement 
highlighted across these definitions include consultation, dialogue, partnership, mutual 
education and respect, and consensus building on all aspects of testing the potential 
biomedical HIV prevention technologies (Frew et al., 2008; Nakibinge et al., 2009; Tindana 
et al., 2007; UNAIDS-AVAC, 2011).  
2.2.1. Focus areas for achieving best practices in community engagement. 
The Good Participatory Practices (GPP) Guidelines for biomedical HIV prevention trials 
(UNAIDS-AVAC, 2011) outline a number of guiding principles that underpin community 
engagement in HIV prevention trials. The principles outlined are respect, mutual 
understanding, integrity, transparency, accountability and community stakeholder autonomy 
Stellenbosch University  https://scholar.sun.ac.za
44 
 
(UNAIDS-AVAC, 2011). Four common themes that encapsulate best practices for 
implementing community engagement activities in high risk communities targeted for 
participation in biomedical HIV prevention research, emerge from the various guidance 
documents available. These four themes are: identifying relevant community stakeholders; 
learning about the community; building partnerships, collaboration and dialogue with 
communities; and promoting the development of community capacity. In this section, I 
discuss three of these themes, reserving my discussion on identifying relevant community 
stakeholders and the conceptualization of community for Chapter 3.  
The guidelines recommend that clinical trial sites develop written community 
engagement plans that have an operational focus, outlining strategies, timelines, and the roles 
and responsibilities of various stakeholders in the research process for achieving the 
objectives of their work in the community in which they are conducting their research (Slevin 
et al., 2008; UNAIDS, 2011). Such written plans should incorporate the four main best 
practice community engagement themes, ensuring that trust is built and opportunities for 
ongoing dialogue and collaboration between researchers and trial site communities are 
maximized (HVTN, 2000). Community engagement plans should also outline different tools 
and mechanisms for implementing participatory strategies, for example community meetings, 
street theatre and other innovative approaches to engaging the community (Slevin et al., 
2008).  
2.2.1.1. Theme One: Learning about the community. 
In order to ensure successful trial implementation, researchers must understand the 
complexities of HIV/AIDS at the behavioural, community and societal levels (Lau, Swann & 
Singh et al., 2011; MacQueen et al., 2011). Understanding not only the science and theories 
that underpin research, but also exploring the practical realities of research involving high 
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risk populations is crucial to deepening community engagement activities that support access 
to target populations and clinical trial implementation (Lau, Swann & Singh, 2011).  
The GPP guidelines recommend that clinical trial researchers conduct formative research at 
the start of their research study (UNAIDS-AVAC, 2011). Understanding the dynamics of the 
local community context in which biomedical HIV prevention research is conducted and the 
characteristics of the community, is important in the initial phase of community engagement 
processes. Through the formative research process, researchers can build trust and lay the 
foundation for meaningful community engagement in HIV vaccine research. In addition, 
formative research enables researchers to gain in-depth knowledge of the local community; 
the local understanding of the HIV/AIDS epidemic; the prevailing socio-cultural norms, 
practices and power dynamics that structure relations in the community; local perceptions, 
communication and decision-making networks; and the history of research projects in the 
community that may influence community attitudes towards scientific research and 
researchers (UNAIDS-AVAC, 2011). Formative research should also document the needs 
and priorities of the local community, who are affected by and able to influence the HIV 
prevention trial. It is not clear how or whether these needs will be addressed over the course 
of the research and engagement process.  
Based on their study on WTP in the USA, Voytek and colleagues (2011) support the 
need for formative research as a mechanism for generating an in-depth understanding of the 
local community in which the research is being conducted. They highlight the fact that 
insight into the structural factors that influence personal agency and participants’ thought 
processes with respect to participation, is crucial to promoting community involvement in 
HIV vaccine trials. Frew et al. (2008) also highlight the importance of understanding the 
contextual dynamics of communities. They emphasize focussing on the dynamics of the 
community setting, the amount of HIV/AIDS and research information available in the 
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community, the level of competition between community organizations for public 
involvement, the personal challenges that target groups face, and their motivations for 
attending HIV vaccine-related events. They point out that understanding these aspects of the 
community context are important for cultivating and sustaining dialogue between researchers 
and the community as it builds trust, acceptance and confidence in the HIV vaccine trial site. 
The focus of these activities, however, continues to serve the agenda of the scientific 
enterprise, as they emphasize dialogue and relationship building as the foundation for 
securing community buy-in and recruitment onto HVTs.  
2.2.1.2. Theme Two: Building partnerships, collaboration and dialogue with 
communities. 
The basis of participatory community engagement is strong community-researcher 
partnerships. HIV vaccine trials are conducted in contexts dominated by disparities between 
various stakeholders. There are disparities in levels of literacy, education and access to 
resources between researchers, clinical trial site staff and the community members who 
participate in their research. In addition, clinical research represents the biomedicalization of 
disease, in other words the reconstitution and extension of medicalization through scientific 
research (Roberts & Matthews, 2012). The notion of the patient-provider relationship 
inherent to the biomedical framework is transferred into the clinical trial context, creating a 
power differential between clinical researchers and their research participants. HVTN (2000) 
points out that HIV vaccine research raises a number of behavioural, political, social, legal 
and psychological issues that may best be addressed by establishing active collaborations 
with community groups that can assist trial sites, their participants and the communities 
affected by the research in dealing with these issues. Constructive, long-term community-
researcher partnerships are crucial to addressing these power imbalances between 
communities and clinical trial researchers, ensuring community input and investment into the 
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research and generating community support for the research process (HANC, 2014; HVTN, 
2000; UNAIDS-AVAC, 2011). Community-researcher collaborations are also crucial for 
transforming the research into a shared activity that is mutually beneficial, leaving both 
communities and the scientific enterprise better off (HVTN, 2000).  
The guidelines emphasize the importance of developing partnerships with the local 
community in which the research is being conducted to ensure community participation in the 
research (Slevin et al., 2008; HVTN, 2000; UNAIDS, 2011). Such partnerships are the 
foundation for establishing networks of community-researcher communication and 
interaction and are promoted as the basis for achieving inclusive, authentic community 
engagement. The guidelines recommend that clinical trial researchers initiate participatory 
processes early on in their research to engage stakeholders across the breadth of the 
community and to continue this engagement across the lifespan of the trial (Newman et al., 
2015; UNAIDS-AVAC, 2011). Such relationships may be informal and/or formal, ongoing 
and substantive, and researchers are encouraged to plan for how they will work to nourish 
relationships with the community in which the research is being conducted (HVTN, 2000).  
The guidelines also promote the idea of shared ownership and equitable relationships 
between researchers and community stakeholders as the basis for community-researcher 
partnerships (UNAIDS-AVAC, 2011). According to these guidelines, shared ownership is 
achieved through collaboration, partnership and community mobilization. Shared ownership 
of the research holds mutual benefit for researchers and the community in which the research 
is being conducted. For researchers, shared ownership increases the likelihood of successful 
trial conduct, ensures better penetration of communities, more acceptable and culturally 
relevant messages that support trial completion, and improved application of research results 
(HANC, 2014; Newman et al., 2006). For communities, shared ownership of the research 
strengthens their stake in the research and promotes their capacity to articulate and address 
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their own development needs and future priorities through their involvement in the research 
process (Slevin et al., 2008). While it is not clear how shared ownership of research will be 
facilitated, the articulation of the benefit that local communities will derive from sharing 
ownership of the research process, represents a departure from the way in which communities 
have been positioned in the research process to date. This renewed perspective on the role of 
communities holds promise for community capacity-building and development agendas that 
may accompany HVT implementation.  
Another feature of community-researcher partnerships emphasized by the guidelines, 
is ensuring continuous, two-way information exchange and dialogue between the community 
and the research team during all phases of the research process (Slevin et al., 2008; UNAIDS-
AVAC, 2011). Establishing dialogue relates to the value of transparency and ensures open, 
honest, timely and clear communication between researchers and communities as the basis 
for transparent, constructive, collaborative and trusting relationships (UNAIDS-AVAC, 
2011). Researchers are, therefore, encouraged to establish mechanisms for promoting 
transparent and ongoing dialogue within trial site communities (Lau, Swann & Singh, 2011; 
Morin et al., 2003; Sahay at el., 2005). Lau, Swann and Singh (2011) expand on this call for 
dialogue between researchers and communities, suggesting that creating spaces for dialogue 
and two-way information sharing between researchers and trial site communities promote 
mutual learning, increasing scientists’ cultural competency and strengthening community 
members’ scientific competence.  
Community representation structures, such as CABs, act as the mediators between 
researchers and trial site communities. Establishing a CAB is a crucial task in the community 
engagement process. In the context of clinical research to test HIV prevention technologies, 
CABs represent the interests of communities in the research process and act as the link 
between researchers and the communities in which the research is being conducted. They 
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represent the community and its interests and act as advisors to the researchers, contributing 
their local knowledge about the community to inform ethical and trial implementation issues. 
CABs offer input into issues such as how to best achieve informed consent; developing 
effective recruitment and retention strategies and activities to promote community education; 
and awareness-raising about HIV/AIDs, HIV vaccines and scientific research (HVTN, 2000; 
Slevin et al., 2008; UNAIDS, 2011). They act as gatekeepers to the community and ensure 
that those affected by the research at the local community level have a channel through which 
to voice their needs and concerns and obtain information about the research (HANC, 2014). 
They also provide a forum through which communities can ask questions and have their 
questions addressed directly by the researchers. 
CABS include volunteers from a range of different perspectives and levels of 
community who have a vested interest in the research (HANC, 2014). CAB members may 
include volunteers from non-governmental organizations (NGOs), community-based 
organizations (CBOs), service and advocacy organizations operating in the community, 
political leaders and decision-makers who comprise a part of the larger community, local 
government officials, healthcare workers, HIV infected individuals, religious leaders, trial 
participants and their family members, and a range of other community groups (HANC, 
2014; Slevin et al., 2008).  
Choosing CAB representatives involves a complex set of recursive activities and 
researchers are challenged to include CAB representatives that are acceptable to the local 
community (Newman et al., 2015; Slevin et al., 2008). The CAB role is a political, advocacy, 
advisory and oversight one (Reddy, Buchanan, Sifunda, James, &Naidoo. 2010). CABS 
represent the interests of the community in the research process and ensure that community 
engagement is conducted in a culturally sensitive and locally responsive manner (Newman et 
al., 2015). Slevin et al. (2008) point out that defining the boundaries of exactly who must be 
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consulted to meet the evolving expectations of community and stakeholder engagement is 
challenging. In addition, Newman et al. (2015) highlight the fact that CAB members must be 
culturally accepted gatekeepers who understand the community’s culturally sanctioned 
communication networks.  
In liaising with CABs, clinical trial site staff must clearly outline the respective roles 
and responsibilities of each stakeholder involved (UNAIDS-AVAC, 2011). The value of 
accountability underpins the development of clear roles and responsibilities for clinical trial 
site staff and community representatives. With respect to accountability, the role of 
researchers is to be accountable to the community for conducting scientifically valid and 
ethical research, using participatory practices and responding to input from stakeholders as 
mutually agreed (UNAIDS-AVAC, 2011). Community stakeholders, on the other hand, are 
accountable for ensuring that they provide fair and constructive input into the research 
process (UNAIDS-AVAC, 2011). Such community input respects the scientific process and 
is in the best interest of the community stakeholders.  
2.2.1.2.1. How do CABs view their role in the process? 
A number of studies have highlighted the complexities and challenges inherent in the CAB 
role within the South African context. These studies have reflected on the role and functions 
of CABs in the research process and the challenges of occupying the role of mediator, acting 
as a conduit between researchers and the community in which the research is being 
conducted.  
In 2010, Reddy, Buchanan, Sifunda, James and Naidoo published the findings of their 
study, which examined the functions and operations of CABs in HIV vaccine trials in South 
Africa. They interviewed multiple stakeholders involved in HIV vaccine research at South 
African trial sites. Their study participants reported that the function of CABs is to protect 
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communities, to stop exploitation of communities by researchers and to ensure that research 
is beneficial to communities. CAB members who were interviewed as part of their study, 
reported that their role included protection and oversight, advancing research goals, providing 
information and liaising with their communities and serving as a buffer between researchers 
and the community. Researchers who participated in the study articulated their expectation 
that CAB members should play an active role in recruiting study participants and assisting 
with the timely completion of the research.  
The study highlighted a number of dilemmas associated with the involvement of 
CABs in HIV vaccine research (Reddy et al., 2010). First, researchers’ expectation that CAB 
members assist with recruitment caused dilemmas, especially in relation to CAB members 
who felt that their primary role related to oversight and ensuring that community interests are 
protected. Second, at the HVTs who formed part of the study, CABs were selected through 
purposeful selection and election processes. However, in reality CABs are often established 
through self-selection processes with organizations indicating an interest in being part of the 
CAB. In addition, CAB members reported that they are recruited by the HVTs. As a result, 
CAB members are dependent on the HVT for financial support and materials needed to 
conduct their activities in the community. They felt that this dependence on the HVT limited 
their autonomy and agency in executing their role as representatives for the community. 
Thirdly, CAB members indicated that they have limited influence on substantive decisions 
associated with the research projects and expressed a desire to have more substantive input 
into the research process. Due to the fact that CABs in South Africa are researcher-initiated 
and driven, rather than legislated by the health system, CABs have no authority or legal 
power and their role is limited to their input as advisor. Based on their findings, Reddy et al. 
(2010) concluded that HVTs should implement methods and structures that promote 
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authentic community participation, in an attempt to move beyond the current status of limited 
CAB involvement, which primarily revolves around consultation and placation.  
Upton’s (2011) research explored the extent to which CABs play a meaningful 
political role at South African HIV vaccine trial sites. Her research highlights the 
complexities of the global context in which health policies are made and the realities of the 
political avenues open to recipients of such policies. Participants in her study reported that 
interacting with HIV/AIDS information, vaccine science and networking with wider health 
and other community-based and civil society organizations, develops agency. Upton’s (2011) 
research shows that the reported ideals of community engagement are often challenged by the 
political dynamics of CABs. These political dynamics in which CABs functions are 
perceived to frustrate collective action, create intermittent contact between trial site 
researchers and CABS, and result in limited representation of heterogeneous communities in 
the research process.  
Based on document and guideline analysis and interviews with community outreach 
staff, Snyder’s (2011) study sought to examine how guidelines for ensuring representation in 
HIV prevention trial advisory groups are interpreted and implemented in practice. A related 
aim of her study was to assess the feasibility and acceptability of these guidelines from the 
perspective of those who implement them in HIV vaccine trial site communities in South 
Africa. Snyder’s (2011) study highlighted problems with defining community as the target 
population of HIV vaccine research. Participants in her study reported that using such a 
definition of community excludes certain groups. They suggested that participatory 
approaches should be used to establish who constitutes the community in the context of HIV 
vaccine research. In addition, they claimed that the manner in which individuals in the 
community identify and interact with one another is an important strategy for establishing 
how people relate to each other in HVT settings. Examining how community members 
Stellenbosch University  https://scholar.sun.ac.za
53 
 
identify and interact with one another may also highlight which groups within communities 
might be excluded from prevailing definitions of community. Based on these concerns, 
participants in this study advocated for the use of participatory techniques to recruit 
community representatives. They suggested that the use of snowballing techniques may hold 
promise for selecting representatives who possess characteristics that they consider key to 
committed CAB members. These characteristics include having peer leadership and interest 
in and commitment to HIV prevention research.  
2.2.1.3. Theme Three: Promoting the development of community capacity. 
The final theme highlighted in the guidance documents as key to ensuring best practices in 
community engagement relates to developing the capacity of HIV vaccine trial site 
communities (HANC, 2014; Slevin et al., 2008; UNAIDS, 2011). Building community 
capacity enables stakeholder autonomy, in other words the right of communities to support or 
refuse to conduct research in a particular area, based on the degree of alignment between the 
community and researchers’ needs and interests (UNAIDS-AVAC, 2011). Therefore, 
developing community capacity serves as the foundation for sharing ownership; equal, 
collaborative partnerships; and constructive dialogue between all stakeholders.  
Developing community capacity includes all activities that aim to educate 
communities and raise their awareness of HIV/AIDS, HIV vaccines and scientific research. 
These activities focus on building community stakeholder literacy and competencies to 
enable them to have greater input and a higher degree of participation in the research process. 
It also addresses the power imbalances between research teams and community stakeholders 
by creating a common understanding of the HVT process in the community setting 
(UNAIDS-AVAC, 2011). Building community competency, while assumed to be targeted at 
community members and their representatives, also includes clinical trial researchers 
(UNAIDS-AVAC, 2011). Building community capacity includes developing socio-cultural 
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competency in researchers and research competency of community members and their 
representatives.  
Socio-cultural competency refers to developing an understanding of socio-cultural 
issues such as norms, practices and beliefs operating in local communities and the social 
circumstances that may influence trial implementation (UNAIDS-AVAC, 2011). Research 
competency refers to enhancing community members and their representatives’ 
understanding of the concepts, purpose, practices, limitations and results of biomedical HIV 
prevention trials (UNAIDS-AVAC, 2011). Improving community stakeholders’ research 
competency enables and empowers them to provide meaningful input into the research 
process.  
Educational programmes to improve research competency target multiple levels of 
community, including community members, their families and peers and CAB members 
(Sahay et al., 2005; Voytek et al., 2011). Focus areas for community education include 
explaining trial-related concepts, such as randomization and placebo; translating such 
concepts into local languages and dealing with lexicon challenges; and addressing 
misconceptions about the research and researchers that hamper effective communication 
between stakeholders (Lesch et al., 2013; Newman et al., 2015; Sahay et al., 2005; Voytek et 
al., 2011). In addition, researchers also highlight a need for community education that 
addresses social harm concerns and community perceptions of risk. Some researchers have 
suggested that incorporating stigma reduction programmes into community education and 
awareness-raising activities, would serve to address community concerns, rumours and myths 
about HIV vaccine research (Kiwanuka et al., 2004; Nyblade et al., 2011).  
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2.2.1.4. The utility of community engagement guidelines in promoting 
meaningful community engagement. 
The available guidelines for community engagement in biomedical HIV prevention research, 
particularly the GPP guidelines (UNAIDS-AVAC, 2011), play a crucial role in the 
implementation of HVTs. In the HIV vaccine enterprise, they provide the blueprint for 
clinical trial site researchers with respect to promoting the participation of local communities 
in the clinical research process.  
Community engagement guidelines represent an operational manual, mechanistic in 
nature and outlining actions based on key ideas and strategies for involving communities in 
the research process. It represents a methodological tool in the design of randomized 
controlled trials. Further, the guidelines serve the agenda of the scientific enterprise, namely 
to promote community participation in the research as a mechanism to ensure successful 
clinical trial conduct. While guidelines outline various sets of principles and activities for 
engaging local communities in the process, the guidance focusses on the operational and 
ethical aspects of trial implementation, benefitting scientific agendas over those of the local 
community. Beyond the necessity for HIV prevention interventions to address high HIV risk 
in local community contexts, community needs and agendas are not integrated into the 
guidelines and the research process. The emphasis on partnership and collaboration with local 
communities, therefore, lacks authenticity, with partnership serving as a means to an end, the 
end being the development of a safe and efficacious HIV vaccine.  
The guidelines co-opt the language of community development and participatory 
health interventions, for example community competence, partnership etcetera into the 
clinical trial process. This language originates from a social justice orientation, concerned 
with addressing social inequalities and promoting access to the resources that promote health 
and well-being in settings where these are absent. The positioning of local communities as 
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resources to the HVT enterprise contradicts these social justice goals. It serves to perpetuate 
and reproduce power inequalities between communities and researchers, leaving little room 
for the co-production of knowledge (Callon, 1999) and continuing to relegate communities to 
the role of subjects in spite of the use of participatory language.  
In short, while the guidance on community engagement in biomedical HIV prevention 
represents a useful starting point, it leaves more questions than answers about how to achieve 
meaningful community engagement in HIV prevention trials. This limitation arises due to the 
lack of recognition that clinical trials are embedded in the social contexts in which they are 
conducted. Given this fact, approaches to community engagement must, therefore, move 
beyond operational plans to plans that view trials as social processes, located in social 
contexts and framed by the complexities and dynamics of relationships between various 
stakeholders in the local communities who host. Such exploration calls for the use of theories 
and models that can illuminate trials as social processes and that can fulfil the notions of true 
collaboration, partnership and community capacity-building as core components of trials. 
This will generate mutual benefit for all involved in the research process, changing the 
everyday realities of community members who participate in the research process.  
HIV vaccine research brings resources into resource-poor communities and offers 
researchers the opportunity to utilize their community engagement processes to generate 
meaningful roles for communities in the research process: legitimizing their research and 
constructing new identities for community members who are involved in the research 
process. The participatory science process through which scientific research is co-produced 
through community-researcher partnerships (UNAIDS-AVAC, 2011), offers the potential for 
creating HVTs as health enabling environments (Campbell, 2003). Transforming HVTs into 
health-enabling environments built on community-researcher partnerships holds much 
promise, with partnerships serving as the mechanism through which community capacity is 
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built. HVTs become a social good that offers direct benefit and access to resources that 
promote health and well-being to the local communities who act as clinical trial hosts. The 
next chapter explores an alternative set of conceptual tools that holds promise for 
transforming HVTs as health-enabling environments (Campbell, 2003).  
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Chapter 3: Contextualizing the Research 
 
The purpose of this chapter is to contextualize the research on community engagement in 
HIV vaccine research. The chapter is organized in three parts. Part 1 of the chapter sketches 
the personal context in which the research is positioned. It takes the form of my reflexive 
analysis, documenting my experiences and role as social science researcher in the HIV 
vaccine research community and how these experiences have shaped my interest in exploring 
community engagement in HIV vaccine research as the focus of my doctoral work. In Part 2 
of the chapter I discuss my perspective on what constitutes meaningful community 
participation in HIV vaccine research, successful HIV vaccine research and the role of 
community engagement in promoting both these aspects. Part 3 of the chapter discusses the 
key concepts that form the conceptual foundation of the research. I discuss the use of the term 
“community” in this research and my focus on the local community level of community 
engagement in HIV vaccine research. The final part of this chapter focusses on the use of the 
terms community participation, community engagement and community mobilization in the 
context of the research.   
3.1. Part 1: Sketching the personal context - Being a reflexive researcher in the HIV 
vaccine research enterprise 
In reflecting on my role in the research that I conducted, I follow the guidance of authors who 
suggest that the task of critical reflection is to make plain the researcher’s personal history, 
values, biases, social status, feeling, experiences, position and location in the study and their 
relationship with those being researched (Holloway & Bailey, 2011; Willig, 2010).  
My exploration of the social dimensions of HIV vaccine research started in 2005 
when I was offered a position as research intern with the Socio-Behavioural Working Group 
of SAAVI. The mandate of our group was to collaborate with HVT sites in South Africa to 
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build social science research capacity at their sites. I brought to this role my training in 
industrial, research and social psychology and a keen interest in conducting HIV/AIDS-
related research. At this stage of my academic career, my personal position on successful 
interventions to address social problems was that such attempts should focus on collaborating 
with those affected: creating space for them in the intervention, developing their skills and 
providing clear roles for those affected by the problem throughout the intervention process as 
experts on their own lived reality. I believed, and continue to believe, that interventions 
should change the lived reality of their beneficiaries. These foundational ideas have endured 
and continue to ground and direct my work. In the initial phase of my appointment with the 
Socio-Behavioural Working Group a few things happened that were instrumental in shaping 
my interest in exploring the dynamics of community engagement in HIV vaccine research.   
In the first couple of months in my new position, I visited Masikhulisane, the 
community involvement arm of SAAVI, to observe HIV vaccine awareness-raising and 
education workshops being conducted by their community educators. Community 
representatives from various community organizations, including NGOs, CBOs and 
governmental service delivery organizations in the areas being targeted for participation in 
HIV vaccine research, were invited to attend these workshops. The workshops were based on 
the premise that community representatives would share the information that they acquired 
during education sessions with their community constituents and through this information 
cascade, broader community awareness about HIV vaccine research would be promoted. I 
watched in fascination as Masikhulisane community educators made use of sophisticated 
PowerPoint slides to present information about HIV vaccine science, ethics in research and 
community involvement in HIV vaccine research to workshop participants. Their slides were 
tightly packed with information and diagrams and used academic language to explain 
complex ethical and scientific concepts. Community representatives sat passively, listening. 
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At the end of a day-long session, they completed a True or False format knowledge checklist 
to test their understanding of what they had learnt on that day. I was puzzled by the concept 
of an information cascade. I was curious to know what these community representatives, who 
brought varying levels of HIV/AIDS, science and research literacy to the process, would take 
away from such a technical and information-dense day to be shared with members of their 
communities.  
A year or so later, my colleagues and I travelled to various HIV vaccine research 
centres across the country to conduct focus groups with community members participating in 
HIV vaccine research. The purpose of our research was to explore the enablers and 
facilitators to trial participation. We encountered similar approaches to HIV vaccine 
education in these settings. Community educators lamented the fact that participants arrived 
with low levels of knowledge about HIV/AIDS on which they could scaffold their HIV 
vaccine education. They explained that they spend a substantial proportion of the time that 
they had in their workshops on providing basic HIV/AIDS education as the foundation for 
providing information about HIV vaccines, science and clinical trials. In spite of low levels of 
knowledge, community members continued to show up to participate in HIV vaccine 
education and research and shared the benefits of participation with us in our data collection 
activities. Participants received a monetary incentive to compensate them for the time and 
any costs incurred while participating in the research. In these impoverished contexts where 
unemployment rates are high, it was hard not to wonder whether it was in fact the incentive 
that acted as the most powerful enabler to participation, ensuring a steady stream of 
community members willing to participate in the HIV vaccine education workshops and 
research studies. These were my first insights into the complexities associated with engaging 
communities in HIV vaccine research in resource-poor communities in South Africa.  
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Over the five years before I began my doctoral work, I actively participated in the 
community of researchers conducting social science research on HIV vaccines. In this 
context, social science was considered an add-on to clinical trial protocols, serving the 
purpose of assisting investigators in recruiting and retaining trial participants and providing 
insight into social harms that may impact the clinical trial process. As the socio-behavioural 
research community involved in the HIV vaccine research enterprise, we engaged in various 
activities to advocate for the integration of social science research into HIV vaccine research 
agendas from the outset. We attended international biomedical HIV prevention and HIV 
vaccine conferences to showcase our work. Reflecting the position afforded to social science 
research in this context, conference programmes focussed predominantly on the biomedical 
aspects of HIV vaccine development, allocating social science research to a singular slot on 
conference programmes, with the rest of this work relegated to the poster presentation 
sessions. We planned and participated in workshops funded by the NIH and IAVI, bringing 
together multiple levels of stakeholders to discuss how social science may be integrated into 
global HIV vaccine research agendas. We wrote articles theorizing participation and 
continued to document the factors associated with willingness to participate in HIV vaccine 
research across various HIV risk groups. We provided input into the development of 
international guidance documents for promoting community engagement in HIV vaccine 
research. We wrote funding proposals that proposed to explore and evaluate HIV vaccine 
research community engagement processes. In spite of all these activities, not much has 
shifted in the power dynamics that govern HIV vaccine research. Social science research, 
while expanding, continues to be relegated to add-on status.  
At the start of my doctoral work in 2011 and at the time of writing this thesis, the 
available social science literature on HIV vaccines still consisted predominantly of articles 
documenting WTP across different settings and populations and some literature on the ethical 
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aspects of HIV vaccine research. In South Africa, research unpacking the ethical aspects and 
challenges to ensuring informed consent is conducted primarily by the HIV/AIDS Vaccines 
Ethics Group (HAVEG). There are, however, a few articles that deal with community 
engagement in HIV vaccine research that serve as the foundation of my doctoral work. My 
doctoral research originates from my curiosity about community engagement in HIV vaccine 
research: how it is practiced in local community contexts, the complexities that it involves 
and the diverging perspectives about community participation that play themselves out 
among those who form part of the local community HVT context.   
According to Holloway and Bailey (2011), qualitative researchers are deeply 
embedded in the research process and cannot be excluded from the data collection, analysis 
and reporting of the research (Holloway & Bailey, 2011). This notion of deep engagement 
and embeddedness in the research is certainly true for me and has presented me with a few 
dilemmas in thinking about how to present the findings of my research. I have a long-
standing relationship with the research centre at which I conducted my research, having 
collaborated and worked with various staff members. I have developed good working 
relationships within this setting and over the course of my research I was received with 
openness and hospitality. I felt part of the setting during the process of data collection when I 
would arrive early and sit in the waiting room to observe what was happening at the research 
centre. In spite of the fact that I was visibly not part of the local community, the participants 
did not seem curious about my presence. I think that to them I was simply part of the 
environment. This perhaps reflects community members’ familiarity with different, new faces 
entering the research environment. I also felt this during the research process in the ease with 
which I was able to build rapport with participants. Throughout this process participants 
engaged openly with me during the focus group discussions and interviews, sharing their 
experiences and opinions enthusiastically and without hesitation. The focus group discussions 
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were vibrant and lively discussions, with research participants offering insight into their 
experiences, building on and challenging each other’s input. Participants in the focus group 
discussions indicated that they viewed me as a resource, there to provide them with 
information about how to protect themselves from becoming HIV positive. They did not 
seem to notice that I was asking questions and not providing any information.  
My data collection revealed many contradictions in the descriptions of the process of 
community engagement in HIV vaccine research at Research Centre X. As a researcher in the 
HIV vaccine enterprise, I am integrally linked to the setting and the research being 
conducted. This left me with dilemmas about my position in reporting the findings of my 
research. Exploring this dilemma with my supervisor, we uncovered a number of possible 
positions that crystallized, essentially, into three options:  
1. dismissing the community engagement activities being conducted as ineffectual;  
2. colluding with and perpetuating ideas about community engagement as “spreading 
the word” and recruiting research subjects; or  
3. fulfilling my intention of conducting critical research that amplifies, reveals and 
makes sense of the community engagement process at Research Centre X.  
I chose the last position. The presentation and discussion of my research findings 
represents my critique of the process of community engagement that I accessed through the 
various stakeholders who participated in my research. In my discussion, I reframe ideas about 
community engagement practice at Research Centre X by revealing what it is and what it is 
not in this context; exploring whose agenda it serves and the role that various stakeholders 
play in the process, while acknowledging the influence of the complex local community 
context in which it is being conducted.  
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3.2. Part 2: Documenting my position on community engagement in HIV vaccine 
research  
In outlining my perspective on what constitutes meaningful community participation, 
successful HIV vaccine research, and the role of community engagement in promoting both 
these aspects, I comment on a few key aspects: the emphasis on the crucial role of local 
communities in HIV vaccine research; the notion of mutually beneficial relationships 
between researchers and local communities; and the utility of current community engagement 
guidelines for promoting meaningful community participation in HIV vaccine research 
conducted in high HIV risk, resource-poor contexts.  
The global HIV vaccine enterprise is pursuing the development of a safe and 
efficacious HIV vaccine as the successful outcome of HVTs conducted with high HIV risk 
populations in various settings. Local communities are considered to have a crucial role to 
play in achieving this outcome (Wakefield, 2005). Community engagement processes are 
designed to promote the participation of local communities in HIV vaccine research. As I 
highlighted in the preceding chapter, there are various sets of guidelines intended to assist 
researchers conducting biomedical HIV prevention research in local communities with 
designing and implementing community engagement processes that promote the involvement 
of communities in their research. These guidelines suggest that creating partnerships and 
building mutually beneficial relationships with those interested in and affected by HIV 
vaccine research is crucial to success (HVTN, 2000; UNAIDS-AVAC, 2011). The health 
promotion and HIV prevention literature considers promoting the participation of local 
communities in interventions to address risk factors that threaten their health and well-being 
as highly beneficial to them (Morgan, 2001). Participation is believed to facilitate community 
capacity-building and the empowerment of local communities (Campbell & Murray, 2004). 
In HIV vaccine research, however, while the participation of local communities in the 
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research is promoted and articulated as crucial, the issue of how such participation generates 
benefits for those who participate in the process is not explicitly addressed. In addition, 
amidst the constant refrain about the central role that communities play in the HIV vaccine 
enterprise, it is not clear what constitutes mutually beneficial relationships between 
researchers, funders and local communities.   
The importance of involving local communities to participate in the scientific project 
of HIV vaccine development is clear and incontrovertible. Communities in which HIV risk is 
high produce and supply the high HIV risk bodies that are the crucial subjects of clinical 
trials to test candidate vaccines. Without the participation of individuals who reside in these 
high HIV risk communities, HVTs cannot be conducted and candidate HIV vaccines cannot 
be tested. In this scenario, however, in which the emphasis is on community engagement to 
promote trial participation and where success is articulated as the development of a safe and 
efficacious HIV vaccine, it is not clear what immediate, short-term benefits community 
members residing in resource-poor local communities will derive from their contribution to 
the HIV vaccine enterprise.   
The local communities that serve as the settings for HVTs are those characterized by 
deprivation. They are subject to a configuration of multiple risk factors that threaten 
community members’ health and well-being. Risk factors in these settings range from the 
individual to the structural and include inter alia high rates of poverty and unemployment, 
poor living conditions, high HIV prevalence and risk, low levels of HIV/AIDS knowledge 
and high rates of AIDS-related stigma (AVAC, 2013; Smit et al., 2005; Voytek et al., 2011). 
These risk factors create community contexts in which individuals lack access to resources 
that promote health and well-being and that confer protection against HIV infection. While 
the promise of a safe and efficacious HIV vaccine that will confer protection against HIV 
infection and reduce HIV incidence in high risk settings holds direct benefit for community 
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members, this is a far-off promise beset with the uncertainties and complexities that 
accompany scientific experimentation. For local communities who contribute to the HIV 
vaccine research process, therefore, an HIV vaccine represents a potential long-term benefit, 
located in a far-off and indeterminate time in the future. This potential final outcome does not 
address immediate threats to their health and well-being. Given this context, how, if at all, 
does community participation in HIV vaccine research generate much needed short-term 
benefit for those who participate in the research?    
In addition to the absence of short-term benefits for local communities, community 
engagement is conceived from scientific, operational and ethical perspectives, crucial to the 
successful execution of HVTs. Within the HIV vaccine research enterprise collaboration and 
partnership with multiple levels of stakeholders in local communities is frequently articulated 
as the mechanism through which the goal of developing a safe and efficacious HIV vaccine 
may be realized (UNAIDS-AVAC, 2011). The notion of participation held in the HVT 
context is limited, however, and community engagement serves the operational purpose of 
maximizing participant recruitment and retention and fulfilling ethical obligations in local 
community settings. Local communities, therefore, act as a resource and serve a token role in 
HVTs (Arnstein, 1969; SAAVI, n.d.). Their function is utilitarian as subjects in the trial and 
as parties that provide input into operational aspects to improve trial execution. Consistent 
with this narrow conceptualization of community participation, local community members 
are offered a limited number of roles in the HVT process that focus on tailoring trial 
implementation to the local context and maximize recruitment and retention of trial 
participants. Local community members, therefore, participate in the research as participants 
in HVTs, HIV vaccine education and awareness-raising events and screening for HVT 
participation, and community advisory board (CAB) members, representing the community 
and acting as key informants on the socio-cultural dynamics of their community. Their 
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decision-making power in this process is limited and does not transcend personal decisions 
about whether to participate in the research or not. Framed in this way, their participation 
solely serves the agenda of the global HIV vaccine enterprise. Such a perspective on 
community engagement does not afford community members a meaningful role in the 
research process by supporting them in developing strategies for overcoming immediate 
threats to their health and well-being.  
Building community-researcher partnerships is important to the successful 
implementation of scientific research in community settings (Emanuel et al., 2004; UNAIDS-
AVAC, 2011). Authentic community-researcher partnerships move the role of communities 
from subjects or consumers of the research, to participants or co-owners of the process 
engaged in dynamic interactions with researchers throughout the life cycle of the research, 
co-producing knowledge (Callon, 1999; Nowotsky et al., 2001). The predominant operational 
approaches to community engagement in HIV vaccine research where community members 
remain subjects in HVTs and have a limited and token role to play in the scientific process, 
fail to harness the full potential of their participation in the research process. Crucially, such 
approaches fall short of the ideal of building community-researcher partnerships in which 
community members are active participants in the process, ensuring that the research being 
conducted holds benefits for them (Minkler & Wallerstein, 2008). This latter component is 
particularly important given the lack of direct, short-term benefits that are available to the 
local, resource-poor communities in which HVTs are conducted. Moving beyond operational 
approaches to community engagement in HIV vaccine research so that communities are 
positioned as a resource supporting the scientific enterprise, depends on researchers’ 
willingness to situate their community engagement efforts beyond available guidelines. It 
also depends on researchers’ willingness to pursue community capacity-building as a goal 
alongside the goals of the scientific enterprise. The development of truly mutually beneficial 
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relationships between researchers and communities lies in the integration of these goals as 
interrelated components of a successful outcome for HIV vaccine research. Pursuing 
mutually beneficial relationships involves expanding the level of participation available to 
communities in the research process by offering them a range of roles over the lifespan of the 
research. The existing body of evidence about the beneficial nature of community 
participation in the areas of health promotion and HIV/AIDS treatment, care and prevention 
may serve as a useful starting point in this regard.  
Current approaches to community engagement in HIV vaccine research, however, do 
not directly address the notion of mutual benefit. While it is clear what benefit community 
participation in HIV vaccine research holds for the HIV vaccine research enterprise, the 
short-term benefits that communities derive from their participation in the process is not 
addressed. For example, the GPP guidelines highlight the fact that HIV vaccine research 
cannot succeed without meaningful stakeholder engagement as a basis for achieving 
recruitment targets for HVTs (UNAIDS-AVAC, 2011). How do community engagement 
processes operate to ensure that local communities derive mutual benefit through their 
involvement in the research process?  
Biomedical HIV prevention research is a form of combination HIV prevention. 
Combination HIV prevention approaches integrate biomedical, behavioural and educational 
and structural HIV prevention strategies (Kurth et al., 2011). HIV vaccine research contains 
all of these components of HIV prevention, except attempting to intervene to address 
structural factors that impact HIV risk. Following this combination approach to HIV 
prevention, clinical research to test candidate HIV vaccines bring resources into resource-
poor communities. HVT-related resources include access to health and HIV/AIDS education, 
quality healthcare and screening procedures, HIV prevention, e.g., VCT and sexual risk 
monitoring and financial resources in the form of participant incentives. In trial contexts, 
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success is defined in biomedical terms as a safe and efficacious HIV vaccine. These resources 
are simply operational components of the clinical trial process, incorporated to maximize the 
chances of successful experimentation. In the resource-poor, high HIV risk contexts in which 
HVTs are conducted, participation in HVTs mediates community members’ access to these 
resources, providing them with access to resources that enable them to stay healthy and HIV-
free. From their perspective, therefore, trial-related resources are beneficial and supportive 
and participation promotes the practice of health protective behaviours.   
Accessing these benefits through participation in HIV vaccine research carries some 
risks/costs for community members. The risks/costs associated with participation may 
include the risk of being stigmatized by virtue of being associated with HIV/AIDS, disruption 
of daily activities to participate in the research process, dealing with the concerns of 
significant others about their participation in HIV-related research, frequent blood draws and 
HVT-related medical procedures and answering questions about the most intimate aspects of 
their lives (Asiki et al., 2013; Jaspan et al., 2006; Ruzagira et al., 2009). In spite of these 
costs, access to the resources that accompany trial participation act as enablers to WTP in 
HIV vaccine research, as has been shown in studies with various target populations and 
across a number of HIV vaccine research settings.    
Bearing the issues raised above in mind, what constitutes success in the HIV vaccine 
research enterprise? In my view success in the HIV vaccine enterprise transcends the goal of 
pharmaceutical product development. It devotes as much attention to the dynamic “social” as 
it does to the science of HIV vaccine development, harnessing the resources devoted to 
scientific experimentation and product development to generate mutual benefit for both 
researchers and local communities. Given the vulnerability and potential for exploitation of 
local communities targeted for their participation in HIV vaccine research, this is a key 
ethical imperative. In this process, community engagement serves as the vehicle for 
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promoting meaningful community participation, integrating ethical and operational goals 
with community capacity-building goals. From this perspective, HVTs are repositioned as a 
social good, leaving the high HIV risk, resource-poor local communities who participate in 
the research better off by virtue of their involvement in the process. Such community 
engagement processes involve communities as co-owners and active participants in the 
process (Green & Mercer, 2001) and use trial-related resources to create health-enabling 
(Campbell, 2003), supportive local community contexts for those participating in the 
research. Within this view of success, however, current guidelines for community 
engagement are inadequate.  
Globally, those who are asked to participate in HIV vaccine research are vulnerable, 
marginalized and historically exploited. In South Africa, Masikhulisane, the community 
involvement arm of SAAVI, framed community participation in HIV vaccine research as a 
human rights issue, arguing that communities have a right to access information about and 
opportunities to participate in HIV vaccine research. This position is, in my view, incomplete 
as it does not directly address issues of social justice that accompany a human rights 
perspective. Given the socio-historical context of South Africa and its history of the 
oppression and deprivation of those who are targeted for their participation in HIV vaccine 
research, community engagement in HIV vaccine research is most definitely political. It does 
have the potential, however, to facilitate the pursuit of social justice, addressing unequal 
access to power and resources in the local community contexts in which HIV vaccine 
research is conducted (Visser & Moleko, 2012). When viewed from this perspective, 
community engagement must be guided by conceptual tools that allow researchers to explore 
the impact of the social context on health and well-being and participation in HIV vaccine 
research. Current community engagement guidelines serve the biomedical HIV prevention 
trial agenda, view success from the perspective of the global biomedical AIDS industry and 
Stellenbosch University  https://scholar.sun.ac.za
71 
 
focus on procedures that will ensure the successful execution of clinical trials. They do not 
fully permit the examination of trials as social processes and as community resources.  
When HIV vaccine research moves out of laboratories and into local community 
contexts, it becomes embedded in those local contexts. It is influenced and shaped by those 
contexts, the social networks and structures that impact community participation in research. 
What is required, therefore, are theories and frameworks that allow researchers to examine 
the social. In particular, with the emphasis on community capacity-building and expanding 
the notion of participation, researchers require frameworks that provide them with the 
conceptual tools to develop a community health psychology of participation in HIV vaccine 
research.   
If we as social scientists involved in HIV vaccine research enterprise remain inside 
current community engagement guidelines while ignoring our disciplinary tools, we 
perpetuate the status quo of imbalanced power relationships between researchers, funders and 
local communities at the local community level of HIV vaccine research. If we ignore the 
limitations of these guidelines and continue our descriptive examination of factors associated 
with WTP and trial-related issues that we have focussed on in the past, we will continue to 
perpetuate caricatures of communities and researchers who are engaged in clinical research. 
We must, therefore, explore theoretical perspectives beyond biomedical community 
engagement guidelines, for example GPP.  
Similarly, if researchers do not take greater account of the dynamics and features of 
communities in which their research is conducted, success will be limited or unlikely. 
Community health psychology offers an important opportunity to advance the agenda of the 
biomedical HIV prevention enterprise in complex and marginalized settings. Chapter 4 
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outlines the application of the community health psychology paradigm to the exploration of 
community engagement in HIV vaccine research in greater detail.  
3.3. Part 3: The use of key concepts in the research  
This research examines the local community context of community engagement in HIV 
vaccine research (Slevin, Ukpong, & Heise, 2008) in one resource-poor community where 
the risk of HIV infection is high. As indicated in Chapter 2, HIV vaccine research is a global 
enterprise and involves multiple levels of stakeholders, ranging from the global to the local 
(Newman et al., 2015; UNAIDS-AVAC, 2011). Though much of the discourse around HIV 
research is global and couched in dominant scientific and biomedical terms, HIV vaccine 
research is implemented at the local community level. Community engagement to promote 
research participation takes place at the local community level. It enters the everyday lives 
and realities of those who reside in these communities and who are targets for HIV vaccine 
research and related activities. These key participants who are the objects and potential 
beneficiaries of research may have little direct involvement with the language and discourses 
of global biomedicine, but are profoundly affected by them. They contribute to the refraction 
of dominant global ideas through local experience. By far the bulk of the available literature 
on community engagement, furthermore, provides insight into notions of community 
engagement from the perspective of those who implement trials: researchers, funders, 
international health organizations and advocacy organizations. These stakeholders articulate 
their perspectives on what community engagement entails, who it should involve, and the 
activities that form part of community engagement to generate community support, buy-in 
and participation in the research. This literature does not and cannot incorporate local 
community members’ perspectives such as those who are tasked with implementing 
community engagement, community members who participate in HVTs and those who 
represent the interests of the community in the research on their experiences of community 
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engagement. It is not possible to have global guidelines that incorporate the views of every 
community or person who will be the object of those guidelines. This level of generality is 
unavoidable in global guidelines, but has consequences. Where community stakeholder 
perspectives are accessed in compliance with global guidelines, the focus is primarily on 
generating community input and experiences of community engagement guideline 
implementation, rather than on accessing the nuance of local experiences and perceptions of 
community engagement and research participation (e.g., Newman et al., 2015). My research, 
therefore, seeks to access the stories of these local community level stakeholders to document 
their experiences and perspectives on HIV vaccine research, research participation and 
community engagement as it is practised in the research setting.  
The concept of community is central to my research, directing both its focus and 
theoretical conceptualization. The notion of community and who constitutes the community 
as the target of research or intervention is the subject of much contention and debate. In 
South Africa, as elsewhere, the use of the term community is political, bearing the history of 
Apartheid oppression and discrimination that created the structural inequalities that endure 
and influence the health and well-being of its poorest citizens. Under Apartheid, the term 
community was used to promote the separation of people by race and as a euphemism to refer 
to Black communities (Yen, 2007). In this context the term community, therefore, evokes 
images of racial oppression, discrimination and unequal access to resources that promote 
health and well-being.  
In global health research, the use of the term community and the task of identifying 
who constitutes the community is no less challenging. According to Lavery et al. (2010), 
identifying the relevant community and those who represent its interests is one of the greatest 
challenges facing biomedical researchers. The process of identifying the community and its 
relevant community stakeholders serves as the foundation of the community engagement 
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process, defining the target for and focus of engagement, outlining with whom community-
researcher partnerships must be built and who researchers must collaborate with throughout 
the execution of the research (HANC, 2014; Slevin et al., 2008).  
The available guidelines on community engagement in biomedical HIV prevention 
provide varying input on how to define and identify the community in clinical trial 
implementation. There are also diverging perspectives on what constitutes community and 
the role that communities should play in the research process (HANC, 2014) among those 
who implement clinical trials in community settings. There is agreement on the fact that 
community represents the target for and hosts of HVTs. However, the notion of community is 
defined in various ways. Firstly, mirroring the predominant definition of community in health 
research and interventions, the notion of community in biomedical HIV prevention has 
tended to be defined in terms of the geographical boundaries within which the research takes 
place. Such definitions define community as referring to trial participants, their families and 
partners, other local stakeholders, service providers, NGOs, CBOs and community structures, 
organizations and representation structures that operate within the geographic boundaries of 
the trial location (HANC, 2014; Nakibinge et al., 2009; Slevin et al., 2008). Secondly, 
community is also defined as sub-groups at risk of HIV infection, in other words the 
population in and for which the research is being conducted. These definitions conceptualize 
community as those high HIV risk sub-groups who are targeted for their participation in the 
research, including MSM and sex workers (Forbes et al., 2008).  
Third, there are also stakeholder-based definitions of community that incorporate 
multiple features of community into their conceptualization of community. In 2001, 
MacQueen et al. published one such definition as a result of their attempts to develop an 
evidence-based definition of community from the perspective of various stakeholders 
involved in HIV vaccine research in the USA. Their research generated a definition of 
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community that defines it as a group of people with diverse characteristics who are linked by 
social ties, share common perspectives and engage in joint action in geographical locations or 
settings (MacQueen, 2001). This definition departs from previous narrow and one-
dimensional conceptualizations of community. It acknowledges that communities are 
dynamic, fluid and made up of individuals and groups with diverse characteristics. It also 
considers the fact that communities may not be pre-existing and homogeneous entities as 
implied by for instance geographical and risk sub-group definitions, but may take shape in 
response to particular issues of common concern and interest (Lavery et al., 2010). Building 
on this definition, the GPP guidelines also bases its conceptualization of community on a 
stakeholder perspective. Within this approach, stakeholder refers to any individual or 
collection of individuals who have a stake in biomedical HIV prevention trials (UNAIDS-
AVAC, 2011). Their GPP model describes layers of stakeholders, including trial participants, 
individuals or groups who represent the interests of those who may be recruited or participate 
in HVTs and others locally affected by the trial.  
In spite of these definitions that acknowledge that communities are diverse and 
dynamic systems made up of multiple levels of stakeholders, in the context in which I 
conducted my research, community is defined in geographic terms by stakeholders involved 
in the process. The community in which Research Centre X is located was chosen as the 
setting for their research because of the high HIV prevalence and HIV risk recorded in this 
geographical area. The location of Research Centre X in this setting provides it with access to 
HIV negative individuals at high risk of HIV infection who may be willing to participate in 
HIV vaccine and other biomedical HIV prevention research studies being conducted. The 
community targeted by Research Centre X includes those lay community members, HVT 
participants, community organizations and representatives who reside in the geographical 
area where it is located. Community engagement at Research Centre X targets lay community 
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members, HVTs participants and members of the CAB. Given my research focus on 
exploring the dynamics of research participation and the current process of community 
engagement at Research Centre X, therefore, my research focussed on the community as 
defined within the research setting. I acknowledge the limitations of adopting this approach 
and reflect on this, discussing the impact of this narrow conceptualization of community on 
the community engagement process, in the concluding chapter.  
3.4. The participation continuum – moving from community participation to 
community mobilization  
The second concept central to the research is participation. Since Alma Ata, community 
participation has been widely held as an important tool for addressing threats to health and 
well-being and ensuring equitable access to healthcare and other health-promoting resources 
in resource-poor settings (Morgan, 2001). The participation of those affected by a particular 
health and psychosocial problem that threatens their health and well-being is promoted in 
global health, development studies and various social science disciplines as the foundation 
for generating solutions that are relevant and acceptable to local communities. Community 
members are offered a number of positions in the participatory process. There are various 
conceptual contributions that describe the positions offered to community members in the 
participatory process, for instance Arnstein’s ladder of participation (1969) and Campbell’s 
(2014) conceptualization of instrumental, dialogical, social capital and critical approaches to 
community mobilization. The role of the local community in participatory processes may be 
viewed as a continuum that ranges from passive, tokenistic participation in which they remain 
subjects in the process, to increasingly more active participation that involves them in the 
process as participants, partners and co-producers of knowledge. The positions afforded to 
community members on the participation continuum are distinguished by the nature of the 
partnership with local communities and the level of participation and roles they are afforded 
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in the process. The latter positions on the continuum, which offer community members a 
more active role in the process, have the potential to facilitate the development of community 
capacity and empowerment. This pursues the goal of community participation as a health 
promotion strategy.   
An emphasis on the participation of local communities has also filtered into the 
biomedical HIV prevention arena. In the HIV vaccine context, the issue of promoting 
community participation in the research process has been raised as a salient concern at socio-
behavioural research agenda setting meetings. The salience of this issue is based on the 
recognition that local communities play a crucial role in the HVT process, and without their 
buy-in, support and participation in the research process, HVTs are unlikely to succeed in 
their goal of developing a safe and efficacious HIV vaccine (Wakefield, 2005). Since I first 
started doing research in this area in 2005, various terms have been used to describe 
community participation in HIV vaccine research. These terms include community 
participation, community involvement, community engagement and stakeholder engagement. 
The meanings of these terms tend to overlap. They are all used to describe efforts that 
researchers undertake to involve multiple levels of stakeholder groups in local communities 
who host HVTs in the research process. The conceptualization of community or stakeholder 
engagement in HIV vaccine research, therefore, seeks to develop communities as an HVT 
resource, offering them the role of subjects in HVTs and as community representatives 
providing input on trial procedures. Participation therefore focusses on the operational and 
ethical aspects of clinical trial implementation that supports successful trial conduct. This 
represents participation at the tokenistic, passive end of the participation continuum 
(Arnstein, 1969). It affords communities an instrumental role (Campbell, 2014) in the 
process, such as serving the agenda of the HIV vaccine enterprise and assisting with the 
implementation of research conceptualized by researchers (Campbell, 2014). Developing 
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HIV vaccine research as a reciprocal resource for local communities, in other words as sites 
of health promotion that facilitate empowerment and community capacity-building via 
participation, does not receive attention. The one-directional benefit implicit in this view on 
community participation is problematic given the resource-poor, high HIV risk contexts in 
which HVTs take place.  
Clinical trial implementation guidance is clear on the benefits of community 
engagement processes for the HIV vaccine enterprise. Community engagement is an ongoing 
process of multidirectional communication that enables sustained, collaborative partnerships 
between all stakeholders who are likely to participate in the research, to be affected by it or to 
influence its conduct (Frew et al., 2008; HPTN, n.d.; UNAIDS, 2007; UNAIDS-AVAC, 
2011). Authentic community engagement helps ensure that trials can and will proceed 
smoothly. Investment in community engagement helps cultivate a sense of community 
ownership that builds trust and deepens knowledge of local realities, improves the quality of 
data collected by ensuring that trial protocols, procedures and strategies are acceptable to trial 
participants and builds on locally understood languages and customs. It also optimizes the 
likelihood of eliciting high levels of adherence and accuracy of self-reporting (Slevin et al., 
2008; p.2). The features of community engagement highlighted across these definitions 
include consultation, dialogue, partnership, mutual education and respect and consensus 
building on all aspects of testing the potential biomedical HIV prevention technologies (Frew 
et al., 2008; Nakibinge et al., 2009; Tindana et al., 2007; UNAIDS-AVAC, 2011) as 
strategies for successful trial implementation. These strategies, if implemented with notions 
of authentic engagement in mind, have the potential to shift the ratio of benefits that accrue to 
researchers and communities to a more equitable level.  
Given notions of participation and community engagement in the HIV vaccine 
enterprise and the lack of focus on HVTs as a resource for community stakeholders who act 
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as partners and collaborators in the research process, I conceptualize participation from a 
community engagement perspective in this research. This research adopts a community 
mobilization approach that offers greater potential for developing mutually beneficial 
partnerships with local communities. Lippman et al. (2013) believe that community 
mobilization has a key role to play in the effective implementation of biomedical 
interventions. Community mobilization approaches create room for local community 
members to actively participate in the research process, building their capacity and 
facilitating their access to power and resources that promote health and well-being (Campbell 
& Murray, 2004; Campbell & Cornish, 2010). Such an approach moves beyond ethical and 
scientific goals to the integration of community development goals with the research process. 
It emphasizes meaningful social participation and builds enabling partnerships between local 
communities and external partners (Rifkin & Pridmore, 2001). In addition, it focusses on 
participation in collective action as a mechanism for increasing participants’ confidence and 
empowerment to exercise agency in those matters that threaten their health and well-being. 
These features of community mobilization interventions are crucial in HVT settings where 
access to health promoting resources is limited and where HVTs are accompanied by such 
resources. The use of the community mobilization approach is, therefore, better placed to 
provide local communities with an authentic and mutually beneficial role in the HIV vaccine 
research process.  
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Chapter 4: Research Rationale and Theoretical Framework 
4.1 Research rationale 
The research examines two areas integral to the successful development of a safe and 
efficacious HIV vaccine, namely the dynamics of participating in HVTs and the community 
engagement processes that target community members at high risk of HIV infection to elicit 
their involvement in the HIV vaccine research enterprise. The literature reviewed in Chapter 
2 highlights a number of key issues that serve as the foundation for this research focus.  
In spite of the investment made in averting the spread of the HI-virus, the rate of 
infection continue to grow among vulnerable, marginalized populations in resource-poor 
social contexts, including South Africa (Merson et al., 2011). HIV/AIDS thrives in areas of 
deprivation and inequality where features of the social context, such as poverty, 
unemployment, gender inequality, high levels of violence, and lack of access to resources 
fuel the spread of the virus (AVAC, 2013; Smit et al., 2005; Voytek et al., 2011). Available 
HIV prevention interventions have had a limited impact in stemming the tide of the pandemic 
in certain settings (Campbell & Cornish, 2010; Coates et al., 2008). Their limited impact may 
be due to their tendency to focus on changing individual behaviours, while paying scant 
attention to the influence of risk factors that originate in the local community contexts in 
which individuals at high risk of HIV infection live (AVAC, 2013; Lesch et al., 2006; Mills 
et al., 2004; Newman et al., 2006; Ruzagira et al., 2009 Smit et al., 2005; Voytek et al., 
2011). In addition, HIV prevention interventions are often imposed on communities in a top-
down-manner, targeting them as passive recipients of intervention rather than as active 
participants and partners in programmes that aim to improve their health (Campbell & 
Cornish, 2010). Those seeking to intervene to disrupt the spread of HIV are, therefore, 
challenged to develop approaches that target behavioural (DOH, 2012; Shisana et al., 2014), 
biological (DOH, 2012; Ramjee & Daniels, 2013) and structural risk factors (Harrison et al., 
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2006; Kagee et al., 2011; MacQueen, 2011; Merson et al., 2008; Parker et al., 2000) that 
impact the spread of HIV.  
Various authors agree that current approaches to HIV prevention are necessary, but 
not sufficient to reduce the rate of HIV infection in contexts where risk is high (Coates et al., 
2008; Kalichman, 2008; Padian et al., 2011). Two HIV prevention approaches are perceived 
to hold much promise for preventing the spread of HIV in high risk contexts, namely 
structural and biomedical HIV prevention approaches. Structural approaches to HIV 
prevention shift the focus of intervention from the individual to the social context by 
attempting to address the social conditions that contribute to HIV vulnerability (Gupta et al., 
2008; Roberts & Matthews, 2012). Structural approaches target multiple levels of risk 
factors, are guided by social change agendas and utilize community mobilization as a key 
strategy for addressing HIV risk factors.  
Biomedical HIV prevention interventions focus on developing biomedical 
technologies, such as HIV vaccines, and are considered to hold promise in effectively 
preventing the spread of the HI-virus by offering immunity, reducing susceptibility and 
diminishing the infectiousness of those at risk of HIV infection (Gwandure & Mayekiso, 
2012). Biomedical technologies are tested in randomized clinical trials in community settings 
where HIV risk is high. While they may have the endpoint of developing a safe and 
efficacious HIV vaccine, clinical trials to test candidate HIV vaccines include a range of HIV 
prevention approaches, for example risk reduction counselling and HIV/AIDS education 
(Asiki et al., 2013; Lesch et al., 2006; Newman et al., 2006; Ruzagira et al., 2009; Sahay et 
al., 2005, Smit et al., 2005; Voytek et al., 2011).  
Developing combination approaches to HIV prevention that integrate structural and 
biomedical HIV prevention intervention is one way of renewing HIV prevention approaches 
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(Padian et al., 2011; Piot et al., 2008). Combination approaches are tailored to social contexts 
and responsive to local community needs. HIV vaccine research, with its inclusion of 
biomedical, behavioural and community engagement components, embodies such a 
combination approach. In South Africa, HVTs implement biomedical and behavioural HIV 
prevention strategies in complex, resource-poor community contexts where the risk of HIV 
infection is high. Community engagement processes form part HVTs and focus on building 
partnerships with local communities who serve as a resource, participating in HVTs and 
providing input on clinical trial implementation to maximize chances of success. Community 
engagement processes, therefore, aim to create an enabling community environment that 
facilitates clinical trial implementation, focussing on generating community buy-in, support 
for and participation in the research process. These community-researcher partnerships 
(Mercer et al., 2001) focus on the agenda of the clinical trial enterprise and do not take into 
account the needs of the local community. The nature of the partnerships with local 
communities raise questions about how HVTs may become a resource for the hosts of such 
trials. In addition, the existing operational guidelines that form the foundation for the 
implementation of the community engagement process have limited utility in facilitating and 
exploring the value of clinical trials in resource-poor community settings as social processes 
that hold mutual benefit for both the HIV vaccine enterprise and the local community.  
Sustained community participation in HIV vaccine research is a key ethical and 
scientific imperative in ensuring the successful conduct of clinical trials to test candidate HIV 
vaccines (Lau, Swann, & Singh, 2011; Newman et al., 2015). Historically, attempts to 
examine HVT participation and community engagement have been conducted using two 
kinds of approaches. Firstly, studies have focused on the individual level, attempting to 
describe the factors associated with research participation from the individual perspective. In 
addition, mirroring dominant approaches to HIV prevention research, researchers focusing on 
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understanding these correlates of participation have utilized individual level explanatory 
frameworks and concepts to understand the human and social dimensions of HIV vaccine 
research (Lau, Swann & Singh et al., 2011). Such research makes an important contribution 
to HVTs by identifying the factors that enable and inhibit participation in HVTs. They are, 
however, limited in their ability provide insight into the experiences of HVT participation and 
the dynamics of the local community contexts in which HVT participation takes place.  
Secondly, at the level of HVT implementation, research participation and community 
engagement worked according to the strictures of research protocols that conform to 
randomized clinical trial methodology. This aspect of HIV vaccine development is guided by 
criteria for the ethical conduct of clinical trials and is governed by sets of procedures such as 
Good Clinical Practices (GCP) and GPP (UNAIDS, 2007; UNAIDS-AVAC, 2011). These 
guidelines emphasize community-researcher partnerships, shared ownership, mutually 
beneficial research and ongoing dialogue between researchers and communities. They also 
stress the importance of building the socio-cultural competence of researchers and research 
competence of community members (Slevin et al., 2008; UNAIDS-AVAC, 2011). There is, 
however, limited research on how these key components of community engagement manifest 
in practice and how they are affected by the dynamics of the local community contexts in 
which HVTs are conducted (Lau, Swann & Singh et al., 2011).  
Viewing HVTs as primarily scientific endeavours in which researchers and their 
expert knowledge control and structure the process, while community members are resources 
that contribute their local knowledge to achieve the goals of the scientific enterprise, creates a 
limiting view of the role of communities in HVTs. MacQueen (2011) highlights the fact that 
the social, behavioural and ethical challenges that plague clinical trials result from an 
inability to recognize that trials are fundamentally about social relationships. The scientific 
process is social, political and deeply embedded in the social context in which it is conducted 
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(Nowotny et al., 2001). When clinical research moves out of the laboratory into community 
settings, it becomes part of the community context and the complex dynamics and networks 
of social relationships that constitute the community HVT setting. Community members who 
participate in HVTs bring crucial insider perspectives and knowledge about their 
communities and how they function. This is crucial to the successful implementation of 
clinical trials. In order to access these community insider perspectives, Newman (2006) calls 
for a move away from ad hoc and trial-and-error approaches to community engagement in 
HIV vaccine research. He challenges researchers to apply their best science to achieve 
scientific and community engagement goals. Understanding how biomedical interventions 
function as components of community contexts and the mutual influence that structures 
relationships in the HVT context is a crucial part of achieving the goal of developing a 
“science of community engagement” (MacQueen, 2011; Newman, 2006, p. 302).   
With calls for participatory science, the co-production of knowledge and community-
researcher partnerships, the terrain for research on community participation in scientific 
research has been mapped out. To deepen research on community participation in HVTs, 
researchers must shift their focus from descriptive to evaluative accounts of current practices 
of community engagement and locate the social in HIV vaccine research in comprehensive 
contextual frameworks (Lau et al., 2009; Lau, Swann & Singh et al., 2011). HVTs bring 
health and HIV prevention resources into communities and invite community members at 
high risk of HIV infection to participate in clinical trials. This research initially developed 
based on the following perspective: through promoting participation in HVTs in local 
settings, clinical trials present an opportunity to integrate the ethical and scientific imperative 
of HVT implementation with community capacity-building agendas in resource-poor 
community contexts. By integrating these agendas, HVTs may become a resource that is 
mutually beneficial to all stakeholders who form part of the HIV vaccine research enterprise. 
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Adopting such an approach promotes scientific innovation, creates health-enabling social 
contexts for community members in high HIV risk settings (Campbell, 2003) and maximizes 
opportunities for HVTs to become a social good.  
The central focus of the research is, therefore, on the community participation in 
HVTs, and the community engagement process that promotes such participation. It focuses 
on exploring the possibilities that participation in the research process presents for lay 
community members to participate in the process of science as a means of accessing 
resources, skills, knowledge and competencies, empowering them to address threats to their 
health and well-being. This research represents, to my knowledge, the first study that 
examines community participation in HVTs and the community engagement process that 
promotes participation in the research process, from a community capacity-building 
perspective.  
4.2 Research Question 
This research is grounded in an interest in examining current processes of community 
engagement in HVTs as a process that is mutually beneficial to researchers and the 
communities in which clinical trials are conducted. In order to explore this interest, the 
research focusses on the local level of community engagement (Slevin et al., 2008) by 
focusing on the current community engagement practices at one HIV Prevention Research 
Centre, Research Centre X. It documents the community engagement process at the Research 
Centre X from the perspective of three key stakeholders involved in the process, namely 
community members who participate in the research, community outreach workers who are 
responsible for implementing community engagement processes that support clinical trial 
implementation at Research Centre X, and CAB members who represent the interests of the 
community in the research process. The research was guided by the following question:  
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How do HIV vaccine researchers operate to achieve the goal of promoting meaningful 
community engagement in HIV vaccine research in a resource-poor community? 
4.3 Research Aim and Sub-aims 
The primary aim of the research was to document the current practice of community 
engagement in HIV vaccine research at Research Centre X in the Western Cape,South Africa. 
The research sought to illuminate the process of community engagement in HIV vaccine 
research and the local community context in which it is implemented.  
The sub-aims of the research were to:   
• gain insight into the local community context in which HIV vaccine research is 
currently being conducted from the perspective of community members who 
participate in HIV vaccine research and community engagement activities at Research 
Centre X   
• examine the current community engagement process at Research Centre X from the 
perspective of the stakeholders involved. This included examining the community 
engagement practices and activities used to promote community participation and the 
roles of each stakeholder in the process.  
• utilize the community mobilization approach and the conceptual framework as a lens 
for interpreting the current process of community engagement at Research Centre X. 
This approach and framework outline three dimensions of social context, namely the 
symbolic, relational, and material contexts. Each context either undermines or 
supports community mobilization efforts, as outlined by Campbell and Cornish (2010, 
2011).This aim includes probing the extent to which this approach enables or inhibits 
meaningful community participation in HVTs in this setting.  
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4.4 Theorizing community engagement in HIV vaccine research 
Clinical trials are assumed to represent a social good in the resource-poor community 
contexts in which they are conducted (Petryna, 2009; Swartz & Kagee, 2006). However, 
community participation in HIV vaccine research is a complex and dynamic phenomenon. A 
number of studies addressing the social aspects of HVT participation suggest that the 
contexts in which people make decisions about trial participation influence their participation 
in the research process (Lau, Swann & Singh et al., 2011). Swartz and Kagee (2006) argue 
that researchers conducting research on HVT participation must exercise caution when 
making assumptions about the relationship between HVT participation and empowerment of 
those who participate in clinical trials. Such assumptions do not take into account the 
complexities involved in trial participation and the configuration of socio-cultural, political, 
behavioural and economic factors that influence decisions about WTP.  
In addition, in 2007 my colleagues and I argued that HVT researchers and community 
members may hold competing narratives about participation in HVTs (Kafaar et al., 2007). 
For researchers, trial participation may be considered an operational and bureaucratic 
requirement associated with the scientific and ethical requirements of trial implementation. 
For community members, by contrast, trial participation may fulfil a health-promotion 
agenda, providing them with access to resources and the opportunity to stay HIV-free in 
settings where the risk of HIV acquisition is high. In the latter narrative, trials may represent 
health-enabling social contexts (Campbell, 2003). This perspective that positions trials as 
health-enabling social contexts (Campbell, 2003), may underpin community participation in 
HIV vaccine research and may hold the potential for aligning researchers’ and community 
members’ narratives about trial participation.  Aligning these two sets of narratives may 
create a space where the needs, inputs and perspectives of all participants may be 
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incorporated into HVT research agendas, creating opportunities for community members to 
become active participants in the HVTs through the community engagement process.  
Given the issues outlined above, the research findings of this study were interpreted 
within the CHP paradigm and in particular, community mobilization approaches to HIV 
prevention, treatment and care (Campbell & Cornish, 2010). This paradigm supports the 
focus on the local community level of engagement in HIV vaccine research. The rationale for 
departing from a community engagement perspective lies in the ability of the CHP paradigm 
and community mobilization perspectives to create active roles for community members in 
the intervention process, to build their capacity and to facilitate their access to power and 
health-promoting resources (Campbell & Cornish, 2010). These features of community 
mobilization approaches may serve as the mechanism for generating mutual benefit for both 
researchers and local communities through their involvement in the research.   
The CHP paradigm emphasizes the importance of examining the community contexts 
that influence how people construct their lives and their behaviours (Murray, Nelson, Poland, 
Maticka-Tyndale, & Ferris, 2004; Visser & Moleko, 2012). It frames health promotion in the 
social, political and cultural contexts targeted for intervention and utilizes community 
capacity building, community mobilization and social transformation as the mechanisms for 
creating health-enabling social environments (Murray & Poland, 2006; Murray et al., 2004). 
The focus in CHP is, therefore, on creating health-enabling social contexts, in other words 
community environments that support and enable the adoption and maintenance of health-
enhancing behaviours (Campbell, 2003; Campbell & Cornish, 2010, 2011). Through the use 
of this theoretical paradigm, this research reflects on the possibilities that community 
engagement processes may hold for transforming HVTs into health-enabling social contexts 
(Campbell, 2003) that address the scientific and ethical imperatives of the scientific 
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enterprise and the community development needs in the resource-poor settings in which such 
research is being conducted.  
As highlighted above, in the context of this research, community engagement in HIV 
vaccine research is examined within the framework of the fourth generation, community 
mobilization approach outlined by Campbell and Cornish (2010). Community mobilization 
approaches recognize that communities have strengths and resources that can be mobilized to 
benefit both themselves and the scientific enterprise (Rifkin, 2009). These strengths and 
resources form the foundation of community mobilization. However, their effectiveness may 
be hampered by the dynamics of the local contexts in which such community mobilization 
efforts are implemented. These contexts are, therefore, crucial determinants of the success or 
failure of such interventions, either supporting or inhibiting community mobilization 
(Campbell & Cornish, 2010, 2011).   
In examining the process of community engagement in HVTs at Research Centre X, I 
used the conceptual framework that incorporates the three dimensions of context that are 
likely to support or undermine community mobilization outlined by Campbell and Cornish 
(2010, 2011), namely the symbolic, material and relational community contexts. This 
conceptual framework has been utilized in various contexts to examine responses to 
HIV/AIDS prevention, treatment and care, including examining the range of dimensions of 
context associated with the engagement of local communities with HIV/AIDS initiatives in 
Gambia (Cassidy, 2010); the impact of traditional leadership on shaping responses to 
HIV/AIDS in rural communities in Zimbabwe and South Africa (Campbell et al., 2013; 
Nhomo, Campbell, & Gregson, 2010) and stigma reduction interventions in India 
(Blankenship, Birdavolu, Jena, & George, 2010). Below I discuss the symbolic, material and 
relational contexts and the socio-psychological processes that act as the mechanisms through 
which participation influences health, namely social capital, dialogue and empowerment.  
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4.4.1 The symbolic context 
The symbolic context refers to the world of culture as it is expressed through the meanings, 
ideologies and world views circulating in a given community context (Campbell & Cornish, 
2010, 2011). The symbolic aspects of local community contexts frame how people 
understand themselves and others in their social environment and the activities that they 
engage in. It is the mechanism that regulates which groups are valued and respected and 
which groups are excluded and stigmatized. Symbolic recognition and the symbolic location 
of marginalized groups in the local context enable our understanding of the symbolic 
dimensions of context. The symbolic context, therefore, affects how community members are 
treated by others and how they feel about themselves. By recognizing community members’ 
worth, dignity, concrete achievements and legal rights to equality, this context facilitates their 
empowerment (Honneth, 1995 cited in Campbell & Cornish, 2011).  
In this research the symbolic context refers to the dialogue about HIV/AIDS, HIV 
vaccines and the research being conducted at Research Centre X among community 
members. The research examines how the nature of the dialogue circulating in the social 
context enables or inhibits participation in the research and community engagement processes 
implemented by community outreach workers at Research Centre X.    
4.4.2 The relational context 
The relational dimension of social context facilitates the possibility for transformative 
communication to take place in community mobilization interventions (Campbell & Cornish, 
2010, 2011). The relational dimension constitutes the space in which those living in 
conditions of poverty and marginalization are enabled to demand the fulfilment of their 
political rights through democratic and accountable leadership, and to advance their 
economic interests. A key feature of the relational dimension is the extent to which it 
promotes the full participation of the poor in the leadership and decision-making structures of 
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projects of which they are the intended beneficiaries. The relational context, therefore, 
focusses on mobilizing and building social capital in the context of interventions.  
In this research, the relational context refers to the roles, responsibilities and levels of 
participation of each stakeholder in the community engagement process at Research Centre 
X. It also examines the extent to which meaningful community engagement in HIV vaccine 
research is pursued at Research Centre X. For the purposes of this research, meaningful 
community engagement includes offering opportunities for full participation to community 
members and CAB members who take part in the research and community engagement 
activities. 
4.4.3 The material context 
The material context refers to the socio-economic features of communities, including the 
levels of poverty and the opportunities for economic gain or lack thereof associated with 
participation in community mobilization interventions (Campbell & Cornish, 2010, 2011). 
The material context examines the extent to which community projects support community 
members in dealing with the features of their contexts that undermine their health and well-
being. The material context has two components, namely resource- and experience-based 
agency (Campbell & Cornish, 2010, 2011). Resource-based agency refers to those resources 
that people have access to in the settings that they live in. It forms the basis for promoting 
symbolic recognition and esteem in resource-poor communities and includes opportunities to 
access financial resources, food, paid employment, funding for community projects and 
education. Experience-based agency refers to the extent to which the social context provides 
concrete opportunities for community members to practise their skills and exercise agency. In 
environments where experience-based agency is present, a process of scaffolding is initiated 
that increases community members’ levels of confidence and competency and enables them 
to act to achieve more ambitious goals.  
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In this research, the material context refers to the opportunities that participation in 
HIV vaccine research and community engagement activities may offer community members 
who participate in HVTs and CAB members to access resources that promote the 
development of resource- and experience-based agency.  
4.5 Key concepts in community mobilization approaches 
Community mobilization approaches utilize three socio-psychological processes that act as 
the mechanism through which participation influences health and well-being (Campbell & 
Cornish, 2010, 2014). Community mobilization approaches, therefore, create health-enabling 
social environments (Campbell, 2003) for HIV prevention interventions by building social 
capital, creating opportunities for dialogue and promoting the empowerment of community 
members who are targeted for their participation in these interventions.  
4.5.1 Social capital 
In the context of this research, I utilize Bourdieu’s social constructivist notion of social 
capital, which defines social capital as access to durable networks of socially advantageous 
relationships of mutual acquaintance and recognition (Bourdieu, 1986). Viewing social 
capital in this way acknowledges that, in spite of their limited access to material resources, 
community members have access to social networks and resources that they can draw on in 
pursuit of their goals (Carpiano, 2006).  
Social capital is a property of communities. Without access to sufficient social capital, 
conditions of poverty and social disadvantage that inhibit individuals from exercising agency 
in improving their health and well-being are perpetuated (Campbell, 2000; Campbell & 
Cornish, 2010). Building on this idea, Wakefield (2005) describes social capital as an 
“important facilitator for and outcome of community development” (p. 2822). Building social 
capital is facilitated through partnership and participation (Campbell & Cornish, 2010).  
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Two forms of social capital are important in community mobilization approaches, 
namely bonding and bridging social capital (Campbell & Cornish, 2010). Both forms of 
social capital focus on the extent to which community members have access to networks of 
support. Bonding social capital refers to within-community solidarity (Saegert, Phillip, 
Thompson, & Warren, 2001). It is represented by community members’ access to relational 
networks that create feelings of solidarity, trust and mutual support (Campbell et al., 2007). 
Access to bonding social capital holds a number of benefits for communities. It provides the 
context for dialogue and community conversations in safe social spaces, promotes a sense of 
ownership and responsibility for tackling HIV/AIDS among community members and builds 
their feelings of agency and confidence in their own strengths (Campbell et al., 2007). In this 
research, bonding social capital refers to the presence of supportive relationships between 
community members, HVT participants, community outreach workers and CAB members.   
The second form of social capital highlighted as important is bridging social capital 
(Campbell & Cornish, 2011). Bridging social capital refers to community members’ access to 
networks of support outside the community. It is represented by marginalized community 
members’ supportive relationships with outside individuals and organizations who hold 
political and economic power and can utilize their power to assist community members in 
achieving their goals (Campbell et al., 2007; Campbell & Cornish, 2010, 2011). In this 
research, bridging social capital refers to the extent to which HVT participants, community 
outreach workers and CAB members are able to access support and resources for their 
community engagement activities and goals from powerful individuals and organizations, 
both within and outside of Research Centre X.  
4.5.2 Dialogue or transformative social spaces 
The second core socio-psychological process by which community mobilization approaches 
achieve their goals is through the creation of safe social spaces for dialogue (Campbell & 
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Cornish, 2010, 2011). Ongoing, sustained dialogue between all stakeholders in the HVT 
context has been cited as crucial to generating support, buy-in, mobilization and building 
trust and mutual respect between researchers and communities (UNAIDS-AVAC, 2011). 
Dialogue is also the space where mutual learning between researchers and community 
members takes place. Community mobilization approaches, therefore, have to facilitate the 
spaces for such dialogue to take place (Campbell & Cornish, 2010). Community 
conversations that bring people together to engage in discussions that explore the underlying 
factors fuelling the HIV/AIDS epidemic in their social context, are successful in creating safe 
social spaces for dialogue (UNDP, 2004; Gueye, Diouf, Chaava, & Tiomkin, 2005; Esma’el, 
Dolamo, Beleke & Kaso, 2015). Community conversations have a social justice orientation 
and represent a departure from conventional, prescriptive methods of conducting HIV/AIDS 
education and awareness-raising lectures in target communities (Gueye et al., 2005). 
According to Gueye et al. (2005), lecture approaches that incorporate the use of pamphlets 
and other visual aids, deny the benefits of dialogic approaches.  
Community conversations are a form of social mobilization that uses participatory 
processes and interactions with community members to build their capacity to develop 
responses to HIV/AIDS in their community contexts (Esma’el et al., 2015; Gueye et al., 
2005). Local community members who hold the trust of the community and have a vested 
interest are trained as facilitators of community conversations (Gueye et al., 2005; UNDP, 
2004). Ideally, dialogue in community conversations is transformative and focusses on 
helping marginalized groups identify obstacles to effective HIV prevention, explore their 
concerns and generate concrete strategies for improving their health and addressing the 
complex challenges of HIV/AIDS (Campbell & Cornish, 2010; Esma’el et al., 2015; Gueye 
et al., 2005).  
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The dialogue in community conversations is at best reflexive and analytical (UNDP, 
2004). Community members assess the socio-cultural, demographic and economic conditions 
that fuel the HIV/AIDS pandemic in their community. In the dialogic process community 
members use their material wealth, social knowledge and positive norms to explore the 
possibility of a more effective response to HIV/AIDS in their community (Campbell et al., 
2007; Esma’el et al., 2015). Dialogue in safe social spaces is often absent in settings where 
HIV risk is high (Campbell et al., 2007). Creating spaces in which such dialogue is facilitated 
supports critical thinking, problem-solving and mutual learning between those engaged in the 
process (Campbell et al., 2013).  
Dialogue may offer community members the opportunity to explore what they and 
others in their community know about HIV/AIDS, allowing them to draw on each other as 
resources. Participants interrogate their own and others’ perspectives, discuss their concerns, 
engage in dialogue about taboo topics, break silences that surround HIV/AIDS, take 
ownership of unfamiliar medical and scientific information, state their doubts and confusions, 
ask questions, access new information, and collectively brainstorm how they can incorporate 
new information into their existing worldview and practices (Campbell et al., 2007; Campbell 
et al., 2010). Dialogue, therefore, serves as the foundation from which community members 
develop new perspectives and exercise creativity and agency in developing solutions that can 
transform their collective response to HIV/AIDS in their community and help them 
implement solutions for change (Gueye et al., 2005).  
The use of community conversations has been successful across a range of rural and 
urban settings with varying political, social and economic environments (Gueye et al., 2005). 
It increases general HIV/AIDS knowledge and awareness, generates help for people living 
with HIV, reduces stigma and discrimination in settings with high HIV risk and deals with 
misconceptions surrounding the disease (e.g., Campbell et al., 2007; Esma’el et al., 2015).  
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This research explores the extent to which safe spaces for transformative dialogue exists in 
the communities that participate in HIV vaccine research. I will also examine whether 
opportunities for the open, transparent dialogue promoted by GPP (UNAIDS-AVAC, 2011) 
are embedded in the community engagement process at Research Centre X.   
4.5.3 Empowerment 
The final socio-psychological process of interest relates to the empowerment of community 
members in communities affected by HIV/AIDS (Campbell & Cornish, 2010, 2011). 
Empowerment is health-enhancing and is facilitated through participation and representation 
of community members in community and structures that shape their lives (Campbell, 2000; 
Campbell & Murray, 2004; Lubek et al., 2014). Wallerstein (1992) argues that people are 
most likely to feel empowered to take control of their health if they are able to exercise 
agency in other areas of their lives. Community mobilization approaches, therefore, focus on 
facilitating the empowerment of community members by involving them in interventions and 
projects that aim to create “health-enabling social environments” that support the adoption of 
health-enhancing behaviours (Campbell & Cornish, 2010, p. 1569).   
Drawing together aspects of Laverack’s (2006) and Rappaport’s (1987) definitions of 
empowerment, empowerment in this research refers to the health-enabling process by which 
marginalized individuals work together to gain mastery and control over events that impact 
their lives and health. By this definition empowerment is facilitated through the participation 
of community members in projects for which they are the intended beneficiaries. It occurs on 
multiple ecological levels; is developed in conditions where those who have access to it work 
together with those who want to obtain it; and it includes a psychological sense of personal 
control, social influence and political power (Laverack, 2006; Rappaport, 1987). 
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Empowerment is health-enhancing and is facilitated through participation and 
representation of community members in community and structures that shape their lives 
(Campbell, 2000; Campbell & Murray, 2004; Lubek et al., 2014). Participation is, therefore, 
an empowerment tool through which local communities take responsibility for diagnosing 
and working to solve their own health and development problems (Morgan, 2001). 
Participation has a social justice orientation and acts as a catalyst for social change by 
becoming involved in political processes that promote access to resources (Cornwall, 2008; 
Rifkin, 1996, 2009). Community members’ participation in collective action may be linked to 
an increase in their confidence and exercising agency in taking control over their lives. 
Empowered individuals are more likely to adopt health-promoting behaviours (Campbell & 
Murray, 2004).  
Participation in health has been conceptualized in various ways. Cornwall (2008) 
argues that in promoting participation, we are charged with moving beyond promoting the 
involvement of community members in projects intended to benefit them. Our approaches 
should create spaces for people to have an influence on the project. In the context of clinical 
trial research, opportunities for participants to have an influence on trials throughout their 
lifecycle are articulated through calls for participatory science and the co-production of 
science (Campbell, 2003; Lengwiler, 2008; Nowotny et al., 2001; Robins, 2008). In the HIV 
vaccine context, the South African AIDS Vaccine Initiative conceptualizes their community 
involvement approach as a ladder of participation (SAAVI, n.d.). Their ladder of participation 
is reminiscent of Arnstein’s (1969) typology of participation that moves from non-
participation to participation, offering citizens increasing access to power through the 
participatory process as they move up the rungs of the ladder of participation. SAAVI’s 
ladder of participation is adapted from UNICEF’s approach and includes eight steps, namely 
manipulation, decoration, tokenism, assigned but not informed, consulted and informed, 
Stellenbosch University  https://scholar.sun.ac.za
98 
 
researcher starts the project and shares decision-making, community starts the project and 
directs it and finally, the community starts the projects and shares the decision-making. With 
each rung up the ladder, community members’ empowerment is facilitated, providing them 
with access to increasingly more power, control, input and access to resources through the 
participatory process. SAAVI advocates for the ongoing participation of communities in the 
HIV vaccine research process towards the top levels of the ladder. This research utilizes the 
ladder of participation approach adopted by SAAVI to examine the roles and levels of 
participation that have been afforded to stakeholders in the community engagement process at 
Research Centre X. 
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Chapter 5: Method 
The research is guided by the following research question: How do HIV vaccine researchers 
operate to attempt to achieve the goal of promoting meaningful community participation in 
HIV vaccine research in a resource-poor community? The research adopted a qualitative 
research approach to examine the current process of community engagement in HIV vaccine 
research at Research Centre X in the Western Cape South Africa.   
5.1. Research design 
The research focussed on examining the current practice of community engagement to 
promote community participation in HIV vaccine research at Research Centre X from the 
perspective of three key stakeholder involved in the process, namely community members 
who participate in HIV vaccine research and community engagement activities at Research 
Centre X, members of the community outreach team and CAB members. The qualitative 
research approach has the potential to empower marginalized groups in society by facilitating 
the process through which they discover, create or voice their stories (Stein & Mankowski, 
2004). My research utilized the potential of qualitative research to discover and access 
accounts of participation HIV vaccine research and the community engagement process from 
the perspective of these stakeholders. In addition, qualitative research offers researchers the 
ability to investigate complex social processes within the social, political and cultural 
contexts in which they occur, which of great use in this research (Mason, 2006). It focussed 
on generating a story about HIV vaccine research and the community engagement process 
that reflects the meanings, perspectives and experiences of those who form part of the process 
in the local community who hosts the work of Research Centre X (Holloway & Bailey, 
2011). In adopting a qualitative approach, therefore, the research focussed on accessing the 
voices of those involved in community engagement processes to support the implementation 
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of HIV vaccine research in a resource-poor context as a pathway for gaining insight into their 
experiences and perspectives on the process (Stein & Mankowski, 2004).  
Various authors who produce social science research on HIV vaccines lament the fact 
that such research rarely engages in in-depth, reflexive social science that examines the 
dynamics of local community contexts and the impact of the trials on these contexts (e.g., 
MacQueen, 2011). They call for research that moves beyond description to analyses of 
community engagement that locate the “social” in HIV vaccine research in comprehensive 
contextual frameworks (Lau et al., 2009; Lau, Swann & Singh, et al., 2011). The “social” in 
HIV vaccine research is complex. HIV vaccine research involves relationships between 
multiple levels of stakeholders, from the local to the global, with different perspectives and 
goals for the process. Using a qualitative research design in my research, therefore, produced 
an account that documents and makes sense of the complexities that accompany efforts to 
involve local communities in the global HIV vaccine enterprise.      
5.2. Research setting 
According to Morgan (2001), context is crucial in participation studies as it provides insight 
into the range of factors that may influence participation. In selecting the context for my 
research, I used a representative or typical case sampling strategy (Yin, 2009) to select the 
research setting that offered me the opportunity to capture everyday HIV vaccine research 
and community engagement practices. The setting for the research, Research Centre X, is the 
setting for HIV prevention research across a range of biomedical HIV prevention 
technologies, including vaccines, microbicides and PrEP. It forms part of the Desmond Tutu 
HIV Foundation and is a recognized HIV prevention clinical trial site for a range of 
multinational clinical trial consortia including SAAVI, HVTN, HPTN and IAVI. 
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Research Centre X is located in a peri-urban community in the Western Cape South 
Africa and is home to approximately one million people. It has a predominantly Black South 
African population and has been conducting HIV prevention research in this area for more 
than 10 years. An adult HIV prevalence rate of up to 30% was recorded among antenatal care 
attendees in the district within which Research Centre X is located, and a population wide 
mean adult HIV prevalence of approximately 23% was recorded in the Klipfontein 
component of this district (email communication, Melissa Wallace).    
The community that Research Centre X is located in is characterized by high 
population density, low socio-economic status, high unemployment rates and high levels of 
violence (Kirby, 2014). Community members live mostly in informal or semi-formal 
dwellings and have access to municipal infrastructure such as roads, overhead electricity and 
shared ablutions, including shared tap water. Within the community, primary healthcare is 
administered from 35 public sector health facilities, 22 of which administer ART. Additional 
healthcare services are provided by a series of Community-based Organizations that provide 
VCT, wellness and care support. Research Centre X also operates two mobile clinics in the 
area that act as referral sites for study protocols.  
5.3. Selecting the research participants 
Selecting participants involves identifying and recruiting individuals who will act as 
representatives of those whose voices we wish to “amplify or reveal” (Stein & Mankowski, 
2004; p. 23). I used a purposive sampling technique to select “information rich” sources in 
relation to the purpose of my research (Babbie & Mouton, 2010; Patton, 1990 cited in Coyne, 
1997). Using this sampling technique, I accessed the voices, opinions and experiences of the 
three key stakeholders of interest for my research. These individuals served as expert 
witnesses, providing their first-hand experiences of the community engagement process at 
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Research Centre X (Morse, 1991 cited in Coyne, 1997). The pre-determined criteria that I 
used to select participants for my research included:  
• Participants were members of the key stakeholder groups whose perspectives were of 
interest for the research, namely community members who participate in the HIV 
vaccine research and community engagement activities at Research Centre X, 
community Outreach Team members and CAB members at Research Centre X; 
• Participants had to be over the age of 18 years old; 
• All research participants and CAB members had participated in at least one HIV 
education, outreach and awareness-raising activity conducted by Community 
Outreach Team members at Research Centre X. 
Beyond the inclusion criteria outlined above, I did not attempt to stratify participants 
by age, gender or any other socio-demographic characteristics. Such characteristics were not 
of concern for my research, which focused on documenting the perspectives of those 
stakeholder groups currently involved in the community engagement process at Research 
Centre X. My focus was, therefore, on ensuring that the research included those community 
members who typically participate in the research and community engagement activities of 
Research Centre X.  
HIV vaccine research samples HIV negative individuals who reside in contexts where 
HIV risk is high. Community outreach workers conduct education and awareness-raising 
activities in various community locations, partnering with local organizations such as 
governmental community healthcare centres and HIV/AIDS-related NGOs, to expand the 
reach of their activities and to maximize the numbers of potential research participants who 
visit Research Centre X. My research sampled those community members who are already 
participating in the research and community engagement activities being conducted at 
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Research Centre X. I recruited these participants with the assistance of a staff member at 
Research Centre X, Mandla (pseudonym). Initial meetings with staff members at Research 
Centre X revealed that recruiting participants to participate in its activities is challenging. 
This is due to inter alia the stigma attached to HIV/AIDS in the community and suspicion and 
mistrust of Research Centre X and its activities. Given these challenges to recruitment, I 
opted to utilize the assistance of staff members at Research Centre X who have experience 
and knowledge of the local community, to act as a conduit between myself and potential 
research participants, assisting me in recruiting community members who were participating 
in the activities of Research Centre X.   
Community members who were at the time participating in the research and 
community engagement activities at Research Centre X were, therefore, recruited using the 
existing recruitment mechanism at the research centre. Mandla served as the conduit between 
potential research participants and me. He approached potential participants to elicit their 
interest in my research. He explained the study aims, goals and activities and invited them to 
participate in the research process. Once participants had agreed to participate in the research, 
he booked them into the focus group timeslot that best suited them.  
Recruitment for the two other participant samples of interest for my research, namely, 
community outreach workers and CAB members, entailed different procedures. Firstly, a 
member of the Community Outreach Team, Sizwe (pseudonym), assisted me with recruiting 
CAB members to participate in my research. These outreach team members are the primary 
point of contact between the CAB and Research Centre X, regularly interacting and 
consulting with the CAB. My research was introduced to the CAB members at their monthly 
meeting and they were invited to participate in the CAB focus group. There were a number of 
challenges in setting up the focus group with CAB members. These challenges were due to 
the competing schedules and levels of availability of CAB members. Eventually it was 
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decided that I would use part of the regular Friday afternoon CAB meeting slot to conduct a 
focus group. 
Secondly, the final participant sample of interest for my research was the members of 
the Community Outreach Team. The Community Outreach Team Liaison Officer at Research 
Centre X introduced my study to members of his team and provided me with their contact 
information. I contacted each member individually to elicit their participation in my research 
process and scheduled interviews with them according to their individual schedules.  
5.4. Data collection 
I used two primary data collection techniques to generate the data for the research, namely 
focus group discussions with community members who participate in the research and 
community engagement activities at Research Centre X and with CAB members; and key 
informant interviews with members of the Community Outreach Team.    
5.4.1. Focus group discussions. 
The aim of this data collection activity was to gain insight into the local community context 
in which HIV vaccine research is conducted. It accessed the views of community members 
who participate in the research and community engagement activities of Research Centre X. 
These focus group discussions documented community members’ descriptions of the 
dialogue in their communities about HIV/AIDS and their own and other community 
members’ views and opinions about the HIV vaccine research being conducted at Research 
Centre X and their role in it. The focus group discussion method, which uses group 
interaction to explore people’s knowledge and experiences in relation to a set of socially 
relevant issues (Kitzinger, 1995; Marková, Linell, Grossen & Orvig, 2007) was well-suited to 
achieving the aim of understanding of the community context and atmosphere in which HVT 
participation takes place, participants’ perception of their role in the research, and the 
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community engagement process. An additional benefit of the focus group discussion 
approach for this research was the fact that focus group discussions create a setting in which 
participants who have a shared and common experience respond to and build on each other’s 
views, generating a range of opinions, ideas and experiences in the process (Litosseliti, 
2003).The use of focus groups in my research afforded me the opportunity to identify shared 
and common knowledge (Kitzinger, 1995) with respect to HIV vaccine research, research 
participation and community engagement at Research Centre X. Through its interactive 
nature, participants shared their experiences: confirming, contesting and amplifying their 
perspectives and generating a rich narrative that represents multiple viewpoints (Litosseliti, 
2003) on participation in HIV vaccine research and community engagement activities.  
I conducted a series of four focus groups with community members who participate in 
the research and community engagement activities at Research Centre X. Twenty-four 
community members participated in these focus groups. I was assisted in this process by a 
note-taker and an interpreter who acted as translator for participants who do not speak 
English or who preferred to communicate in Xhosa. Lindelwa, a Xhosa-speaking research 
assistant with extensive experience in collecting data in health-related projects in community 
settings, acted as the interpreter in my focus group discussions. In working with Lindelwa, I 
adopted the steps suggested for maximizing the effectiveness of working with an interpreter 
as outlined by Williamson et al. (2011). In the introductory phase of the focus group 
discussion I partnered with Lindelwa in the facilitation of this phase of the process. I 
introduced the study and our team to the focus group participants, and Lindelwa facilitated 
the completion of the informed consent documentation, reading through the form and 
explaining key sections to the research participants. As suggested by Williamson et al. 
(2011), her inclusion in the facilitation served to build rapport and enhance participants’ 
comfort with her presence. Prior to the focus group discussions, I trained Lindelwa on the 
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content to be covered in the focus group discussion and the process to be followed. After 
each focus group discussion, we debriefed, discussing our experiences of the focus group 
discussion process, clarifying our understandings of the process and content and our 
interpretations of our observations throughout the focus group discussion.   
In planning for the focus group discussions, we aimed to recruit 8-12 participants to 
participate in each focus group. Due to various pragmatic obstacles such as transport, 
inability to reach participants via the telephone numbers that they provided, participants’ 
competing commitments on the day of the focus group discussions, on average between six 
and seven participants arrived to participate in the research. This number falls within the 
acceptable range of a typical size for focus group discussions (Litosseliti, 2003). I developed 
and used a focus group guide (Appendix 1) containing a few areas of discussion aimed at 
uncovering participants’ shared and common knowledge and perceptions with regard to 
HIV/AIDS, HIV vaccines and participation in HIV vaccine research. I followed the focus 
group guide, monitoring the discussion throughout the process, adding questions and probes, 
reflecting back content to participants and attempting to draw quieter participants into the 
discussion. A total of 24 community members who had participated in HIV vaccine research, 
education and awareness-raising activities at Research Centre X participated in the focus 
group discussions.  
All focus groups were conducted in the boardroom of Research Centre X. We set up 
the focus group space in a circle format in the middle of the room to create a space that would 
facilitate conversation. Lindelwa and I sat in the circle and at opposite ends of it to facilitate 
communication between us, and between ourselves and the research participants. We placed 
two audio-recorders inside the circle to ensure that we produced a reliable record of the 
discussion. The note-taker sat on the outside of the circle, at a desk behind the group, where 
he could observe the interactions, document key points discussed and document patterns of 
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interaction between participants. The notes taken by the note-taker and the debriefing process 
between Lindelwa and I, served to support the audio-recordings and the process of generating 
an authentic description of the focus group discussion process.     
At the start of each focus group discussion I introduced the study and the focus group 
team to the research participants. I also explained my research, the purpose of the focus group 
discussions and their role in the research. Participants were given the opportunity to ask any 
questions or to request clarification of the information that I had shared with them at this 
point. Lindelwa assisted me in responding to questions and queries from participants, and 
once we had addressed all these questions we proceeded by handing out informed consent 
forms. Informed consent forms were available in both English (Appendix 2) and Xhosa 
(Appendix 3). Lindelwa explained the information in the informed consent forms to the 
participants in Xhosa, highlighting key issues in the forms and assisting them in completing 
them. After signing the forms, participants were asked to complete a form requesting 
biographical information, information about their involvement in the HIV vaccine research 
and educational activities being conducted at Research Centre X (see Appendix 4). The focus 
groups lasted between 60-90 minutes each.   
Information about the community members who participated in the focus groups is outlined 
in the table below.  
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Table 1: Descriptive information – Community members who participate in HIV vaccine 
research and community engagement activities at Research Centre X 
Demographic variables Focus group n= 24 
Age (years)  
16 – 20 1 (4.17%) 
21 – 25 8 (33.33%) 
26 – 30 7 (29.16%) 
31 – 35 6 (25.00%) 
36 – 40 1 (4.17%) 
41 – 45 0 
46 – 50 0 
51 – 55 1 (4.17%) 
56 – 60 0 
  
Sexa  
Female 14 (58.33%) 
Male 8 (33.33%) 
  
Level of Educationb  
None  
Grade 1-7 0 
Grade 8-11 7 (29.17%) 
Matric 10 (41.67%) 
Tertiary  1 (4.17%) 
Honours 0 




Yes 3 (13.64%) 
No 19 (79.17%) 
  
Home languaged   
English 1 (4.17%) 
Sesotho 0 
Xhosa 20 (83.33%) 
  
Have you attended a vaccine 
information/ discussion group?  
Yes 100% 
No 0 
a Missing data for two participants 
b Missing data for five participants 
c Missing data for two participants 
d Missing data for three participants 
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The focus group with CAB members at Research Centre X followed the same 
procedure as outlined above. In addition to accessing CAB members’ views on research 
participation, the research and community engagement activities being conducted at Research 
Centre X, I also used this focus group to elicit CAB members’ experiences of their role as 
representatives of the community in the community engagement process. I facilitated this 
focus group without the assistance of an interpreter, as I was assured by Sizwe that all CAB 
members were able to converse and interact in English. I was assisted in the focus group 
discussion process by a note-taker. The interview guide for the CAB focus group is outlined 
in Appendix 5. The focus group with CAB members covered a number of areas that included 
their role and activities in the HIV vaccine research and community engagement process at 
Research Centre X and their experiences of their role as representatives of the community. 
After introducing my study and the purpose of the focus group discussion, I explained the 
informed consent form to CAB members and they completed these forms (see Appendix 6). 
They also completed the participant information form (see Appendix 4).  
We recruited 12 participants for this focus group discussion. However, on the day of 
the focus group discussion, only eight CAB members arrived to participate in the process. 
The CAB members who participated in the focus group discussion represented various 
community organizations and constituents, including organizations that provide health-care 
and support services to people with TB and living with HIV/AIDS, support to children at 
risk, or that focus on community development through advocating for provision of services 
and access to resources for community members. All CAB members described themselves as 
advocates for social justice, citing histories of political activism in the fight against 
Apartheid. A number of CAB members also identified themselves as members of the African 
National Congress (ANC). CAB members had joined the CAB at Research Centre X via two 
routes: they had been identified as community leaders by members of the Community 
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Outreach Team and invited to join the CAB; they had been introduced to members of 
Community Outreach Team via a referral system through members of their own social 
networks. The focus group discussion with CAB members lasted approximately 90 minutes. 
Information about the CAB members who participated in the focus group are outlined in the 
table below. 
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Table 2: Descriptive information – Community members who serve on the CAB at Research 
Centre X 
Demographic variables Focus group n= 8 
Age (years)  
31 – 35 1 (12.50%) 
36 – 40 0 
41 – 45 5 (62.50%) 
46 – 50 0 
51 – 55 2 (25.00%) 
56 – 60 0 
  
Sex  
Female 5 (62.50%) 
Male 3 (37.50%) 
  
Level of Education  
Grade 8-11 2 (25.00%) 
Matric 2 (25.00%) 
Tertiary 3 (37.50%) 




Home language  
English 1 (12.50%) 
Sesotho 1 (12.50%) 
Xhosa 5 (62.50%) 
  
Have you attended a vaccine 
information/ discussion group?a  
Yes 7 (87.50%) 
No 0% 
a Missing data for one participant 
 
5.4.2. Key informant interviews. 
In the final data collection activity, I conducted key informant interviews, in other words 
interviews with people who have direct and expert knowledge of the subject being studied, 
(Family Health International, n.d.) with Community Outreach Team members at Research 
Centre X to gain insight into the process of community engagement as it is currently 
practiced and understood by those who operate at the coalface. These are the people 
responsible for creating and implementing community engagement practices and activities at 
Research Centre X. I conducted interviews with staff members involved in community 
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engagement activities at Research Centre X, three men and two women. These interviews 
covered two areas, namely current community engagement processes, practices and activities 
at the trial site and the stakeholders involved in these processes (see Appendix 5).  
All interviews took place in the board room at Research Centre X. Each interview 
started with a description of the study and its aims and an overview of the informed consent 
form (see Appendix 6). Due to the fact that the focus of the interviews was on participants’ 
experiences of their roles within the research centre and the challenges associated with those 
roles, participants were reminded of confidentiality of the interviews and the handling of the 
data collected.  
5.5. Data analysis 
All focus group discussions and interviews were recorded with the permission of the research 
participants. Audio-recordings were transcribed by a transcription service. Focus group 
discussions that contained extracts in Xhosa were transcribed and translated by language 
experts in the Department of Modern and Foreign Languages at Stellenbosch University. 
Their transcriptions and translations were verified by an independent Xhosa-speaking 
translator.  
In preparing the data for analysis, I verified all transcriptions against the audio-
recordings of the focus group discussions and key informant interviews. Once I was satisfied 
that the transcriptions were an accurate record of participants’ reports during the data 
collection process, I uploaded the transcripts into Atlas Ti 4.2, a computer program that 
assists with the analysis of textual data.  
I analysed my study data using the thematic analysis approach outlined by Braun and 
Clarke (2006). I used an inductive approach, in other words a bottom-up strategy to generate 
themes that are grounded in the data. I coded the data without trying to fit it into an existing 
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coding frame (Braun & Clarke, 2006). The data analysis proceeded through a number of 
phases. In Phase 1 of the data analysis process, I read through each focus group discussion 
and key informant interview transcript a number of times to familiarize myself with the data. 
I focused on reading the “data as data” (p. 205, Braun & Clarke, 2013), actively engaging 
with the data collected and reflecting on what it reveals about HIV vaccine research 
participation and community engagement at Research Centre X from the perspective of the 
research participants. During this process of reading and familiarizing myself with the data, I 
borrowed from the grounded theory approach outlined by Strauss and Corbin (1998), creating 
memos to note down my initial ideas about the data, issues to explore across my analysis of 
the data set and the salient ideas that were emerging from the reading of the data. In the 
second phase of my data analysis process, I proceeded to first level coding by going through 
each transcript and coding the data line-by-line, using both in vivo (Strauss & Corbin, 1998) 
and descriptive coding (Miles & Huberman, 1994). Through this process of complete coding 
(Braun & Clarke, 2013), I worked across my entire dataset, namely focus group discussions 
and key informant interviews with all research participants, to identify and label anything of 
interest to the research and related to the research question. I worked through the transcripts, 
coding data line by line, labelling sections of the data with a relevant descriptive label. This 
line-by-line coding process generated an extensive list of preliminary codes. I used a process 
of constant comparison (Strauss & Corbin, 1998) to refine and cross-reference coded 
concepts with the data as a whole. In the third phase of my data collection, I printed out the 
list of codes and focused on identifying common codes that could be collapsed into categories 
within the dataset. I created diagrams in AtlasTi to assist me with the process of creating 
themes that represented “central organizing concepts” (p. 224, Braun & Clarke, 2013) in the 
data. Within this notion of a theme representing a pattern within the dataset, the next level of 
analysis involved deriving sub-themes that represent different ideas and aspects of the 
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“central organizing concept” (p. 224, Braun & Clarke, 2013). I listed the themes and sub-
themes in an Excel spreadsheet, including representative quotes from the transcripts for each 
theme and sub-theme. I arrived at my final list of themes and sub-themes and finalized the 
descriptive label for each theme and sub-theme by working through the Excel spreadsheet 
generated and checking the consistency of the themes and the alignment between the theme 
label and the quotes that represent it. In the final phase of my data analysis, I created a 
thematic map, generating an overall story about community engagement in HIV vaccine 
research from the multiple perspectives of the research participants (Braun & Clarke, 2006). I 
also selected quotes or extracts of participants’ descriptions that I could use to report their 
perspectives in my study findings (Braun & Clarke, 2006). In the presentation of my findings 
I have selected the quotes that best represent the central idea/s being expressed by the 
participants in each theme.  
I worked closely with my research supervisor throughout the data analysis process, 
documenting each phase in the process and presenting him with the output that I generated 
from each phase of my data analysis for verification and checking.  
5.6. Ethical issues 
Ethical approval for my research was granted by the Committee for Human Research of the 
Faculty of Health Sciences at the University of Stellenbosch (see Appendix 7), as well as the 
Human Research Ethics Committee of the Faculty of Health Sciences at the University of 
Cape Town (see Appendix 8). All participants were drawn from stakeholders involved in 
community engagement activities at Research Centre X. Community members who 
participated in the research were recruited using the existing recruitment mechanisms utilized 
by the research centre staff. All research participants were over the age of 18 years.  
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At the start of data collection, the research and its aims were described to potential 
participants and they were invited to participate in the research. Once they agreed to 
participate in the research, I obtained written informed consent from them using the forms 
provided in Appendices 2, 3 and 6. Informed consent documents were available in both 
English (Appendix 2) and Xhosa (Appendix 3), the language spoken by the majority of 
people in the local community. Community members who participate in the HIV vaccine 
research and community engagement activities at Research Centre X and the CAB members 
received R75 as compensation for their time spent participating in the focus group 
discussions. This amount was calculated in consultation with staff members at Research 
Centre X and is consistent with that offered as compensation for once-off visits to the 
research centre. Focus group discussion participants were also provided with refreshments. 
Members of the Community Outreach Team who participated in the research were not 
offered a participant incentive.   
The study adhered to strict guidelines for maintaining confidentiality and ensuring the 
safety of data. No identifying data were collected and participants were assigned a participant 
number on the participant information form. In instances where participants’ names were 
mentioned in focus groups or key informant interviews, pseudonyms are used in the 
presentation of the data. I use a pseudonym to replace the name of the research centre, and 
the staff members who assisted me with recruiting participants throughout my dissertation. 
All audio-recordings and transcriptions of interviews and focus group discussions are stored 
on a password protected computer to which only I have access. In addition, all forms 
completed and other study documentation are stored in locked cabinets in my office in the 
Psychology Department at Stellenbosch University. I am the only person with access to these 
cabinets. Research participants were informed of the data protection procedures to be 
followed in the informed consent document.  
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There were no risks associated with participating in the research. The benefits of the 
research include providing stakeholders with the opportunity to articulate and reflect on their 
experiences of their involvement in HIV vaccine research and community engagement 
activities at Research Centre X. It also provided them with a forum in which they could 
provide input into the ways in which the process of community engagement in HIV vaccine 
research at Research Centre X may be transformed. 
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Chapter 6: Findings and Discussion 
This chapter utilizes the community mobilization approach and Campbell and Cornish’s 
(2010, 2011) conceptual framework that incorporates three dimensions of context that may 
inhibit or support effective community mobilization efforts to present the findings of the 
research. I present the findings and discussion in three parts that document the research 
participants’ perspectives on the symbolic, relational and material contexts of community 
engagement in HIV vaccine research at Research Centre X. The thematic map below outlines 
the themes and sub-themes that provide the framework for the discussion of the research 
findings.   
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Table 3: Thematic Map  
Overarching themes Themes Sub-themes 
The symbolic context  
“Coming to fetch 
AIDS” 
Fear and avoidance of HIV/AIDS 
in the community  
HIV/AIDS surveillance in the 
community 
Surveillance of community 
members’ bodies 
Surveillance of community 
members’ movements 
Myths, beliefs and rumours about 
HIV vaccine research 
Myths, beliefs and rumours 
about Research Centre X 
Myths, beliefs and rumours 
about HIV vaccine research 
participants 
Myths beliefs and rumours about 
HIV vaccine research   
The relational context   
“I am the mouth” 
Community Outreach Workers’ 
understanding of community 
engagement and their role in the 
process 
 
Building relational networks in the 
local community  
Building partnerships with lay 
community members 
Building partnerships with 
organisations in the community 
Building partnerships with the 
CAB 
The material context   
“I am taught how to 




Learning about HIV/AIDS and 
accessing health-related 
information 
Access to quality healthcare and 
supportive relationships 
Representing the community in 
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6.1. PART 1: “Coming to fetch AIDS” - The symbolic context of community engagement 
in HIV vaccine research 
This section discusses the research findings with respect to the symbolic context in which 
community participation is being conducted at Research Centre X. The symbolic context 
relates to the worldviews, values, culture and beliefs that operate in a social context (Cornish 
& Campbell, 2010). The GPP guidelines recommend that researchers gain in-depth 
knowledge of the local community in which they will conduct their research (UNAIDS-
AVAC, 2011). Researchers must, therefore, explore local understandings of HIV/AIDS, 
social norms, perceptions and communication and decision-making networks that may 
influence community members’ attitudes to scientific research and researchers. In this 
section, I examine local understandings of HIV/AIDS, worldviews, values, culture and 
beliefs about HIV/AIDS, HIV vaccines and the research being conducted at Research Centre 
X that create the symbolic context in which community participation in HIV vaccine research 
takes place.  
Gilbert and Walker (2010) point out that stigmatization has endured as a core feature 
of people’s experiences of HIV/AIDS. HIV/AIDS continues to be accompanied by stigma 
and discrimination and people living with or perceived to be associated with the disease are 
stigmatized, rejected and discriminated against across various settings, ranging from the most 
personal and intimate to the public. In this section I present three themes and their related 
sub-themes in which my research participants describe the stigmatization of HIV/AIDS and 
anything related to it in their communities. These themes represent the symbolic context for 
community engagement in HIV vaccine research at Research Centre X, and I shall discuss 
each in turn:  
• Fear and avoidance of HIV/AIDS in the community 
• HIV/AIDS surveillance in the community 
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a. Surveillance of community members’ bodies  
b. Surveillance of community members’ movements  
•  Myths, beliefs and rumours about HIV vaccine research in the community 
a. Myths, beliefs and rumours about Research Centre X 
b. Myths, beliefs and rumours about HIV vaccine research participants  
c. Myths beliefs and rumours about HIV vaccine research   
6.1.1. Theme 1: Fear and avoidance of HIV/AIDS in the community.    
In South Africa HIV/AIDS-related stigma has been described as a cause of discrimination 
and inequality, impacting on willingness to test for HIV, acknowledge HIV risk and initiating 
HIV treatment (Gilbert & Walker, 2010; Naidoo et al., 2007; Skhosana et al., 2006). 
Research participants described their community environment as one in which HIV/AIDS 
and anything related to it evokes reactions of fear and avoidance. They report that HIV/AIDS 
is associated with death and community members fear contracting the virus and testing 
positive for HIV. In this context, talking about the disease and encouraging people to test for 
HIV and to practise safe sex is difficult. Participants report:  
They don’t want to hear anything about what is HIV.  
(FGD 1, Community Members, Female)  
We live among people who has the fear to know their own statuses.  
(FGD 1, Community Members, Male) 
Participants ascribe community members’ avoidance of HIV/AIDS as rooted in the 
fact that there is no cure for the disease and people therefore equate an HIV diagnosis with 
death. These fears of dying endure in spite of the knowledge that treatment is available for 
those living with HIV. Community members are reported to dismiss the availability of 
treatment and are said to continue to view an HIV positive diagnosis as a death sentence. 
Fatalistic notions therefore continue to accompany discussions of HIV/AIDS, with death 
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perceived as the final and inevitable outcome of an HIV positive diagnosis. The quotes below 
illustrate this point:  
I think it’s a matter that that many people are afraid of HIV and AIDS because 
there’s no cure, it’s not like TB. If ever there was a cure for HIV and AIDS it 
would, it would be accepted in and around the communities such as TB. Because 
if ever a person has the TB it’s not, it’s a big issue because they, you know er its 
six months treatment then you (inaudible recording). So I think that’s the 
problem. Whereas, there’s no, there’s no cure for HIV and AIDS and lack of 
education to other people I think it’s that.  
(FGD 1, Community members, Female) 
And what they make people die about HIV. Why? It’s every day that I see in my 
community. They didn’t accept that thing. I’ve got this virus and need, what do 
you need to do if the doctor say ok there’s the treatment? We going to give 
antiretrovirals is difficult it’s less than to worried then you need to to start to eat. 
Those are antiretrovirals and therefore most of people, what they say, no I don’t 
care about those things. Because I’m still dead. So there’s no life. You see?  
(FGD 4, Community members, Female) 
Because they are, they they tell all, they say they are already dead, already dead. 
Others say “it’s one the same, I’m gonna die, what’s the use of taking treatment”.  
(FGD 2, Community Members, Female) 
According to Goffman (1963), the most stigmatized diseases are those that are 
progressive, incurable and poorly understood. The participants’ reports in the quotes above 
highlight community members’ beliefs that, in spite of the availability of treatment, 
HIV/AIDS is a death sentence. HIV/AIDS is distinguished from TB, which is understood to 
be treatable within a given timeframe, while HIV/AIDS continues to be viewed as incurable 
and fatal, rather than treatable and manageable with ARV treatment.  
HIV/AIDS is also feared because it brings with it concerns about becoming HIV positive and 
being rejected by family, friends and others in the community. In the quotes outlined below, 
participants report how people who are HIV positive are judged and rejected by others:  
Er, for example, if you tell me about your problem. You have HIV, I’m gonna 
judge you. And I don’t want to hear anything from you. And I’m also gonna 
criticize you.  
(FGD4, Community Members, Female) 




If like I tell them that I'm HIV positive they will tell me ‘oh Lydia she’s HIV 
positive’ I don’t want to be her friend anymore.  
(FGD 2, Community members, Female) 
 
And then whatever you’re saying to the family you think it doesn’t considered 
because you got HIV. Nothing positive can come of your of your mouth. The only 
thing its negative will come out your mouth. Well they think it. You of, you’ve got 
that virus or that disease.  
(FGD 4, Community Members, Male) 
These quotes describe people’s fears of being rejected by people in their community, 
their peers and their families. These fears were also articulated by participants in Gilbert and 
Walker’s (2010) study with patients at an HIV clinic in South Africa. In their study, 
participants reported fears of being rejected by their families, partners and other people in 
their communities. Families were identified by some participants in this study as 
stigmatizing, labelling and rejecting family members who are HIV positive. Rejection by 
friends, as described in the quote above, may also reflect courtesy stigma (Goffman, 1963), 
where people who are HIV positive may be rejected by their friends due to their fears of 
being stigmatized by being associated with someone who possesses a discrediting attribute, 
like being infect with the HI-virus. Fears of rejection by those in their inner circle may 
continue to create fears of HIV/AIDS or testing HIV positive, and may contribute to 
avoidance of HIV/AIDS and anything associated with it, including HIV vaccine research.  
The research participants reported that people who are HIV positive are feared and 
avoided. They are viewed as being untrustworthy and having a malicious intent to infect 
others with the virus by virtue of their diagnosis or discrediting attribute (Goffman, 1963). 
Participants express distrust of people who are HIV positive and fear for their safety in 
interactions with such people as they perceive them to be interested in purposefully infecting 
others with the virus, starting a network of infection. The quotes below illustrate these views:  
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Er, for people who says they won’t die alone they will rather have to infect other 
people er, to to kind of, using their own kind of judgement. Right? That you you 
should also infect the other person when you are infected.  
(FGD 1, Community members, Male) 
 
He said also when ... also when they find out they are HIV positive they don’t ... 
they, they expose their, they expose the other people on the, on the disease 
because they don’t use condoms to protect. (Translated by Interpreter)  
(FGD 4, Community members, Male) 
Women who participated in the research reported that men in their communities 
avoid discussing HIV/AIDS or testing for HIV. The reluctance of men to get tested for HIV 
has been documented in other studies (e.g., Skovdal, Magutschwa-Zitha, Campbell, 
Nyamukapa & Gregson, 2013). In this context, HIV is referred to as “TB” by women to 
denote their belief that, like TB, it is treatable and no longer a death sentence. They report 
that their partners refuse to visit healthcare clinics to be tested for HIV, and use the women’s 
test results as markers of their own HIV status. The quotes below illustrate this:  
They don’t want to go to the clinic, and especially the men. You can see now it’s 
only one man on us. You can see it’s only one…The men, I don’t know there is 
something about the men, they don’t want to go to the clinic. You can see even, 
even here they say I must come with my boyfriend. My boyfriend don’t want to 
come. That’s the other problem. That is why this, you say it’s what, that’s why 
this TB, it’s not now, it’s not HIV anymore. That’s why, this TB, you know? It’s 
because the men don’t want to go to the clinic and get treated. That’s the 
problem.  
(FGD 1, Community Members, Female) 
I understand it. It’s like I’m pregnant now ne? I went to the clinic everything, but 
when I’m telling my boyfriend that he must go for a check-up he’ll say “you are” 
he’s telling me “you are safe mos1” (agreement and laughter). I will see on the 
baby that you are OK. If the baby is okay, even me I’m okay.  
(FGD 2, Community Members, Female) 
                                                 
 
1A conversational device used to elicit confirmation or agreement.  
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A few female participants also reported how men blame women for becoming HIV 
positive and accuse them of being unfaithful:  
Men are doing that because they are pointing fingers. Saying “I don’t have HIV 
because you the one who is sleeping around”. 
 (FGD 2, Community Members, Female) 
But I think, even if, even if it’s STD too, ja, they will say you are the one who is 
doing this. Last time, the last time I slept with you I got this.  
(FGD 2, Community Members, Female) 
The unwillingness of men to acknowledge or learn about HIV/AIDS, accompanied by 
“unhelpful male attitudes to HIV/AIDS prevention and care” (p. 714, Campbell et al. 2012), 
has also been found in a rural community in South Africa. In addition, Skovdal et al.’s (2013) 
findings from their study examining masculinity as a barrier to men’s use of HIV services in 
Zimbabwe may also offer some explanation for men’s avoidance of HIV testing. Participants 
in their study reported that they delay testing for HIV due to their fear of the disease and their 
fear of how an HIV diagnosis may impact their social construction of the masculine as strong, 
superior and resilient. Another finding from Skovdal et al.’s study (2013) that may be 
relevant in this context, is the finding that men view healthcare settings as female spaces and 
are, therefore, reluctant to visit healthcare clinics. This was evident in this research as, 
mirroring the demographic profile of those who participate HIV vaccine research and related 
activities, few men participated in the focus group discussions with community members who 
participate in HIV vaccine research and community engagement activities at Research Centre 
X. In the context of this research, therefore, men may be reluctant to test for HIV due to their 
fear of the disease and a positive diagnosis. In using their partners’ HIV status as a proxy for 
their own status, they may believe that they have a marker of their own status and have no 
need to enter the female space of the healthcare setting.  
Finally, in this context where HIV/AIDS is associated with death, judgement and 
rejection by family and friends, participants reported that people in their communities are 
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afraid of going to clinics to test for HIV as they fear having their HIV status exposed by 
healthcare staff. They report a lack of trust in healthcare staff who live in their communities 
and a belief that staff will not keep their status confidential. The quotes below highlight this 
fear:  
And another people they scared to go to the clinic to check HIV. They blame, me, 
most of them, I blame, I blame, uhm, the counsellors. Maybe I will find the 
counsellor who knows me when I got there to check HIV and the counsellor she’s 
suppose to, to take that secret information, you understand? For her. But 
tomorrow when she’s go out there, she will tell everyone that “I know her she is 
HIV, she’s what. She was my, er, participant, you understand? And I saw her she 
was nega-, positive I mean.” That’s what I hate another thing. Me, I prefer to 
check with the person who doesn’t know me, who stay far because I’m talking 
from experience. There’s a woman there was working there, at the clinic he told 
everyone about those people who was, e, having a HIV, but she’s still working 
there, that’s the thing I don’t understand. You understand? That’s why, that’s 
why some people they don’t want to go into the clinic and check, because they 
know I’ll find Naledi there, she’s my counsellor and then Naledi is gonna tell 
Michelle, she’s gonna tell everyone, Amanda “Joh2, Anthea she’s got HIV”, you 
understand? That’s what I hate about, e, most of the people they don’t know that. 
(FGD 2, Community Members, Female) 
Most of them are, are, we are staying with them in our community so they know 
us. If, if, I go to, to NY 1 TB clinic and I, and I’m going maybe to test myself and 
at the, they find me positive, she’s gonna tell my next door, next door neighbour, 
you know “I, I, I found Rene positive she was there yesterday”.  
(FGD 2, Community members, Female) 
Simbayi et al. (2007) contend that HIV/AIDS is potentially the most stigmatized 
medical condition. The discussion presented in this theme resonates with this statement as it 
highlights the stigmatization of HIV/AIDS and those who are HIV positive in the local 
community contexts in which the research participants reside. In this setting HIV/AIDS and 
an HIV diagnosis is viewed as a deeply discrediting attribute (Goffman, 1963) and is feared 
and avoided in conversations between community members.  
                                                 
 
2A conversational device used to express disbelief or shock.  
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6.1.2. Theme Two: HIV/AIDS Surveillance in the community. 
Surveillance of community members’ bodies and movements within their communities is 
another feature of HIV/AIDS stigma described by participants in the research. Goffman 
refers to this form of stigmatization as the stigmas of the body (1963). Participants in this 
research describe an atmosphere of hypervigilance prevailing among community members as 
they engage in constant evaluation of each other’s bodies and visits to various settings in the 
community. Community members engage in an ongoing process of looking for signs and 
symptoms of HIV infection in others who they interact with. If they suspect infection, they 
withdraw from that person/s to protect themselves from infection. There are two kinds of 
surveillance under way in the community contexts where the research participants reside, 
namely surveillance of community members’ bodies and surveillance of community 
members’ movements in the community setting. In this community context, people mistrust, 
judge and accuse each other of being HIV positive as the quote below illustrates:  
Hey hey wena, wena3 you are positive” I, I’m just telling you, “You are pointing 
me and the four fingers are pointing to you.  
(FGD 2, Community Members, Female) 
Goffman (1963) describes the process of excluding and disqualifying someone from 
group membership as being based on the identification of physical, behavioural or social 
traits that are perceived to diverge from the group norm. In this setting, surveillance becomes 
an HIV prevention strategy where people’s bodies (physical traits) and movements 
(behavioural traits) are under constant observation for visible signs of and associations with 
HIV/AIDS. Those judged to possess perceived signs of HIV infection by virtue of changes to 
                                                 
 
3Literally means “you”. Used in conversation to affirm that the speaker is addressing the listener specifically.  
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their bodies and the HIV/AIDS-related healthcare settings that they visit in the community, 
are excluded and relegated to outgroup status.  
6.1.2.1. Sub-theme 1: Surveillance of community members’ bodies  
The surveillance of community members’ bodies refers to people’s observations and scrutiny 
of community member’s bodies for physical changes such as weight loss that are perceived to 
be associated with being HIV positive. In the quote presented below, a participant describes 
people in his community as ‘marrow-minded’4 and as judging people’s HIV status based on 
what can be seen with the eye where any change in physical appearance or illness is regarded 
as evidence that the individual is HIV positive. He states that:  
Let’s say I’m sick, I like got maybe, er diabetic like you know and then my, my 
immune system is very low. So what they will do, they will just know that ok I’m 
dying of HIV and AIDS. Whatever disease you’ve got they know it’s, they don’t 
even, even if you have a, a what you call it a virus. They know it’s a disease it’s 
AIDS. They don’t say no you got you got HIV. They say ok you’ve got AIDS 
simple as that.   
(FGD 4, Community members, Male) 
The participant quotes below describe how body weight is scrutinized and monitored 
for indications that people are HIV positive. Those community members who are seen to 
have lost weight are presumed to be HIV positive.  
And then I’m gonna judge you because of your thin. You got HIV, I don’t have 
HIV. I’m well and I’m fat, I’m present. Because by the looks you can’t say that 
one is HIV, this one is HIV. By the looks. Even the fat one can get HIV.  
(FGD 4, Community Members, Male) 
 
In 2007 the time that I was, I was sick. The whole 2006 I was spending my time in 
the Jooste5. I was very sick. Because I, I had a kidney problem so I had to took 
that kidney out. So I was very thin. Thinner than this pen. I was very thin really. 
                                                 
 
4 The participant was intending to use the word “narrow-minded”.  
5 A local governmental hospital.  
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So they will, they will say to my mother, no my mother must tell the truth she she 
knows the, her daughter is positive why don’t she take her daughter to … for 
counselling and all those things. So I just, when, when I came, when I came back 
from the hospital I just showed them I, I’ve got a scar full of blood to prove what 
I, what I have, what I’ve been through. “No, no, no, she’s telling lies. She must 
tell the truth”. Now I’m, now I’m gaining they say “Oh! The, the drugs, the drugs 
are, are taking, are taking care of her” and I said, “Joh! How are the people?” 
 (FGD2, Community Member, Female) 
The association of HIV/AIDS with weight loss has been documented in other studies 
(Dickinson, 2014; Ezekiel et al., 2009). Participants in Dickinson’s study in South Africa 
reported that they could identify people likely to be infected with HIV by looking for visual 
clues of the disease, such as weight loss. They reported that they believed that fat people or 
healthy-looking people are not infected with HIV. In addition, based on changes in physical 
traits, Ezekiel et al. (2009) found that among his research participants in Tanzania, people 
believed that it was possible to tell if someone was infected with HIV with “the naked eye” 
(p. 961).  
The quotes presented above illustrate, how in the study setting where HIV prevalence 
is high and people fear anything related with the disease, participants believe that they are 
able to identify people who are HIV positive by looking for visual clues in the form of 
changes in weight. They discard alternative explanations for weight loss and remain 
suspicious of community members who have for instance lost weight due to surgery. In 
addition, they associate weight gain after surgery with being on ARVs as outlined in the 
quote above. The function of surveillance in this context mirrors that outlined in Ezekiel et al. 
(2009), namely using visual clues to identify those who are HIV positive as the basis for 
avoiding them and relegating them to the out-group (Goffman, 1963).  
6.1.2.2. Sub-theme 2: Surveillance of community members’ movements  
Surveillance also extends to people’s movements within their communities. Community 
members are monitored and observed when they visit settings perceived to be associated with 
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HIV/AIDS testing and treatment. The quotes below illustrate how people are judged to be 
HIV positive due to behavioural traits (Goffman, 1963) such as visiting healthcare facilities 
that offer HIV/AIDS services in their communities:   
Even there by the clinic nê6? There’s the, I think there’s the TB side, there’s the 
HIV side, there is the family clinic side. All the sides. So nê? I’m passing nê? 
Maybe I’m going to abortion side. You see mos I’m gonna pass, so they know that 
there is abortion. After five minutes you sit and “Woe! I did see Karen, she was 
going to do the abortion. They don’t even what I was doing there in that room, so 
that’s why the people like are so scared to go there because maybe my 
neighbours is gonna be there. She’s gonna see, see me sitting in HIV side.  
(FGD 2, Community Members, Female) 
Because. I think, as Naledi says, said, someone will see you there and have that 
mind pointed at you that “you are HIV positive because I saw you going in that 
room”. So obviously, what are you doing in that local clinic, there’s a TB, there’s 
a HIV nothing else. They don’t think that there like people are sick that they just 
flu or something like that, they need to be checked. They don’t see like that. 
People don’t see they like that. They want, if they put their mind on something 
that is that. Nobody can change their minds.  
(FGD 2, Community members, Female) 
The participants also report that, in their community environment, requesting 
information is scrutinized and regarded with suspicion. Such questioning leads to conclusions 
about the person asking for information. As a participant states below:  
And then also like you find out now if that, er, situation, it’s gonna be difficult 
even if to go to the clinic because it’s gonna ask you why you asking that. Even if 
you say my friend got this - because we all know everybody if he’s asking 
something, he’ll say my friend. Where he is the one with the problem.  
(FGD 2, Community Members, Female) 
The quotes above highlight how alternative explanations are discarded in favour of a 
conclusion that labels the individual as HIV positive by virtue of their visits to healthcare 
                                                 
 
6Used as a device to keep the listener engaged or to express questioning such as “really?” 
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settings that provide HIV-related services. In this context, people are afraid of being seen or 
simply asking questions that may result in conclusions about their HIV status.  
The surveillance of bodies (physical traits) and movements (behavioural traits) 
(Goffman, 1963) within the community as described by participants in this theme are based 
on the assumption that judgements of HIV status can be made by looking for visual clues 
(Ezekiel et al., 2009). Based on this assumption, research participants describe how 
community members engage in constant surveillance of others in their community 
environment, searching for visual clues or bodily signs of HIV infection. They withdraw 
from those perceived to be HIV positive on the basis of their observation of such discrediting 
attributes.  Moller and Erstad (2007) attribute such actions of withdrawal to the fact that the 
transmission of HIV is poorly understood and therefore people feel threatened by the mere 
presence, or as in this case, the perceived presence of the disease. In this context, surveillance 
becomes an HIV prevention strategy as community members use it to protect and distance 
themselves from people who they perceive to be “active agents of HIV transmission” 
(Ezekiel et al., 2009, p. 962). Surveillance also creates an atmosphere in which community 
members are afraid to talk about HIV/AIDS for fear of being associated with it.  
6.1.3. Theme 3: Myths, beliefs and rumours about HIV vaccine research. 
The preceding themes outlined participants’ descriptions of fears and beliefs about 
HIV/AIDS and people living with HIV in their community contexts. Moving the focus to 
HIV vaccine-related beliefs, this theme presents participants’ reports of the factors that may 
inhibit participation in the HIV vaccine research being conducted at Research Centre X. 
HVT-related discrimination has been identified as a community-level barrier to HVT 
participation. HIV/AIDS is highly stigmatized in communities in which HVTs are being 
conducted, raising the potential for HVT participants to be stigmatized, discriminated against 
and avoided by virtue of their participation in the research and its associations with 
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HIV/AIDS (Lesch et al., 2006; Mills et al., 2004; Nyblade et al., 2011). Such discrimination 
may impact the daily lives of participants, with research participants reporting fears that they 
will be stigmatized by virtue of their participation in HVTs.  
In my research, participants report that there are myths, beliefs and rumours about the 
research centre, people who participate in the research and research-related procedures 
circulating in their communities. These myths, beliefs and rumours form the basis for the 
stigmatization of research participants and the research being conducted at Research Centre 
X. The myths, beliefs and rumours about Research Centre X and its activities are consistent 
with the narratives of harm outlined by Saethre and Stadler (2013) in their research on 
community perceptions of microbicide research in South Africa. Based on participant reports, 
Research Centre X and the research being conducted there are viewed as harmful to the 
community and as contributing to the spread of HIV in the community.  
6.1.3.1. Sub-theme 1: Myths, beliefs and rumours about Research Centre X. 
As discussed in the preceding themes, HIV/AIDS-related stigma in the communities targeted 
for their participation in HIV vaccine research at Research Centre X has created a community 
context in which HIV/AIDS and anything associated with it is feared, avoided and viewed 
with suspicion. The research participants report that Research Centre X is viewed with 
suspicion by community members who speculate about the function of the research centre 
and its activities. They report that their family members, friends and other community 
members are sceptical about the activities of the research centre and its association with 
HIV/AIDS. In the quotes below, community outreach workers highlight some of the 
responses to Research Centre X that they encounter during their attempts to promote 
participation in the research:  
I've mentioned before, about the myths and misconceptions about the site, I think 
that gives a bad picture to those who are participants here at the site.  Now we 
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are trying to create a good platform or a good way for them to be accepted in 
their own communities, because the stigma is attached even to them when they 
are entering the site.  Now if there is a stigma attached to them when they are 
entering the site, that would make our job very difficult because everyone would 
try to hide him or herself when he or she has to come to the site.  If we can take 
the information and give it to them, what the site is all about and what the people 
who come in and out of here are busy doing, then that would make it easy for 
everyone to feel welcome when they come here. 
(Key informant interview 2, Community Outreach Worker, Male) 
 
We have found that there's a lot of stigma attached to the site, specifically. 
Because you would see participants coming in and out here, but there are those 
who are standing at a distance and looking at them and saying, everyone who 
comes into the centre is HIV positive, or everyone who is working here at the 
centre is HIVpositive. So these are the responses that you get when you go to the 
communities and talk to people about what our job is. Then they would tell us, no, 
we know that place as 1, 2 and 3, and make up about this and that and that. It's 
totally different from what we are actually doing.  So these are the things that we 
need to go out there and rectify and correct, and clarify to the community exactly 
what we are doing there.  
(Key informant interview 2, Community Outreach Worker, Male) 
 
First of all they ask them where they stay they say oh we stay here in Crossroads. 
Ok have you heard about Research Centre X? Somebody will say what’s that it’s 
a Research Centre I don’t know about it what’s research? What do they do? Who 
are they? Then they say Mmm (Yes) ok we’ve seen some people here. Some White 
people drive in and out but we don’t know what they do, I mean who they are. We 
thought maybe they are doing their own stuff.  
(Key informant interview 5, Community Outreach Worker, Female) 
The quotes presented above highlight the misconceptions and erroneous beliefs about 
Research Centre X that community members hold. People are uncertain about its purpose and 
the agendas of the White researchers who occupy the space. In this community context, its 
associations with HIV/AIDS creates scepticism and stigmatization of the Research Centre, its 
activities and the people who are seen to visit it. Community members who visit it, do so in 
secrecy for fear of the community surveillance system by means of which their movement 
into the research centre would be monitored and they would be judged to be HIV positive. 
Subsequently, the lack of knowledge about Research Centre X and its purpose leads to 
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community members making their own interpretations about its purpose, attaching an HIV 
diagnosis to those who visit the research centre. In this way narratives of harm (Saethre & 
Stadler, 2013) about Research Centre X and the stigmatization of the centre and its staff and 
research participants are created based on lack of knowledge, fear, anxieties and taboos about 
HIV/AIDS in the community (Deacon & Stephney, 2007).   
Extending the narrative of harm associated with the research centre, research 
participants report that there are rumours about the activities of the research centre. In 
particular, a participant describes “being stigmatized and being called those guinea pigs”. 
Labelling of participants as “guinea pigs” and “lab rats” in experiments has been cited in 
other studies documenting social harms and discrimination experienced by HVT participants 
(Allen & Lau, 2008; Mills et al., 2004; Newman et al., 2006; Voytek et al., 2011).  
In addition to being labelled as “guinea pigs”, participants report that community 
members are suspicious about the “needle” and believe that they are being injected with HIV 
by researchers at Research Centre X. Participants state:  
They say that when you come to Research Centre X, they are coming to fetch 
AIDS and then more specially when they were get ... when they were injected. 
(FGD 4, Community Members, Female) 
 
Like I said before they said “that vaccine needle is going to give you HIV”. They 
can participate at the start and get the money of the transport but at the end they 
don’t want to participate when it comes to the needle part.  
(FGD 3, Community Members, Male) 
In an extract from Focus Group Discussion 2 in which all participants were female, 
participants reported:  
Participant: Oh you say they put you something here… 
A few participants together: They put HIV!! 
Participant: That’s they only thing they say. 
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Participant: OOO, Joh, Joh, you have HIV!  
Participants laughing. 
Participant: Don’t go dig your own grave.   
Interpreter: She say that when you come here they think you are diagnosed 
with HIV.  
Interviewer: So they think you HIV positive?  
Participant: Ja.  
Participant: I don’t care what they say about me as long as I know my HIV 
status.  
 
Another participant suggests that even healthcare staff at the clinics who conduct 
HIV/AIDS education and awareness-raising activities hold inaccurate perceptions and myths 
about the research and research centre that have to be addressed. A participant describes an 
interaction with a nurse at one of the clinics:   
I talk to the nurses and they were like Mmm (Yes) we’ve heard of that place but 
we don’t trust you guys. Why is it that they come all the way to come and test 
their stuff here? Is it because you are poor? Is it because when we hear that small 
bit of giving us more money you use our bodies to test things that are so foreign 
we don’t understand so even the nurses themselves don’t understand. So it’s like 
more community education must be done.  
(Key informant interview 5, Community Outreach Worker, Female) 
Participants in other HIV vaccine related studies have echoed this fear that scientists 
exploit Black communities, purposefully exposing them to HIV risk by testing untested 
medicines in their communities and experimenting on them (Lesch et al., 2006; Newman et 
al., 2006). Various other studies have also reported myths of purposeful infection of poor 
Black populations by White scientists. Bogart, Kalichman and Simbayi (2008) reported the 
existence of myths that the HI-virus is a secret weapon developed by White people to reduce, 
control and eliminate the Black population. In addition, in the context of microbicide research 
in South Africa, Saethre and Stadler (2013) reported rumours among their research 
participants that clinical trials are a tool through which malicious White people infect 
participants with HIV and sell their blood. These beliefs may also reflect the impact of AIDS 
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denialism through which conflicting messages and misunderstandings of HIV/AIDS were 
perpetuated and communities rejected scientific explanations for HIV/AIDS (Kalichman, 
2009; Nattrass, 2007).  
6.1.3.2. Sub-theme 2: Myths, beliefs and rumours about HIV vaccine research 
participants. 
The prevailing belief about HIV vaccine research participants reported by the research 
participants is the belief that people who participate in HIV vaccine research at Research 
Centre X are HIV positive. They report that visits to the site are associated with being HIV 
positive and therefore anyone seen entering the premises is assumed to be HIV positive. The 
quotes below highlight this belief and accompanying feelings of mistrust in research 
participants who are believed to be “disguising” and encouraging others to come to Research 
Centre X to be infected with HIV:   
Maybe they think the reason we come to this clinic is because we are positive. We 
are just disguising and if they also come here they will also be positive. We are 
calling them to come here and be injected by these needles and get infected by 
HIV.  
(FGD3, Community Members, Female) 
 
Er some think that the site is being attended by the HIV positive people. 
Whenever one gets into the site then they will think that we are all positive living 
people. We are all infected to HIV that’s why we attend the Research Centre X.  
(FGD 1, Community members, Male) 
 
About the, about their ... I think about the lives of the people. If I ... about the lives 
of the people because maybe someone they said Research Centre X or those 
people they came here to visit the Research Centre X and they came here they 
said you got HIV. It’s just ... When you just get in in that gate... it will be obvious 
you’ve got that issue.  
(FGD 4, Community members, Male) 
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Related to the surveillance of movements described in the preceding theme, research 
participants describe how they are subjected to scrutiny and interrogation by fellow 
community members when they are seen leaving Research Centre X:   
I met some people here at the clinic they asked “are you also here in this study” 
then I said yes, they said “We just want to know our status” (Translated from 
Xhosa)  
(FGD3, Community Member, Female) 
 
He said support, support for his statement because the other day when he came 
out of here, the people and there were people standing outside, they looked him 
all the way around the corner. (Translated by Interpreter)  
(FGD4, Community Member, Male) 
The research participants’ experiences of being presumed to be HIV positive by virtue 
of their involvement with Research Centre X is consistent with findings from other studies 
across various settings. These studies show that, like the participants in this study, HVT 
participants are often presumed to be HIV positive by their families, friends and other 
community members who use their participation in the research as the basis for judging them 
to be HIV positive (Nyblade et al., 2011). Mistaken presumptions of a HIV positive status 
have resulted in HIV vaccine research participants being targets for stigma and 
discrimination. These mistaken presumptions are believed to result from community 
members’ lack of knowledge about HIV/AIDS and HIV vaccines (Lesch et al., 2006; Sahay 
et al., 2005).  
6.1.3.3. Sub-theme 3: Myths, beliefs and rumours about HIV vaccine research. 
With respect to misconceptions, rumours and stories about the research and research-related 
procedures, the participants report that community members who had visited the centre, but 
were not participating in the research, have an attitude of scepticism towards HIV vaccine 
research and the procedures involved in the research process. In particular, participants who 
had undergone screening to assess their eligibility to participate in the research being 
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conducted viewed these processes with mistrust and avoided returning to the research centre 
or participating in the studies being conducted. The source of the mistrust and scepticism is 
the possibility of testing false positive, concerns about the being injected with HIV and 
suspicions about other research procedures.  
With respect to the possibility of testing false positive, a participant stated that: 
There are still some who do not strongly believe unto being false positive.   
(FGD 1, Community members, Male) 
According to the participants, the possibility of testing false positive is misinterpreted 
by other organizations in their community and strengthens the suspicions that people are 
being injected with HIV at the research centre. The quotes below illustrate:  
Now the next thing that happens when one gets er into the study you get this er, 
false positive results that is now what I’ve learnt and being on this study for quite 
a time. Er, then the other NGO’s would, would misinterpret this and say that you 
would be injected with HIV already because when you go for a test somewhere 
you will be testing HIV positive.  
(FGD 1, Community members, Male) 
 
Because, they told me, what they told me, my friends, they said no you ... that 
thing has been made by AIDS. Hehehe. So when you, when they vaccinate you 
right, there’s a AIDS on that er whatever it is right, there’s AIDS. So there’s a 
possibility right there’s chances that you can be affected by HIV/AIDS.  
(FGD 3, Community members, Female) 
 
In my community people spread wrong rumours about the vaccine saying that it 
gives people HIV. According to my understanding, vaccine in Xhosa is called 
prevention. It prevents certain disease from being infected by HIV, like sexual 
transmitted diseases so that you are not infected with HIV so easily. When we 
explain this to people they say the vaccine is going to draw disease to them. I am 
talking about my community but still they are concerned when you try to explain 
to them they don’t want to come to Research Centre X.  
(FGD 3, Community members, Female) 
A participant speculates on the reasons why people do not return to the research 
centre after undergoing screening to assess their eligibility to participate in the research:  
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For example the taxi fare is R6 then its R12 for return, can you see that the 
money is more than enough there is even change. I don’t think the money is the 
problem I think the injection is the problem, the vaccine injection. Because when 
you start here the number is 48 but you end up having only 10 people because of 
the injection. People do not want to get involved because of the injection. The 
main thing is about testing whether the vaccine works but it was discovered that 
the vaccine does not work at all, including the placebo. (Translated from Xhosa) 
(FGD3, Community Members, Male) 
Concerns about vaccine-induced seropositivity (VISP) have been highlighted as an 
inhibitor to trial participation in other studies (e.g., Dhalla & Poole, 2011; Newman et al., 
2006). In Newman et al. (2006), participants who cited concerns about VISP as an inhibitor 
to their participation, reported that they would find testing HIV positive as emotionally 
challenging. In the context of this study, it appears that people’s concerns about VISP relate 
to their misunderstanding of the concept. This may be attributed to the difficulties in 
educating lay community members about complexities of HIV vaccine science in contexts 
where levels of education and scientific literacy may be low. Newman et al. (2015) cite 
vernacular vocabularies across multiple languages, belief in traditional healers and lack of 
experience with research as key challenges to explaining important scientific concepts to 
community stakeholders. These researchers also found misunderstandings about VISP in the 
communities in which they conducted their research.   
Community members are also suspicious of the purpose of trial-related procedures 
that involve blood draws. They are reported to believe that participants sell their blood to the 
researchers. A few of the participants report conversations with community members who 
believe that their blood is being sold to the researchers, with the participant incentive serving 
as payment for blood taken.  
I told them that sitsala amagazi (blood is taken) (Translated from Xhosa), then 
they say “they are going to use your blood, sell blood and get money”.  
(FGD 3, Community Members, Female) 
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I don’t know. Maybe because you are giving us money after taking blood... They 
think you are buying us to take the blood and so to sell it.  
(FGD 3, Community Members, Female) 
 
Yes most people ask when we give blood “how much are you going to get” 
(Translated from Xhosa)  
(FGD 3, Community Members, Male) 
Members of the community outreach team also report encountering the myth of the 
sale of blood and other body fluids in their HIV/AIDS and HIV vaccine education, outreach 
and awareness-raising activities. Community members are suspicious of blood draws and 
providing samples of other body products as they perceive it to be related to witchcraft and 
bewitchment. The quote below represents and attempt to correct the perception that research 
participants’ blood is sold:  
Of course you tell them no listen this is how the blood story comes. This is a 
vaccine trial and maybe they need to test your blood and the only way how they 
can test your blood is to draw your blood and then you ask them have you ever 
gone for HIV testing? They say yes. How do they do it? They draw blood. You say 
you see they draw your blood so that they can test this otherwise if they don’t then 
they can’t know that’s how they draw your blood. They don’t take it to sell it so 
then they’re like ok I didn’t understand because why is it that every time they 
draw my blood I thought maybe you guys sell blood. So it’s just giving them more 
information and explaining to make them understand.  
(Key informant interview 5, Community Outreach Worker, Female) 
Concerns about frequent and large volume blood draws, as articulated in the quotes 
presented, have also been mentioned by research participants in other study settings. It has 
been cited as an inhibitor to HIV vaccine trial participation among participants in studies in 
South Africa, Kenya and Tanzania (Asiki et al., 2013, Jaspan et al., 2011; Ruzagira et al., 
2009). Perceptions of blood draws and the sale of blood were also found by Saethre and 
Stadler (2013), where participants are believed to sell their blood to researchers for money. In 
Gambia, Leach and Fairhead (2007), reported that rumours about blood stealing accompanied 
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their research. Inhabitants believed that researchers steal good African blood to be used in 
Europe or America for transfusions or to make medications.  
Finally, in relation to trial-related procedures, participants report that fellow 
community members, friends, and family members communicated suspicion about the 
physical examination and routine medical procedures that they were required to undergo as 
part of the screening procedure. The quotes below provide further insight:  
I also brought 4 people here who are my friends, who said we get money here. I 
said to them they must come here and find out about themselves, I left them here 
it was Thursday. When I went to visit them again to find out how was their visit at 
Research Centre X, they said “that place is not right they asked us to undress and 
show them our private parts”, so I did not know what to say (how to respond) to 
them. (Translated from Xhosa)  
(FGD 3, Community Members, Male) 
I also told my cousin that at the study I did pap smear, because they want to 
check if there is anything wrong with my private parts. She said “Wow, why do 
they do that you are so young for that” I said it is a process of the study then she 
said “Wow, now I don’t trust this study” (Translated from Xhosa) 
(FGD 3, Community Members, Female) 
They also report that community members are unwilling to take contraceptives 
to protect themselves from pregnancy while they are participating in the research for fear that 
it will impact their future fertility:  
The other thing is that there are young girls who do not want to come because 
they will be required to use contraceptives. They do not want to use prevention 
they want to do stuff without prevention. That is the requirement of the study and 
they say they are going to struggle to have children.  (Translated from Xhosa) 
(FGD3, Community Member, Female) 
The use of routine medical screening procedures that are unfamiliar to potential 
participants are, therefore, also articulated by participants as causing concern and 
contributing to their scepticism and mistrust about the research being conducted at Research 
Centre X. Concerns about reproductive screening procedures have not been mentioned in 
other HIV vaccine studies. However, concerns about the need to delay pregnancy and take 
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contraceptives for the duration of participation in HIV vaccine research has been reported as 
an inhibitor to HVT participation by participants in Uganda and Kenya (Asiki et al., 2013; 
Ruzagira et al., 2009).  
6.1.4. Summary: The symbolic context of community engagement in HIV vaccine 
research  
Goffman (1963) highlights the fact that stigma is attached to diseases that are progressive, 
incurable and poorly understood. All these features are present in community members’ 
understanding of HIV/AIDS as reported in the study data. The findings outlined above 
highlight a number of features of the symbolic context of community engagement in HIV 
vaccine research at Research Centre X that inhibits participation in such activities. First, the 
research participants’ reports provide insight into how high levels of HIV/AIDS stigma in 
their community context frame community members’ engagement with HIV/AIDS, people 
living with HIV and the HIV vaccine research being conducted at Research Centre X. In their 
community context, community members describe HIV/AIDS as being associated with death, 
judgement and the rejection of those believed to be HIV positive. People living with HIV are 
viewed with mistrust and suspicion and has having malicious intent to infect others with the 
deadly virus. HIV/AIDS and anything or anyone associated with it, is therefore, feared and 
avoided in their community contexts.  
The second feature of the symbolic context that inhibits community engagement in 
HIV vaccine research follows from the stigmatization of the disease among community 
members and relates to the surveillance of community members’ bodies and movements in 
the community setting. Due to the fear, avoidance and secrecy in which HIV/AIDS is 
shrouded in this setting, surveillance is utilized as an HIV prevention strategy. Surveillance is 
based on the assumption that signs of HIV infection are “visible to the naked eye” (p. 961, 
Ezekiel et al., 2009). Community members observe the bodies of others for weight loss, a 
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perceived marker of HIV infection. They also monitor people’s movements into HIV-related 
healthcare settings in the community setting to observe whether they are “sitting in the HIV 
side”, another perceived marker of HIV infection. Surveillance is used as the basis for 
withdrawing from those who are perceived to be “active agents of HIV transmission” (p. 962, 
Ezekiel et al, 2009).  
The final feature of the symbolic context of community engagement in HIV vaccine 
research that inhibits participation, relates to the narrative of harm (Saethre & Stadler, 2013) 
that has been created about Research Centre X and the research being conducted there. These 
narratives position the research as harmful to the community and as contributing to the spread 
of HIV in the community. As a result Research Centre X, the research being conducted there 
and the research procedures are viewed with mistrust and scepticism. Issues of race and 
power are also evoked by the narrative of harm created. In these narratives malicious White 
people at Research Centre X are perceived to be buying good African blood and testing 
foreign products on community members.  
Deacon and Stephney (2007) point out that the expression of stigma within a given 
setting is a social construct and its impact is exacerbated by the presence of fear, ignorance, 
anxiety, lack of knowledge, denial, shame, taboo, racism and misleading metaphors. Many of 
these contributing features are present in the research setting. In the community setting 
described by the research participants, the possibility of community conversations (Gueye et 
al., 2005) or dialogue about HIV/AIDS in safe social spaces (Campbell et al., 2007) is 
inhibited by the atmosphere of active avoidance and fear of HIV/AIDS and people perceived 
to be associated with the disease. 
Safe spaces for open dialogue about HIV/AIDS and HIV vaccine research (Campbell 
et al., 2007) is crucial to the collective exploration, challenging and reconstruction of 
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perceptions, misconceptions, beliefs and rumours about HIV/AIDS and HIV vaccines 
circulating in this community setting. A key benefit of open dialogue is that it offers 
community members the possibility of exploring their own and other’s knowledge about 
HIV/AIDS and to use each other as resources (Campbell et al., 2007). Such open spaces for 
dialogue have been shown to increase HIV/AIDS knowledge and awareness, to reduce stigma 
and discrimination and resolve misconceptions surrounding the disease (Campbell et al., 
2007; Esma’el et al., 2015).  
In the community context described by the research participants, however, dialogue 
about HIV/AIDS, the benefits of mutual learning and breaking the silence around HIV/AIDS 
through dialogue is not possible given that people avoid talking about the disease for fear of 
being discriminated against by others. For the research participants, this fear holds even in 
settings where their confidentiality is guarded by legislation and healthcare professionals are 
prohibited by law from disclosing information about patients. In this setting, therefore, the 
research participants report that people do not feel safe engaging in health-protective 
behaviours such as seeking information and knowledge about HIV/AIDS and accessing HIV 
testing services for fear of being associated with the disease. Through the absence of dialogue 
in safe social spaces, the status quo about HIV/AIDS and people living with the disease in the 
research setting may, therefore, endure and people may continue to live in fear of contracting 
HIV, of dying and of participating in the research being conducted at Research Centre X.  
6.2. PART 2: “I am the mouth” – The relational context of community engagement in 
HIV vaccine research at Research Centre X  
In this section I present and discuss the findings with respect to the relational context of 
community engagement at Research Centre X using Campbell and Cornish’s (2010, 2011) 
conceptualization of the relational dimension of community mobilization, and the associated 
socio-psychological processes of social capital and empowerment through participation. I 
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present this discussion for the perspective of the community outreach workers who are 
responsible for implementing community engagement processes that support clinical trial 
implementation, and CAB members who provide input into the research and represent the 
interests of the local community in the research process. I present the discussion using a 
number of themes that represent the relational context of community engagement in HIV 
vaccine research at Research Centre X:  
• Community Outreach Workers’ understanding of community engagement in 
HIV vaccine research and their role in the process. 
• Building relational networks in the local community. 
o Building partnerships with lay community members 
o Building partnerships with organizations in the community  
o Building partnerships with the CAB  
In the summary section of this chapter, I reflect on the extent to which the relational 
dimension of community engagement at Research Centre X facilitates empowerment and 
access to social capital for local community members, including the CAB.   
6.2.1. Theme 1: Community Outreach Workers’ understanding of community 
engagement and their role in the process.  
At the time at which the data for this research were collected (2012 to 2013), community 
cutreach workers were aware of the newly published GPP guidelines, but had not received 
training on how to use it in their community engagement activities. Their community 
engagement activities were framed by the prescriptions and requirements of various trial 
sponsors and the training that they received on operational and ethical requirements for 
community involvement at the start of each new trial. This created various challenges for 
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community outreach workers in executing their role of implementing community engagement 
at Research Centre X.  
When asked to describe the purpose of community engagement, community outreach 
workers articulated the operational and ethical goals of community engagement, for instance 
developing establishing linkages and collaborations that facilitate trial implementation. The 
quote below illustrates:  
Primarily really it’s to link the site to the community from a community 
involvement point of view; from a recruitment and retention point of view; as well 
as general awareness or education around err clinical trials.  
(Key informant interview 1, Community Outreach Worker, Male) 
Building on these aspects and echoing community engagement guidance documents 
(e.g., GPP), they describe the community engagement process as a collaborative one in which 
partnership and working “together with” a range of community stakeholder groups is of 
crucial importance.  
One of, of, of the important roles of community engagement is liaising with the 
community through the community advisory board, and liaising with the general 
community stakeholdership through other organizations and structures that are 
in the community so that, you know, they know what is happening here. And in 
any other way, if they are not part of er, the community advisory board, they can 
take part one way or the other, and really to ensure partnership overall in terms 
of reaching out to the community with other stakeholders within the health or 
HIV and AIDS field.  
(Key informant interview 1, Community Outreach Worker, Male) 
Their efforts, therefore, focus on taking the research into the community through 
various community structures that act as mechanisms through which they generate 
community support for and interest in the research process. From this perspective, one of the 
community outreach workers indicated that community engagement involves: “trying to 
please everyone! (laughs)”, providing some insight into their experience of their role in the 
research process and juggling interactions with multiple stakeholder groups, each with 
different needs and requirements. 
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A key challenge that they experience in implementing community engagement at 
Research Centre X, relates to the pressures placed on them to meet recruitment targets as set 
by clinical trial protocols. In contrast to the community engagement guidelines that promote 
partnership and collaboration between all stakeholders across the lifecycle of the trial (Green 
& Mercer, 2001), they report that their input is not sought in clinical protocol development 
and operational planning of clinical trials. The quote below illustrates the frustration that they 
experience with their lack of input and limited access to power and agency in the process:     
So that’s what I think is what I find really frustrating. There’s always constraints 
that stand in the way of us being as good of this as we really could be…it always 
ends up being top down because our top is in the States. We’re not at the top of 
the food chain here. So we’re beholden to them and their timelines. 
(Key informant interview 3, Community Outreach Worker, Female) 
Expanding further, they explain that recruiting participants, a key function of their 
role as it plays itself out in practice, is:  
Ja, it is very, very, very challenging. It's extremely challenging. 
(Key informant interview 3, Community Outreach Worker, Female)  
 
Participant: Yeah like drawing blood from a stone. 
Interviewer:  Oh wow.  
Participant: Yeah and that’s the sort of stuff that people who are writing the 
protocols don’t think about when they’re designing it. No one’s 
talking to say Martha who’s everyday like desperately 
wracking her brain trying to find creative solutions to this 
recruitment issue. Asking her is this feasible? 
(Key informant interview 3, Community Outreach Worker, Female) 
While the purpose of community engagement is building community-researcher 
partnerships with the community in which HIV vaccine research is being conducted to ensure 
their continuous involvement in the process and there is mutual respect and shared ownership 
of the research (Frew et al., 2008; UNAIDS-AVAC, 2011), the community outreach workers 
refer to “recruitment” and encouraging community members to visit Research Centre X, as 
Stellenbosch University  https://scholar.sun.ac.za
147 
 
the primary objective of their community engagement activities. Community outreach 
workers have little input and power in the process of executing meaningful community 
engagement that moves beyond recruitment. Meeting timelines by which clinical trials 
operate and enacting their role, takes priority over their community engagement role, as they 
are challenged to get bodies for experimentation into clinical trials by “drawing blood from a 
stone”. 
Furthermore, community engagement guidelines emphasize the crucial role of socio-
cultural competency, insider perspectives and local knowledge (UNAIDS-AVAC, 2011), yet 
as reported in this context, those who hold such insider perspectives are not consulted about 
the feasibility of recruitment targets set in the local community context. Crucial consultation 
with community outreach workers about the feasibility of such targets within the local 
community context and climate relating to HIV-related research does not form part of the 
target setting process. This has important implications for ensuring the successful 
implementation of clinical trials. Therefore, as community outreach workers’ reports 
illustrate, at the coalface of community engagement, none of the guiding principles of 
community engagement guidelines are enacted and power continues to reside outside of the 
local community context, with clinical trial researchers and funders. These tensions and 
frustrations felt by community outreach workers in their role constitute the context in which 
relational networks are built and in which community outreach workers build partnerships 
with community stakeholders. Their articulation of community engagement falls far short of 
the goals of participatory science that focus on creating room for the active involvement of 
community members as co-producers of knowledge in the research throughout its lifecycle 
(Callon, 1999; Green & Mercer, 2001). 
In response to the challenges that they face in implementing community engagement 
activities and meeting participant recruitment targets, community outreach workers create a 
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supportive network of relationships with stakeholders in the local community, including lay 
community members, local community organizations and CAB members. The purpose of 
these relationships, which make up the relational dimension of community engagement at 
Research Centre X, is to support community outreach workers in “spreading the word” about 
the research being conducted and recruiting community members onto studies being 
conducted, thereby fulfilling operational and ethical requirements crucial to successful trial 
implementation.   
6.2.2. Theme 2: Building relational networks in the local community.   
The relational dimension of community engagement at Research Centre X is expressed in the 
supportive network of relationships created by community outreach workers. In order to 
support their community engagement activities, community outreach workers utilize the 
socio-psychological process of social capital to build a supportive network of relationships or 
partnerships with key community stakeholders, forming networks of social advantage 
through relationships of mutual acquaintance and recognition (Bourdieu, 1986). Social capital 
is built through partnerships and participation (Campbell & Cornish, 2010), and in their 
efforts to build social capital, community outreach workers offer varying levels of 
participation to community stakeholders. Community engagement at Research Centre X as 
described by community outreach workers, therefore, takes place in the context of multiple 
levels of relationships with multiple stakeholders and focusses on building bonding social 
capital or within-community solidarity (Saegert et al., 2001). These partnerships constitute 
three key relational resources that they draw on for support in disseminating information and 
educating the community about HIV vaccine research and ultimately, recruiting community 
members into such research. The three relational resources are: partnerships with lay 
community members (including current HVT participants); partnerships with other HIV-
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related health organizations and government community health centres; and partnerships with 
CAB members.  
6.2.2.1. Sub-theme 1: Building partnerships with lay community members. 
The participation of community members who reside in the community in which the research 
is being conducted has been cited as important to successful trial implementation and the 
development of a safe and efficacious HIV vaccine (Fuchs et al., 2010; Wakefield, 2005). 
Local community members are the target for the first relational resource created by 
community outreach workers as part of the relational dimension of community engagement. 
In developing this relational resource, community outreach workers draw on and establish 
partnerships with lay community members, including current HVT participants. Building 
these relationships on which they draw and tap into to expand their reach into the community 
and maximize access to potential new research participants represents a key source of 
bonding social capital or within-community solidarity for community outreach workers 
(Saegert et al., 2001).  
Community outreach workers describe the focus of their community engagement 
activities as centred on taking the research into the community and “spreading the word”to 
recruit community members into the research being conducted at Research Centre X. Their 
focus is, therefore on providing information, raising awareness and educating community 
members about HIV vaccines and the research being conducted at Research Centre X. Their 
starting point in taking the research into the community is:  
But I think a lot of community outreach would really identify where do you find 
your stakeholders? Where are they? So our stakeholders are the people in the 
community, so we find them at the clinics, you know at the public service centres, 
at clinics, errr social service departments, libraries and, to, to an extent, schools. 
You know? So those are the main places where you’d find groups of people going 
for services. So basically, I can't really say who decided on those, but I think it's 
really standard practice to say, where are the people that you looking for? Where 
do they go?  
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(Key informant interview 1, Community Outreach Worker, Male) 
In the interviews with community outreach workers, many describe how they identify 
locations in the community that afford them access to large numbers of local community 
members who may be potential research participants. They move into local settings, both 
formal and informal, “anywhere where they get a big gathering” to find an audience for their 
awareness-raising and education activities. They also use ad hoc strategies, approaching 
community members in informal settings. They report that they go door-to-door in sections of 
the community and stop to talk to community members about Research Centre X wherever 
they encounter groups of people on the streets. The quote below illustrates:  
What we do, we’ve got a strategy that we call door-to-door campaign where we 
go to knock at peoples’ doors with the aim of recruiting the, recruiting people 
that will be interested for our studies. We also go to train stations where we also 
recruit there as a team. We also go to taxi ranks where we also go as a team and 
recruit there. We also go to ... I mean we go to everywhere that there is a lot of 
people.  
(Key informant interview 4, Community Outreach Worker, Male) 
Therefore, any setting in the community is utilized for community outreach and 
awareness-raising and education about HIV/AIDS and HIV vaccines. Community outreach 
workers use their local knowledge and membership of the community to access community 
members for this purpose. Their purpose in these encounters is to establish initial contact 
with lay community members, providing information, generating interest, inviting lay 
community members to Research Centre X and collecting contact information that they can 
use to maintain contact.  
In addition to taking the research into settings in the communities where “there is a 
lot of people”, the community outreach team also describe using a snowball sampling 
strategy (Sadler et al., 2010), using the social networks of existing research participants to 
access new participants. Sadler et al. (2010) have highlighted the benefits of using this 
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strategy that focusses on using people’s social networks to recruit participants with similar 
characteristics as a vehicle for overcoming recruitment challenges.  
Using the language of partnership, liaising with community members and ongoing 
dialogue are suggested as key to building community-researcher partnerships (HANC, 2014; 
Slevin et al., 2008; UNAIDS-AVAC, 2011). In the quotes below, community outreach 
workers describe how they network with community members and outline the roles that are 
available to them in the HIV vaccine research process:   
They are the people who go out from the site to the community to say there is a 
site there, and it's doing this, you can take part in this way.  Er, you can take part 
either by supporting the site, by being a trial participant, or by being a CAB 
member, or just by spreading the word of what we are doing out in the 
community.   
(Key informant interview 1, Community Outreach Worker, Male) 
Community outreach worker descriptions outline a number of roles for lay 
community members in the research process that includes traditional research participant 
roles such as information and awareness-raising event participant, research participant and 
CAB member, representing the interests of the community. These roles are offered at the 
lowest rungs of the participation ladder, ranging from manipulation (community members are 
involved to serve the goals of research with no role in decision-making processes) to three 
rungs higher up the ladder to a position called “assigned, but informed” (researchers start the 
project and make decisions, assigning community members roles in the project and keeping 
them informed about the project) (SAAVI, n.d.). These low levels of participation do not 
allow community members access to power, control and decision-making in the research 
process. This will not facilitate empowerment of community members to equip them to deal 
with immediate threats to their health and well-being in the community setting.  
In utilizing communities as a resource to expand their information dissemination 
activities, community outreach workers use a snowball sampling recruitment technique, 
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creating a “chain-referral” network (Sadler et al., 2010, p. 3) through which community 
members introduce their friends and family to the activities of Research Centre X by 
“spreading the word” and “starting a dialogue with their friends or family or neighbours”. 
In the quote, below a member of the community outreach team explains how he uses 
community members’ credibility within their family and friends’ networks to access potential 
participants:   
I would tell a particular participant, look here, organize me a group of your 
friends, relatives or whomever that you can find, then phone me or send me a 
please call so that I can come and do a short presentation. Then from that short 
presentation that I'll be doing for them, and then they would believe it because 
they have already seen their sister or their cousin down at the site.  That is what 
I'm actually doing  
(Key informant interview 2, Community Outreach Worker, Male) 
Another community outreach worker describes how existing community structures 
can be used as a resource for keeping community members informed about education and 
awareness-raising events:  
We usually make sure that we go out there in advance and then inform the 
community. We usually work hand-in-hand with the street committees of the areas 
that we are going to be hosting the event in. Then we would go there maybe a 
week before the event, and then that day before the event we would go and make 
door-to-door campaigns so that people are aware of the event that is coming to 
their shores.  Then on the same day, in the morning, we go there again just to 
remind them that the event is today at ten o'clock or nine o'clock, so we would 
like everyone to be there.  
(Key informant interview 2, Community Outreach Worker, Male) 
Community outreach workers also have a supporter role that utilizes community 
members as supporters of Research Centre X, assisting with the dissemination of information 
about the research to others in their community. The roles of CAB members and supporters 
outlined by community outreach workers are consistent with promoting the active 
participation (UNAIDS-AVAC, 2011) of community members in the research process and 
represent a departure from the role of community members as subjects in the research process 
(Green & Mercer, 2001; UNAIDS-AVAC, 2011). These roles involve community members 
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in actual research practices (Lengwiler, 2008) such as sharing information, raising awareness 
of the research and assisting with recruitment of community members into the research. In 
these roles, community outreach workers utilize community members as a resource to 
support the achievement of their goals in the research process, namely spreading the message 
about the research and recruiting community members to participate in the research being 
conducted.  
The articulation of the supporter role for community members is promising and has 
the potential to serve as the foundation for constructing new identities for communities in the 
research process, fostering a sense of empowerment, agency and voice of community 
members over the lifespan of the trial (Frew et al., 2008; UNAIDS-AVAC, 2011). The level 
of participation currently afforded to community members in the process, limits the potential 
for constructing new identities that may facilitate lay community member empowerment 
through their participation in the HIV vaccine research process. Based on their descriptions, 
the role assigned to community members in the community participation process aligns with 
the “assigned but informed” position on the ladder of participation (SAAVI, n.d.). In this 
position, projects are initiated by researchers who retain decision-making power. Researchers 
keep the community informed about their project and assign them roles in the project. In 
assigning community members, this level of participation in the process, consultation and 
incorporation of community members’ views and needs, and their involvement in the 
planning of community participation activities is absent.  
Therefore, while community outreach workers capitalize on and have the advantage 
of the support of lay community members through the bonding social capital that they have 
built, this bonding social capital is not a resource available to lay community members, given 
the low levels of participation and limited roles that they are afforded in the research and 
community engagement process. This is due to the narrow practice of community 
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engagement by community outreach workers at Research Centre X. Lay community members 
are utilized as tools in the process, serving as a mechanism through which community 
outreach workers may disseminate their message deeper into the community and access more 
research participant to meet their recruitment targets.  
6.2.2.2. Sub-theme 2: Building partnerships with organizations in the 
community. 
The second key relational resource that community outreach workers develop in their 
community engagement efforts is partnering with other organizations and integrating their 
own HIV prevention messages into existing forums. This may be viewed as a form of 
relationship-building where members of the community outreach team establish themselves 
as trusted insiders and build solidarity (Campbell et al., 2007) with organizations who share 
their HIV prevention objectives.  
In the quotes below, members of the Community Outreach Team describe the 
community organizations that they engage, collaborate and establish partnerships with in the 
execution of their community participation role:  
So clinics are our primary contacts within the community, so we go to a clinic.  
So the clinics have got targets that they have, as required by the Department of 
Health.  So if they have to have HIV testing, this much HIV testing this much, 
family-planning and so on.  So we work with them because we also have similar 
kinds of targets.  So let's all go to a certain community and say, go to the clinic 
for HIV testing.  Go to family-planning.  Go and treat STIs and so on.  You know, 
we have those contacts.  So mainly that is how we (inaudible recording) the 
community structures: if we have an organization that is doing community 
education, we work with them to say, okay, if we have these companies...for 
instance, the World AIDS Day...it's an effort that involves everybody to say, okay, 
the clinic within that area, Yabonga, which is another organization that's doing 
like youth outreach and so on, let's all meet and let's go to a community.  This is 
who we are, and this is how we are sort of working together to try and develop 
the community.  
(Key informant interview 1, Community Outreach Worker, Male) 
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As described above, community outreach workers report that they collaborate and 
build partnerships with various organizations in the study setting who they believe share their 
agenda of raising awareness, educating and promoting participation in HIV/AIDS prevention 
activities. The process of building partnerships is facilitated by the fact that members of the 
community outreach team reside in the community setting. Gueye et al. (2005) support the 
use of local community members in the implementation of community conversations about 
HIV/AIDS. Local community members hold socio-cultural competence about the community 
(UNAIDS-AVAC, 2011) and may be viewed as trusted insiders who have a vested interest in 
the well-being of the community (Gueye et al., 2005). The trusted insider status of 
community outreach team members may be beneficial to the creation of partnerships that 
serve as the relational networks within which community engagement in HIV vaccine 
research at Research Centre X takes place.   
In their partnership strategy to build bonding social capital and within-community 
solidarity (Saegert et al., 2001) with healthcare clinics, NGOs and HIV-related organizations, 
community outreach workers focus on developing solidarity and mutual networks of support 
that are socially advantageous and supportive of their community participation goals 
(Bourdieu, 1986; Campbell et al., 2007). They integrate their community engagement 
activities into existing infrastructure for HIV prevention in the community, for example 
healthcare clinics that target high HIV risk groups, using these settings to disseminate 
information about HIV/AIDS, HIV vaccines and HIV vaccine research. Through this 
strategy, they ensure that the message about HIV vaccine research and Research Centre X is 
shared with multiple levels of stakeholders throughout the relational network of community 
resources created. It also assists them in drawing on the expertise of healthcare staff who 
have the trust of community members to support their research and influence lay community 
members’ view of the research:     
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Because some of the people would go to the clinic and hear about the Desmond 
Tutu HIV Foundation, then the nurses or whoever are there needs to explain to 
whoever is asking questions around that, what is Desmond Tutu all about. The 
nurses should have some information on what we do, because we go there almost 
every week, on each and every day to do sessions. Now, they need an explanation, 
maybe not from me, but from the other sources like the nurses and the doctors. 
(Key informant interview 2, Community Outreach Worker, Male) 
Various sets of community engagement guidelines promote the establishment of 
consultation, dialogue and active partnerships between stakeholders in the HIV vaccine 
research process (Frew et al., 2008; Nakibinge et al., 2009; UNAIDS-AVAC, 2011). The 
community outreach team’s descriptions of the partnerships established with related 
organizations in the research setting, focus on partnership development as a resource on 
which they draw in their efforts to raise awareness about HIV vaccines and the research being 
conducted at Research Centre X. While they mention the objective “to strengthen the 
relationship between different stakeholders” through their activities, the extent to which the 
collaborations developed by the community outreach team constitute the active and mutually 
beneficial partnerships promoted by “best practice” guidelines (UNAIDS-AVAC, 2011), is 
not clear from participants’ descriptions. Their descriptions emphasize their own access to 
existing networks and does not provide insight into whether such partnerships incorporate bi-
directional communication and input of community stakeholders into their activities and vice 
versa. In fact, one may speculate that the organizations with which they partner do not derive 
benefit from the partnership, and serve merely as a source of support and mechanism through 
which they can access lay community members and achieve trial implementation goals.    
6.2.2.3. Sub-theme 3: Building partnerships with the CAB. 
The final relational resource that community outreach workers develop is partnerships with 
the CAB. CABs act as community representation structures and link researchers to the 
community in which the research is being conducted (Quinn, 2004). The development of 
partnerships with the CAB serves as the third key resource that forms part of the relational 
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network created by community outreach workers and a source of bonding social capital that 
they draw on in “spreading the word” about the research and recruiting participants. Much of 
the CAB reports about their understanding of their role in the community engagement 
process and their experiences as CAB members working with Research Centre X mirrors the 
understanding and experiences reported by community outreach workers. Firstly, community 
outreach workers and CAB members both report their understanding that the CAB plays a 
linking role:  
CAB they play a very big role in terms of the message. What’s happening at the 
site we educate them we give them information. We let them understand what the 
research is and then their role is to go and talk about it in the community you 
know and hear what the community will say and the community will have some 
questions and then the CAB will come back and say you know what this is what 
the community says you know. So we will talk to them and say this is the question 
that the community, they come so these are the questions coming from the 
community and then we try to answer those questions and then they will go back 
and you know. So we work with them like that and then we give them the 
information and then they go and give them you know because we cannot reach 
the whole entire community but also ourselves.  
(Key informant interview 4, Community Outreach worker, Male) 
Members of the CAB echoed the elements of their role in the research process 
outlined by the community outreach workers:   
Ja we, we as this CAB, we actually try to practise the ... I mean for us, how to be 
very well known by the community we ... it actually started with us, trying to move 
around them and be very, very much active within our community, in working 
together with the site. We have tasked each other on certain events together with 
the site going into the community and doing and introducing us ourselves to the 
community at the site as well.  
(FGD CAB members, Male) 
CAB members are chosen on the basis of their membership in key organizations in 
the community (HANC, 2014). CAB members at Research Centre X were invited to serve on 
the CAB as they are all members of organizations providing healthcare and social support to 
at-risk groups within the community. By virtue of their experience of working in these 
organizations in the community and because they reside in the community, they bring their 
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socio-cultural competence or local understanding of the social context in which community 
members make decisions about research participation (Quinn, 2004; UNAIDS-AVAC, 2011) 
to their relationship with researchers, the community outreach team and the lay community 
members who they interact with. Members of the CAB echoed the elements of their role in 
the research process:    
Ja we, we as this CAB, we actually try to practise the ... I mean for us, how to be 
very well known by the community we ... it actually started with us, trying to move 
around them and be very, very much active within our community, in working 
together with the site. We have tasked each other on certain events together with 
the site going into the community and doing and introducing us ourselves to the 
community at the site as well. As we now just from the event our will vaccine they, 
that we had within the community and introduced ourselves and the doctors had 
to do some representation about this site so that we can also be known by the 
CAB by the community at large. 
(FGD CAB members, Male) 
The descriptions above highlight an understanding of the CAB role as a linkage one 
that is consistent with perceptions of their role in HIV vaccine research reported by CAB 
members who participated in Reddy et al.’s (2010) study. At Research Centre X, the 
community outreach workers use their partnership with the CAB as a resource to extend the 
reach of their HIV vaccine research message into the community. The CAB acts as a 
gatekeeper to the community (HANC, 2014) and facilitates information exchange between 
Research Centre X and the community. The information exchange facilitated through the 
mediation role of the CAB constitutes a bi-directional communication and feedback system 
between the two entities. Information about the research is shared at multiple levels of the 
community through the CAB and community members’ complaints and questions about the 
research are fed back to the Research Centre through this informational exchange. The CAB, 
therefore, serves as the foundation for enacting a form of community consultation (Quinn, 
2004). Consultation, however, focusses solely on addressing community questions about the 
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research being conducted at Research Centre X, and does not appear to take into account 
community needs, views and opinions.  
Community outreach workers offer CAB members training to facilitate CAB 
members’ effectiveness as a source of bonding social capital in the community. This expands 
their research competency (UNAIDS-AVAC, 2011). This training is intended to enable them 
to accurately disseminate information about HIV vaccines and HIV vaccine research within 
the community. CAB members are, therefore, offered a level of participation in the 
community engagement process that moves high up the ladder of participation. Their level of 
participation is a position referred to as “consulted and informed”, which denotes a situation 
where researchers start the project and make decisions, but consult the community and take 
their views seriously (SAAVI, n.d.). Parties offered this level of participation are involved in 
the planning of the project, executing it and are kept informed of all research-related 
activities. While CAB members provide input into study documents, community engagement 
activities and recruitment of trial subjects and are kept updated about HVT implementation, it 
does not appear that they have any substantive input into the HVT implementation process 
that aligns it with community views and needs. Based on reports by CAB members who 
participated in Upton’s (2011) study that their interaction with HIV/AIDS information, 
vaccine science and networking opportunities developed their sense of agency, the 
involvement of CAB members at Research Centre X in such activities may similarly promote 
their sense of agency. From their reports, however, it appears as aspects of their participation 
acts as a barrier to their empowerment.  
In spite of a common understanding of the linkage role between the CAB and 
community outreach workers, CAB members express an additional component of their role 
that they view as central to their role as CAB members at Research Centre X. Moving beyond 
their role as mediators between the research and the community, serving the agenda of the 
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scientific enterprise to ensure successful HVT implementation, they assign themselves the 
role of social change agent in the research setting. Many of the CAB members who 
participated in the focus group discussion reported involvement in political and social 
activism. Based on these personal histories, they articulate their social change agent role as 
being activists in the research context, ensuring that community members are not exploited in 
the research process (Visser & Moleko, 2012). CAB members articulate their role as a 
political one, describing it as engaging in advocacy and taking leadership in representing the 
community interests in the research process. They use the language of community 
mobilization used by organizations such as the TAC campaign for access to ARVs (Robins, 
2008), describing themselves as activists for AIDS, fighting the political struggle and 
campaigning for the rights of members of their communities. CAB member describe his 
perceived advocacy role in the HIV vaccine research process in the quotes below:  
I've been doing this work of advocacy for quite some time now you see because at 
school, at a younger age I was at school advocacy, advocating for the rights of 
accessing books free from the department during the apartheid era you see. 
Advocating that, there should be free education, advocate you see it's all those 
things. So I’ve been in that, in the work of advocacy for some time. 
(FGD CAB members, Male) 
CAB members describe themselves as guardians of community interests in the HIV 
vaccine research process, protecting the community interests by acting as “the mouth” to 
ensure that historical experiences of human right violations are not repeated. They report that 
they execute this component of their role by overseeing the research activities, questioning 
the researchers on research-related issues and ensuring that the products generated through 
the research are culturally acceptable to the community. In the quotes below they articulate 
this:   
We have to look for the interest of the communities in that sense but also from an 
HIV prevention point of view the products can be there but if there is no one to be 
tested on and worst part of it is that because of our vulnerabilities I would 
encourage people from our communities to take part in the study because we do 
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not want products that have been tested in communities ... Products that will not 
work for us. Because there are things that just won’t work for us for many, for 
cultural reasons, for many different reasons there are things that won’t work for 
us. So sometimes when a product is tested from that particular community, you 
cannot get the sense of whether it’ll work for that community and also the fact 
that we’ve got very high HIV communities or from those vulnerable communities 
it’s more the reason why we really have to be part of it.  
(FGD CAB members, Female) 
The notion of CAB members protecting community members was also evident in the 
contributions of other CAB members. In this regard CAB members report how they engage 
critically with issues that researchers ask them to consider. In the extract below, they describe 
their role in protecting and representing their community:  
We need communities buy-in also you know and not say but if you look at 
research most of the scientists and researchers coming into Black communities 
are White people you know and we are there to avoid that tension and issues and 
suspicion you know and make people understand to say but we are representing 
you and we are scratching you know. We are on the research side, we are looking 
around.  
(FGD CAB members, Male) 
The South African struggle for liberation and the exploitation of marginalized, Black 
communities is expressed as CAB members use political struggle discourse such as 
“protecting people”, “I’ll die for the community” and rights-based language to articulate 
their role in the community engagement process. They frame their involvement as rooted in 
the pursuit of social justice for the community whose interests they represent. The CAB 
descriptions of their role in protecting and preventing community members from being 
exploited by researchers were also found by Reddy et al. (2010) in their study on the role and 
operations of CABs in HIV vaccine trials in South Africa. In addition, in the quotes, issues of 
mistrust of researchers are articulated by CAB members who express their concern about 
White scientists coming into Black communities to conduct their research. Historical mistrust 
was also reported among South African participants in Newman et al.’s (2015) study. 
Community stakeholders who participated in their study reported mistrust of scientists 
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resulting from the historical oppression and exploitation of Black people in Africa. The myth 
of Research Centre X infecting community members with HIV also surfaces in CAB 
members reports. This belief, that people are harmed in HIV vaccine trials, was also found in 
Newman et al.’s (2015) study. Therefore, mistrust of researchers and the exploitation of 
vulnerable, Black communities frame the relational context and influence how stakeholders 
construct their role in the community engagement process. CAB members, therefore, report 
that they are involved in the community engagement process at Research Centre X to perform 
an oversight and monitoring role, assuring that the research is being scrutinized and that 
community interests are protected, and rights realized.   
The tension between the CAB members’ roles as representatives and gatekeepers of 
their community and their political role as social change agents in the research process, 
creates frustration and tensions for CAB members with the way in which they are engaged in 
the research process. This frustration and dissatisfaction relates to the limited level of 
participation that they are offered in the process. First, they report their dissatisfaction with 
the fact that community consultation and involvement was not initiated before the start of the 
research. Establishing dialogue and two-way information exchange with communities early is 
suggested as important as the basis for transparent, constructive, collaborative and trusting 
relationships between research teams and communities (Lau, Swann & Singh, 2011). The 
CAB reports that this early engagement was not fulfilled and that this has served to create a 
sense of mistrust in community members about the research centre and its activities. The 
quote below illustrates:   
Ja rather than just it’s there and then you go to them they’ll say ok they come and 
then they just want to use us but we don’t know what they’re even doing because 
they just come like you’ll hear about the blood and stuff and say oh maybe they 
came there because they knew we can provide what they want. So they can’t 
imagine it’s for their own good you see ja.  
(FGD, CAB members, Female) 
Stellenbosch University  https://scholar.sun.ac.za
163 
 
Secondly, CAB members also reported their frustration and discomfort with the way 
researchers seek their input into the procedural aspects of the research is sought. CAB 
members report that their input into the design of study documentation is often sought at the 
last minute, offering limited opportunities for consultation with the community members who 
they represent. This frustration is articulated in the quote below:    
Participant: You get frustrated. You know especially… 
Interviewer:  Why? 
Participant: Especially when trials are conducted and you get a informed 
consent document and information sheet to say this you need to 
quickly review and you know the thing is going to Ethics 
Committee, I mean I serve at UCT’s Ethics Committee and 
sometimes I find out that the thing is on the meeting schedule 
and it’s just been given to the CAB you know and people, some 
of people is not available who are competent enough to review 
these documents now we must make time and go through it 
hastily you know, we don’t have time to go out to consult like I 
said we need to operate on a mandate and ask are you 
comfortable with the changes that we are asking… 
Interviewer:  Yes. 
Participant: You know that process because it is a sponsor chasing, now the 
thing must go through, the trial must start and all that. You 
know so that is something that we are battling with. 
 (FGD CAB members, Male) 
This mirrors the issue of power and agency in the process expressed by community 
outreach workers, where timelines for trials take precedence over meaningful community 
input into the process. This may create feelings of dissonance where CAB members are 
assured that their input is valued, but are not treated in ways that support this notion, nor 
given sufficient time to provide the input for which they are sought. 
Providing input into study documentation is a key part of the advisory and oversight 
role of CAB members, ensuring community input into the research process and ensuring that 
study documentation is tailored and adapted to the local community context (Quinn, 2004; 
Reddy et al., 2010; Slevin et al., 2008). In addition, Lavery et al. (2010) promote early 
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community involvement in research activities as a way of ensuring that communities do not 
feel rushed into making decisions of which they have not fully considered the implications to 
meet researcher timelines. The current engagement with CAB members on this key aspect of 
their role results in them feeling hampered in the consultation role for which they have been 
sought as there is often no time for them to consult with the community who they represent 
about key aspects of study documentation. Their role becomes performative, lacking 
authentic and meaningful input into the process in which the power is held by researchers and 
sponsors. UNAIDS-AVAC (2011) points out that it is important to recognize the power 
inequalities between various stakeholders in the HIV vaccine research process and to address 
it. If such power inequalities remain unaddressed, they threaten the notion of equal 
community-researcher partnerships and hamper opportunities for CABs to prevent ethical 
lapses (UNAIDS-AVAC, 2011). They may also impact CAB members’ belief in the 
authenticity of their role in their process and their power to influence the research process 
(Quinn, 2004), as is evidenced from CAB members’ feelings about their involvement at 
Research Centre X above.   
6.2.3. Summary: The relational context of community engagement in HIV vaccine 
research at Research Centre X  
Community engagement is considered crucial to the successful HVT implementation in the 
HIV vaccine research context. Community engagement guidelines emphasize collaborating 
and building partnerships with local community stakeholders to support operational and 
ethical aspects of trial implementation. Guidelines such as the GPP further emphasize 
principles such as community-researcher partnerships, shared ownership, mutually beneficial 
research and ongoing dialogue between researchers and communities (UNAIDS-AVAC, 
2011). Building such community-researcher partnerships, however, rests on the ability of 
community engagement processes to build strong relational networks with local community 
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stakeholders. When built with the focus on achieving authentic and meaningful community 
engagement in the research process, such relational networks have the potential to ensure the 
successful development of a safe and efficacious HIV vaccine, and promoting community 
development in the high-HIV risk, resource poor communities that host HVTs. In presenting 
the findings on the relational context of community engagement, I sought to explore how 
community outreach workers at Research Centre X operate to build a relational network to 
support their community engagement activities. I framed the exploration in the relational 
dimension of Campbell and Cornish’s (2010, 2011) conceptual framework and the related 
socio-psychological processes of social capital (Bourdieu, 1986) and empowerment through 
participation (Laverack, 2006; Rappaport, 1987).  
The exploration revealed a number of features that characterize the relational 
dimension of community engagement at Research Centre X. First, my results revealed the 
fact that the activities of those who implement community engagement activities at Research 
Centre X, namely community outreach workers, are heavily regulated by “outside experts” 
such as clinical trial researchers and funders who place pressure on outreach workers to meet 
recruitment targets. Community outreach workers have limited access to power and agency in 
this process in which their primary function becomes to source research participants to 
participate in the research process. The result is that, at the coalface, they engage in a very 
narrow set of activities: awareness-raising, education, recruitment that has come to represent 
the community engagement process at Research Centre X. In the pressurized environment 
that community outreach workers operate, they are not afforded time to conduct formative 
research to illuminate the contextual complexities that may impact their activities and that 
permits them to develop community engagement strategies that maximize the role of the local 
community in the research process. In addition, the narrow set of strategies that they utilize to 
access potential participants results in them accessing community members who already 
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display agency in accessing healthcare and other resources. They are not accessing hard-to-
reach populations who may be eligible to participate in the research and who may benefit 
from participating in the HIV vaccine research being conducted at Research Centre X. 
Further, in their emphasis on information provision and education as the vehicle to recruiting 
participants, they appear to assume that decisions about participating in HIV vaccine research 
rests on access to information about HIV/AIDS, HIV vaccines and the research process. 
From this perspective, “spreading the word” will lead to an increase in the number of 
community members WTP in the research being conducted at Research Centre X. This 
assumption, as pointed out by Swartz and Kagee (2006), may not hold true and does not take 
into account the dynamics of the personal, family, community and broader social contexts 
that may impact decisions about participation in HIV vaccine research.  
Secondly, community outreach workers draw on the language and terminology of best 
practice guidelines to describe the set of activities that they engage in to promote community 
participation in the HIV vaccine research being conducted at Research Centre X. Drawing on 
key features emphasized for building community-researcher partnerships and promoting 
community participation in biomedical HIV prevention research, they refer to their activities 
as building partnerships, liaising and collaborating with stakeholders and promoting dialogue 
about the research in communities (e.g., HANC, 2014; Slevin et al., 2008; UNAIDS-AVAC, 
2011). The application of this language to describe the activities that constitute community 
participation in this setting, namely HIV/AIDS and HIV vaccine education and recruitment, 
is discomforting as it denies the complexities, inherent power dynamics and socio-political, 
cultural and economic features of the social context that deeply impact the community 
participation process. These aspects hamper the extent to which the goals of best practices are 
achievable, and/or relevant within the social constraints of local clinical trials contexts.  
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Thirdly, successful community engagement is one that is mutually beneficial, serves 
the goals of the scientific process and the community development agenda. It builds social 
capital in the community and empowers community members to address threats to their 
health and well-being. It promotes active participation of community members in the research 
process. At Research Centre X the examination of the relational dimension highlights the fact 
that the community outreach workers operate in an environment where there is tension 
between community engagement goals and trial implementation goals, raising questions 
about the implications of such an approach on how community outreach workers operate to 
build a relational network through which they can recruit community members. The data 
reveals that community outreach workers have developed a set of three key relational 
resources, generating social capital and within-community solidarity (Saegert et al., 2001) 
that they draw on in the execution of their community engagement agenda. Their relational 
network consists of partnerships with lay community members, local organizations and the 
CAB. Community outreach workers attempt to generate within-community solidarity for 
their HIV prevention agenda as the basis for building bonding social capital (Campbell & 
Cornish, 2010; 2011; Saegert et al, 2001).  
In the relational network created, the roles afforded to CAB members and lay 
community members represent limited community consultation and involvement in the 
community process. The extent to which their partners’ capacity-building needs and 
objectives are incorporated into the partnerships created is not clear. It is also not clear to 
what extent their interactions with community outreach workers, as representatives of 
Research Centre X and the resources that it brings into the community, serves as either a 
source of bonding or bridging social capital (Campbell et al., 2007; Campbell & Cornish, 
2010, 2011) for lay community members and CAB members that they can draw on in the 
pursuit of their own agendas and as a resource for promoting their health and well-being. The 
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process by which they offer members of their relational networks roles in the community 
engagement process, serves to deny them an active role in the process and limits their access 
to the social capital available. The within-community solidarity or bonding social capital, 
therefore, exists simply as a resource, for community outreach workers do not promote the 
empowerment of community members and CAB members through their participation in the 
process. In this scenario, the research is not mutually beneficial and solely serves the agenda 
of the scientific enterprise. Bringing the agenda of biomedical HIV prevention and 
community development into closer alignment requires support from those who hold power 
in the research context, clinical trial researchers and funders. 
Biomedical HIV prevention research can become a social good for local community 
members who participate in the research process. Given the extensive resources invested into 
the science of HIV vaccine development and the limited resources available in communities 
who host clinical trials, such research has an ethical imperative to ensure that it leaves 
communities who host their research better off. The goal of leaving communities better off 
while simultaneously pursuing the goal of developing a safe and efficacious HIV vaccine, 
cannot be realized if social processes, such as community engagement, are treated as an add-
on to the process and are limited to focussing on operational and trial implementation goals. 
If clinical trial procedures continue to be prioritized over processes that illuminate the 
dynamics of the local community contexts that support these trials, the notion of community 
members as subjects of research will continue to be perpetuated, impacting both the 
objectives of the HIV vaccine enterprise and the local communities who host clinical trials.   
6.3. PART 3: “I am taught how to take good care of myself” - The material context of 
community engagement in HIV vaccine research at Research Centre X.  
In this section, I present and discuss my findings with respect to the material context of 
community engagement in HIV vaccine research at Research Centre X. The material context 
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refers to the socio-economic features of the community contexts in which community 
mobilisation interventions are conducted (Campbell & Cornish, 2010, 2011). The material 
context has two components: resource- and experience-based agency that permits an 
examination of the extent to which community projects, in this context, HIV vaccine research 
and community engagement processes, support community members in dealing with those 
features of their local contexts that undermine their health and well-being (Campbell & 
Cornish, 2010, 2011). Resource-based agency refers to those resources that people have 
access to in the settings that they live in and includes opportunities to access financial 
resources, food, paid employment, funding for community projects and education. 
Experience-based agency refers to the extent to which the local context provides concrete 
opportunities for community members to practice their skills and exercise agency. Both 
resource- and experience-based agency promote the empowerment of individuals.  
As I have highlighted in earlier chapters, the local communities who host HIV vaccine 
research are characterised by deprivation and multiple risk factors that threaten community 
members’ health and well-being. Risk factors range from the individual to the structural, 
including high rates of poverty and unemployment, poor living conditions, high HIV 
prevalence and risk, low levels of HIV/AIDS knowledge and high rates of AIDS-related 
stigma (AVAC, 2013; Smit et al., 2005, Voytek et al. 2011). These risk factors create 
community contexts in which individuals lack access to resources, including health 
promoting resources that confer protection against HIV in high HIV risk, high HIV 
prevalence environments. It is, therefore, crucial that efforts to develop a safe and efficacious 
HIV vaccine provide short-term and ongoing access to health promoting resources to 
community members who participate in the research process.  
HIV vaccine research is conducted in complex social contexts and involves 
interactions amongst diverse stakeholder parties who participate in the clinical trial process 
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with different perspectives, agendas and levels of access to power and resources (MacQueen, 
2011; Petryna, 2009). In Part One of this chapter, research participants described the 
symbolic context of community engagement in HIV vaccine research as one in which 
HIV/AIDS and anything associated with it is highly stigmatised, feared and avoided, and in 
which the myths, beliefs and rumours about HIV vaccine research and Research Centre X 
that circulate in the community and inhibit participation in its activities. In this setting, the 
symbolic context is described as one that lacks opportunities for open dialogue in safe social 
spaces (Campbell et al., 2007; Gueye et al., 2005). The lack of safe and supportive social 
spaces in the local community in which people can talk openly about HIV/AIDS, their fears, 
and its impact on their own and others’ lives is also illustrated in participants’ descriptions of 
the surveillance networks that operate in their communities. Thus, in this context, the lack of 
safe social spaces, inhibits participation in the activities of Research Centre X, limiting 
opportunities to transform the community dialogue about HIV/AIDS, the factors that fuel its 
spread and HIV-related stigma and fear (Campbell & Cornish, 2010; Esma’el et al., 2015). 
In addition, descriptions of the relational context of community engagement in HIV 
vaccine research at Research Centre X highlight the fact that community engagement is 
characterised by the performance of a narrow range of strategies with the objective of 
recruiting sufficient numbers of participants into the research being conducted. Community 
members who participate in the research and community engagement activities at Research 
Centre X, and CAB members are crucial resources in the relational network created by 
community outreach workers to support them in the execution of an operational task that is 
experienced by those responsible for implementing it as “like drawing blood from a stone”. 
In their role as relational resources in the community engagement process, the participatory 
positions offered to community and CAB members fall far short of ideals for participatory 
science and community-researcher partnerships that position community members as co-
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producers of knowledge (Callon, 1999; Lengwiler, 2008; Slevin et al., 2008; UNAIDS-
AVAC, 2011).  As reported, community and CAB members are offered levels of 
participation at the lowest rungs of the participation ladder. These participatory roles range 
from manipulation to assigned but informed (SAAVI, n.d.) and limit their access to power, 
control and decision-making in the research process. Providing opportunities for those who 
participate in the research to access power, control and decision-making are the crucial 
foundation upon which community and CAB members may develop resource- and 
experience-based agency. Such opportunities may also facilitate their empowerment through 
the development of skills and mastery that equip them to address threats to their health and 
well-being in the local community setting.  
Empowering community members is a core component of, and catalyst for achieving 
social change in community mobilisation interventions (Cornwall, 2008). Empowerment is a 
health-enabling process that uses participation as an intervention strategy and mechanism by 
which community members access knowledge and resources and build skills and 
competencies through collective social action (Campbell & Murray, 2004). Participation is, 
therefore, the pathway through which community members gain mastery and control over the 
social conditions that undermine their health and well-being (Laverack, 2006; Lubek et al., 
2014; Rappaport, 1987). Given the complex social contexts in which HIV vaccine research 
takes place and the description of symbolic and relational contexts that inhibit meaningful 
community engagement in the research being conducted at Research Centre X, in the 
presentation of the findings and discussion outlined below, I examine the perspectives of 
community and CAB members who participate in HIV vaccine research and community 
engagement activities on the material context of community engagement and the extent to 
which it offers them opportunities to access resources that facilitate their empowerment: 
developing resource- and experience-based agency that supports their health and well-being 
Stellenbosch University  https://scholar.sun.ac.za
172 
 
(Campbell & Cornish, 2010, 2011).  I discuss the material context of community engagement 
in HIV vaccine research at Research Centre X using the following themes and sub-themes:  
• Participation promotes empowerment   
o Learning about HIV/AIDS and testing for HIV  
o Access to quality healthcare and supportive relationships 
• Representing the community in HIV vaccine research is challenging  
6.3.1. Theme 1: Participation promotes empowerment  
HIV vaccine trials take place in complex social environments where levels of poverty, 
unemployment, violence and HIV/AIDS are high and access to resources that promote health 
and well-being are low (Lesch et al., 2013). These features of the social context limit access 
to health-enabling resources and undermine the health and well-being of community 
members who reside in these contexts.  As highlighted above, when clinical trials enter 
resource-poor community settings, they expand the levels of health-related resources 
available to community members. HIV vaccine research is a form of combination HIV 
prevention that integrates biomedical, behavioural and educational HIV-prevention strategies 
(Kurth et al., 2011). HIV prevention strategies such as HIV/AIDS and HIV vaccine 
education, VCT, sexual risk counselling and monitoring are embedded in HIV vaccine trials 
as key components of trial design (AVAC, 2009; IAVI, 2009). Participating in HIV vaccine 
research, therefore, mediates community members’ access to health promoting and HIV-
prevention resources. It facilitates their empowerment by providing them with access to three 
key health promoting resources, namely, information and education about HIV/AIDs, quality 
healthcare and screening and supportive relationships with knowledgeable others that enable 
them to address contextual threats to their HIV status. Access to health promoting resources 
is crucial in light of the symbolic context in which participants report that they and others in 
their community lack access to such resources.  
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In this theme, participants report their motivations for participating in the research and 
community engagement activities being conducted at Research Centre X. In contrast to the 
negative and inhibiting views about the research and Research Centre X that they ascribe to 
their friends, families and other community members, they report that they derive numerous 
benefits from their participation. Their descriptions of their participation highlight the fact 
that they view Research Centre X centre as a key resource that provides them with access to 
HIV-prevention services, quality healthcare, support and other related resources.  
6.3.1.1. Sub-theme 1: Learning about HIV/AIDS and accessing health-related 
information 
Accessing information about HIV/AIDS and HIV vaccine is the first health promoting 
resource that participants highlight as an enabler to their participation in the activities of 
Research Centre X. Access to health and HIV/AIDS information (Asiki et al., 2013; Voytek 
et al., 2011) and confidential HIV counselling and testing services (Asiki et al., 2013; Lesch 
et al., 2006) have also been cited as enablers to HVT participation in a number of other 
studies. This sub-theme focusses on participants’ reports of access to opportunities to learn 
more about HIV/AIDS and testing for HIV that serves as the basis for protecting and 
monitoring their own risk of becoming infected with the HI-virus, through their participation 
in the activities of Research Centre X. Participants report that their interest in learning more 
about how to take care of their health motivates them to continue participate in the research 
and other activities being conducted at Research Centre X:  
I like being part of the study because I am taught how to take good care of myself. 
(Translated from isiXhosa)  
(FGD 3, Community members, Female) 
In discussing the benefits that they derive from participating in the activities of 
Research Centre X, the participants reported how they were initially told about the research 
centre by others in their social networks:  
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I heard about the status from my cousin and I was very curious and I like to know 
about my status because I know, other conversations that I’m taking to and 
therefore I like to to find out what is this AIDS all about.  
(FGD 4, Community members, Male) 
To get the info. Because the guy that, in fact not the guy. I think the lady, he was 
working here. No longer working here. Alright. He introduced, he approached me 
to come to Research Centre X and then what he did, he said no go there. You’ll 
get a R20.00.  
(FGD 4, Community members, Male) 
We all started together with this young man attending. Then we were told to come 
here and the class was going to come out at 10. Other people did not accept that 
because people put money first. The information came later when we came here 
the one we got from school was little. What made me to keep on coming here is 
the information I received.  (Translated from isiXhosa)  
(FGD 3, Community Members, Male) 
Mirroring findings of previous studies (e.g., Lesch et al., 2006; Voytek et al., 2011) 
participants report that visiting Research Centre X offers them access to material benefits. 
Their initial research screening visits were, therefore, motivated by their curiosity to know 
their HIV status, access HIV/AIDS information and because of the financial incentives 
attached to research screening visits. Access to material benefits associated with HIV vaccine 
participation, e.g., incentives, has consistently been documented as an enabler to HVT 
participation across a number of settings in which vulnerable, marginalised populations are 
targeted for their participation in HIV vaccine research (Lesch et al., 2006, Newman et al., 
2006; Voytek et al., 2011).  
In a 2006 study conducted by my colleagues and I to investigate enablers and 
inhibitors to participation amongst HIV vaccine trial site members, participants stated that 
they would be likely to participate in HIV vaccine research if they received a financial reward 
for doing so (Lesch et al., 2006). A participant in this study explained his perception that in 
poor communities, being offered a financial reward for HVT participation would overshadow 
people’s concerns about the science associated with HIV vaccine research. In these settings, 
therefore, there are concerns about participant incentives serving as perverse incentives to 
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community members to participate in research in resource poor settings. While these 
incentives also serve as a form of resource-based agency, as highlighted in the quotes above 
for the participants in my study incentives served as an initiating enabler to their 
participation. Community members soon move their focus beyond the financial to the 
opportunities available to access other forms of resource-based agency and experience-based 
agency (Campbell & Cornish, 2010, 2011). These forms of agency take the form of three key 
health promoting resources available to them through participating in the activities of 
Research Centre X, namely, opportunities to learn more about HIV/AIDS and their health, 
access to quality healthcare services and access to supportive relationships with 
knowledgeable others, i.e., staff members at Research Centre X who they interact with via 
their participation. 
In a local community context where HIV is salient, carries high levels of stigma and 
fear and where community members lack safe spaces to access information and talk about 
HIV/AIDS due to the community surveillance system, research participants highlighted 
access to information about HIV/AIDS and confidential VCT services as enablers to HVT 
participation. The quotes below illustrate the importance of accessing information and 
knowing their HIV status:  
Because it’s, it’s, it’s,  ... I think it’s, it’s very exciting. Maybe about about myself. 
I think it’s very exciting that you just know your status and therefore you know 
where you where you stand. And therefore to take forward. That’s where I am.  
(FGD 4, Community members, Male) 
For instance, it motivates me a lot, you see to find out where I am with my status 
and then afterwards, I told myself everything I do, every time I have a sex 
practice, I’ll use a condom, not matter how.  Just to stay positive. So it’s helped 
me a lot.  
(FGD 4, Community members, Male) 
And therefore I told myself anything would happen I would assist myself. Because 
I’ve got brain, I’ve got eyes to see and therefore it depends for me.  
(FGD 4, Community members, Male) 
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Accessing information in this context is accompanied by the second key health 
promoting resource that participants describe, namely access to HIV testing in a safe and 
confidential environment. In the quotes below, participants describe how they engage in 
repeated HIV-testing as part of their HVT participation. While testing for HIV at each 
research visit is a component of the research process, in this context they explain that 
knowing their HIV status serves a health promotion function, motivating them to practice 
safe sex to ensure that they continue to test negative for the HI-virus.  
I want to add to what sisi7 is saying. I believe it is better to know your status than 
not to know. I believe in the saying that “Knowledge is powerful” When you 
don’t know you can get sick and not knowing you will be forced to go to the 
doctor and they will test you because they want to know what is wrong with you. 
You will end up knowing your status and sometimes it’s too late. If you know your 
status early maybe your CD4 count is still low then they will tell you what to do 
so that you don’t get sick. But if it is late then you might get very sick and even 
die because your system is weak. (Translated from isiXhosa) 
(FDG 3, Community members, Male) 
Ja. I’ve been there tested so many times. Nineteen times as u-Nomfundo said, 
many times so I’m fine (laughter). So I’m, I’m definitely fine, so I will not go with 
my boyfriend or I will not go to other places and get tested. So it just, it’s just me 
me and myself and I, nobody else but me and myself and I.  
(FGD 2, Community members, Female) 
What I can say is that what makes me different in my community is that I know my 
status. Whatever do I do it safe more than the one who does not know his status 
he sleep wherever he wants to. So I do as what I am told here. (Translated from 
Xhosa)  
(FDG 3, Community members, Female) 
In this sub-theme, as highlighted in the quotes presented, research participants report 
that participation in the research being conducted at Research Centre X provides access to 
health promoting resources in the form of access to HIV/AIDS information and VCT. These 
                                                 
 
7 Sister  
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resources form the basis of their learning about how to protect themselves from HIV-
infection. They report that the HIV/AIDS knowledge that they acquire empowers them to 
adopt HIV protective practices. Their participation, therefore, becomes a form of personal 
health surveillance and monitoring by which they develop resource-based agency (Campbell 
& Cornish, 2010), i.e., access to health promoting resources such as HIV/AIDS information 
and VCT. Their HVT participation also provides them with access to experience-based 
agency (Campbell & Cornish, 2010) through the monitoring and personal surveillance system 
that it promotes and whereby they monitor their own sexual risk and implement safe sexual 
practices in order to ensure that they continue to test HIV-negative. Their participation and 
the HIV information and education that they access is, therefore, utilized to implement health 
promoting and HIV-protective practices in their everyday lives in-between HVT visits.  
The results in this sub-theme also highlight the fact that research participants credit 
HVT participation with improving their self-efficacy and increasing feelings of 
empowerment mastery, control and agency in an environment in which they report that it is 
“every man for himself when it comes to HIV/AIDS”. Their reports indicate that they 
experience their participation as empowering: it facilitates their ability to exercise mastery 
and control over the threat of HIV/AIDS that they report as salient in their local community. 
Their reports also provide evidence that participation in the research and other activities of 
Research Centre X builds another component of empowerment, i.e., it promotes a 
psychological sense of personal control over their health and well-being (Laverack, 2006; 
Rappaport, 1987). For my research participants, participation thus serves as a health 
promotion intervention, providing them with access to information and creating a supportive 
context in which they can practice health protective behaviours. 
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6.3.1.2. Sub-theme 2: Access to quality healthcare and supportive relationships  
Another element of resource-based agency (Campbell & Cornish, 2010) that participants 
report having access to due to their HVT participation relates to the quality healthcare, and 
the accompanying supportive relationships with knowledgeable others, that they access 
through their participation in the activities of Research Centre X. This represents the third 
key health promoting resource that participants identify as an enabler to their participation. 
Free quality medical care at HVT clinics has been cited as a material benefit that promotes 
HVT participation other studies on WTP (Asiki et al., 2013; Newman et al., 2006). In the 
quote below, the participants in my research report that they value the quality of healthcare 
and screening that they receive at Research Centre X:  
And the other thing is, it’s very important to to to to make people aware of the 
benefits of coming here in terms of knowing about their health. Because it’s not 
just vaccination and er those blood that are drawn and taken to to the UCT 
laboratories or whatsoever. They, they people there in those Labs they check a lot 
of things they don’t only check your, your status you understand? So people 
should be make, even the doctors they say each and everyone should go for check 
up.  
(FGD 2, Community members, Female) 
Well I’m just have to add on to what you have now said that I mean the site’s 
benefits is now actually the most, first one is the whole screening of one and er 
you don’t get er injected with anything unless you you have going through the 
screening which you don’t easily get from any other clinics. If you go to Day 
Hospital8, …you gonna be checked what you have came for and not be 
thoroughly screened and that’s the very first benefit that you gain from the site. 
(Focus Group 2, Community members, Female) 
Because I find that to my advantage. Firstly I get a doctor free, I don’t pay and 
then I like er yeah, and then also if ever I’ve got a problem  no matter I’ve got a 
diarrhoea or vomiting, I phone. Like a, I’ve got like a medical aid similar but for 
free. So, it’s a advantage.  
(FGD 4, Community members, Male) 
                                                 
 
8Community health centre where Primary Health Care services are available.   
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The same participant expands on the healthcare benefits that he derives through his 
participation in the activities of Research Centre X:  
….Like firstly like, the, the what you can get cause I chose this place than going 
to the clinic. Firstly in the clinic I have to woke up early in the morning, 
roundabout past 4. Right? And then wait until 8 o’clock the gate has been opened 
and then there’s a long line. Right? So I arrive at my place around about 3, 
whereas I wake up at 4. But, here I wake up maybe sometimes maybe about 8 and 
then here, I [Inaudible] and then five minutes or, ok, and then even I don’t take a 
taxi. I just walk right, and then for a few minutes right. I’ve got my own thing. 
Sorted. So I chose this place I’m going to the clinic. 
(FGD 4, Community member, Male) 
The quotes provided above highlight participants’ belief that the healthcare treatment 
and screening that they receive at Research Centre X is easily accessible and of superior 
standard to that offered at the community clinics in the area. They highlight the fact that 
screening at Research Centre X is thorough, moving beyond simple testing for HIV. A lack 
of resources characterises the healthcare experience of community members who live in 
impoverished communities in South Africa. It is not surprising, therefore, that these features 
of the healthcare provided at Research Centre X are reported as a benefit associated with 
participation in a context where overcrowding, long waiting times and short, cursory 
consultations characterise the overburdened governmental healthcare system in South Africa.  
Consistent with findings from other studies examining WTP (Asiki et al., 2013; 
Voytek et al., 2011), my research participants also report that, at Research Centre X, access to 
information and healthcare is provided in the context of what they perceive to be supportive 
relationships with the staff members who they engage with. Their perceptions of these 
supportive relationships are outlined in the quotes below:  
I have learnt a lot of things here. They’ve ere r er, they’ve got a good approach. 
They’ve got respect. All those views that you look for for other person and 
therefore you are unable to say anything that you want. Because they are free. 
Because this space there is open for anybody maybe she needs help or he needs 
help you see and therefore they, where were you from those years. Why you came 
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here to know about your status. They didn’t ask those question. They just focus 
where am I supposed to go from here to go on. I think is the best they told me. 
(FGD 4, Community member, Male) 
For instance, I’ve got someone. He’s going to assist me. And therefore here, what 
you said earlier on, this place commercial (?) and therefore I  do believe that 
thing. And therefore there’s a lot of people that can speak to. Even to the 
counsellor, the doctor, you are free to ask anything that you’d like to know. And 
therefore those people, they know their job.  
(FGD 4, Community member, Male)  
The quotes highlight the fact that in the context of the relationships described, they 
believe that they have access to valued expert HIV/AIDS knowledge in a setting where they 
are respected, and are allowed to ask questions in an open and non-judgmental environment.  
The supportive relationships described, therefore, contrast with the prevailing atmosphere of 
stigma, fear and avoidance of HIV/AIDS in their environment, and represent a safe social 
space (Campbell et al., 2007) in which they can engage in dialogue about HIV/AIDS with 
experts at Research Centre X, gathering information to maintain their HIV-negative status. 
These supportive relationships with staff at Research Centre X also serve as form of bridging 
social capital (Campbell et al., 2007; Campbell & Cornish, 2010, 2011). From the perspective 
of community members who participated in my research, it provides them with access to 
networks and relationships of support with staff members at Research Centre X, who are 
external to the community, and who facilitate their access to resources that assist them in 
achieving their goal, i.e., remaining HIV-free in an environment in which HIV-infection 
presents a threat to the health and well-being of community members.  
As outlined above, in my research, participants report that HVT participation provides 
them with access to health promoting resources that promote their active engagement with 
their health. They report that HVT participation makes them feel empowered to adopt health 
protective behaviours as it mediates their access to quality healthcare and supportive 
relationships with healthcare staff. In the participant narrative, therefore, HVT participation 
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fulfils a health promotion agenda. This competes with the researcher narrative in which 
community members serve the role of subjects in the process of scientific experimentation. 
These competing narratives highlight the complexities associated with HVT participation in 
resource-poor settings. In such settings, judgements about the opportunities that HVT 
participation affords for participants to access resources that facilitate their empowerment rest 
with community members who make decisions about HVT participation with consideration 
of the ways in which their local social context undermines their health and well-being. In 
these settings, as expressed by my research participants, HVT participation offers community 
members access to resources that they can use to address health threats, empowering them to 
become active agents in matters of their health and well-being.   
6.3.2. Theme 2: Representing the community in HIV vaccine research is 
challenging. 
“You are not a scientist, you are not a researcher, therefore you need to 
represent the community. You are the mouth”.  
(FGD CAB members, Male) 
A CAB represents the interests of the community in the research process. CABs are expected 
to act as gatekeepers to the community, performing the crucial function of relaying and 
translating information between researchers and community stakeholders (HANC, 2014; 
UNAIDS-AVAC, 2011). In the discussion presented of the relational context, CAB members 
described their role in the community engagement process at Research Centre X as a political 
one. As described in Chapter 5, the CAB members who participated in my focus group 
discussion represented various community organisations and constituents that provide 
healthcare and support services to community members. All CAB members reported histories 
of political involvement and activism in the fight against Apartheid, and articulated their 
involvement in the activities of Research Centre X as a political one, representing the 
interests of the community, and ensuring that the community is not exploited and harmed in 
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the context of the research process. They emphasize key features of their role in the research 
process, including: linking the research to the community, representing community interests 
in the research and protecting the community from having their rights violated. In this theme, 
CAB members describe how the material context of community engagement in HIV vaccine 
research impacts their ability to execute their role in the research process. 
In contrast to research participants, who report that participation in the research and 
activities of Research Centre X affords them access to material benefits, CAB members’ 
reports of the material context represents an extension of their frustration with their role in 
the community engagement process at Research Centre X in the relational context. They 
report that they feel hampered by the material context in which they play the community 
representation role. In this role, they report that lack of access to material resources that they 
perceive to be crucial to performing their advocacy and community protection role inhibits 
their ability function effectively. The quotes below illustrate:  
Participant: Yes and like I said we’re restricted because of resources. 
Interviewer: Ja, ja. 
Participant: You know to have public meeting wherever and talk to the 
community and stuff like that. So that is one of the challenges 
that we face. You know we don’t have the resources to do what 
we really feel like being done out there. 
(FGD CAB members, Male) 
In the extract below, CAB members expresses their frustration with the lack of 
financial and structural resources at the disposal of the CAB to support their operations and 
activities:  
Participant: So that they know exactly what we are planning there are 
resources that’s needed you know and sometimes we’ve got to 
scale down our plan. 
Interviewer:  Yes. 
Participant: Because of there is not enough resources. 
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Participant: Lastly our frustration I told my treasury, you’ll see we 
mentioned is of the, of the budget. We playing without any 
budget. You don’t see the budget. 
Interviewer:  Yes. 
Participant:  That we have a CAB that’s frustrating us. We are good in terms 
of putting things in black and white just a protocol because our 
Comrade has said because there is a challenge we count in 
terms of the resources we are not more pulling the weight all of 
us because of the resources that we don’t have. Had that been 
in (inaudible1.01.48) where we were advocating to have this 
side… 
Interviewer:  Ja. 
Participant:  We’re been told that the CAB will have an office but today we 
don’t have a office. 
(FGD CAB members, Male) 
They also report that lacking access to their own bank account as a CAB separate 
from the rest of the research centre, inhibits their ability to build bridging social capital by 
accessing support from organisations that hold economic and political power (Campbell & 
Cornish, 2010, 2011):  
Participant: I was given a mandate. I don’t care really but I went to a 
director of community building in the City of Cape Town trying 
to hook that particular person for our event that is coming. She 
bought in everything, you know what she ask what’s your 
account… 
Interviewer:  Your account? Your bank account? 
Participant: Yes. Ja the community advisory board their structure, do you 
have an account. I said no. You know she said now how am I 
going to give money, I can't give X Foundation because it’s a 
big foundation, it’s rich such things. I'm glad that he touched 
that thing, I don’t want to touch over money, I don’t want to 
handle monies but this thing is of a higher person who asked 
me what's your account number, I will be the part, I’ll be 
talking because I am the community director in your community 
there and I’ll be pumping something so that refreshments and 
everything can be done in that particular day. I said I’m going 
back to my CAB again. 
(FGD CAB members, Female) 
Finally, a member of the CAB reports feeling that they lack the research competency 
and literacy to assess the documentation that they are provided with by the researchers to 
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explain HIV vaccine science in a way that is accessible to community members. The quotes 
below highlight:  
And another issue is that science does not invest on cover (inaudible1.00.09) the 
CAB and then come up with documents where, because my main issue is that this 
documents all of them including the SOP and the, at the end of the day it is for 
each one of us to clean our conscience to say it was a fair process, I mean being 
a South African I’ve seen that in with the consultation processes of this country. 
So when that document comes to us we must be able to read it and when we say 
yes, when I sign this contract form that you’ve given me I must make sure that I 
understand exactly what does this mean to me. So I don’t think there is much 
effort that is spent on by science to ensure that we understand. So for us at least 
we must read it because sometimes you are nice to the, because you want the 
(inaudible1.00.58) to go on but at the same time we are not sure if we are really 
standing now for what we must stand for really in terms of our communities 
(inaudible).  
(FGD CAB members, Female) 
Reddy et al. (2010) points out that CAB members are recruited by and depend on 
HVT sites for access to resources that they require in order to execute their role in the 
research process. The material context of community engagement for CAB members at 
Research Centre X is one in which these resources have not been provided. The material 
context that they operate in, therefore, is one characterised by a lack of access to resource- 
and experience-based agency (Campbell & Cornish, 2010; 2011). The absence of resources 
includes funds to conduct their community events, office space at the research centre, a bank 
account and sufficient knowledge about HIV vaccine science. The absence of these resources 
creates a material context that, according to CAB members, inhibits their ability to execute 
their community representation and linking role effectively. As a consequence, they feel that 
the integrity of their function within Research Centre X is compromised, leaving them feeling 
disempowered both by the lack of mastery and skills that they are able to develop within the 
Research Centre to execute their role effectively, and also by the limited roles that are 
afforded to them in the community engagement process.  
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6.3.3. Summary: The material context of community engagement in HIV vaccine 
research 
The findings on material context of community engagement highlight contradictory 
perceptions of the community engagement process as promoting the empowerment of those 
who participate in the research and community engagement activities being conducted at 
Research Centre X. From the perspective of community members who participate in the 
research, participation is perceived as empowering as it provides them with access to three 
health promoting resources that assist them in adopting health protective behavioural 
practices and remaining HIV-negative. They also report that access to bridging social capital 
(Campbell & Cornish, 2010, 2011) in the form of supportive relationships with staff at 
Research Centre X in which they are able to ask questions and access information about how 
to maintain their HIV-negative status. For research participants, therefore, participation in the 
research being conducted at Research Centre X provides them with access to resource- and 
experience-based agency and bridging social capital (Campbell & Cornish, 2010, 2011) and 
facilitates their feelings of empowerment and promotes their active engagement with their 
health and HIV-status.   
The data on the symbolic context highlighted the fact that, due to the lack of 
opportunities to access information about HIV/AIDS and the fear and avoidance of 
HIV/AIDS in the community setting, people in the community use the surveillance of the 
bodies and movements of others as an HIV prevention strategy. In the material context 
participants’ reports that “knowledge is powerful”, echo notions about the importance of 
information and ‘’spreading the word’’ in promoting participation in HIV vaccine research 
articulated by community outreach workers. In the case of community members, however, it 
appears that knowledge forms the foundation of action and engaging in health-protective 
behavioural practices, e.g., testing for HIV and practising safe sex. This finding is important 
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as, in the context of HIV prevention, it has been argued that providing individuals with 
knowledge as the platform for behaviour change is likely to have limited chances of success 
(Coates et al., 2008). However, in this context, participants implicate increased knowledge 
about HIV/AIDS as the foundation for adopting health-protective behavioural practices. This 
finding may suggest that, while the local community environment does not permit open 
engagement with HIV/AIDS and inhibits access to information and discussion about the 
disease, Research Centre X, creates a supportive context in which individuals can access 
information and implement HIV-protective practices. Thus, in the provision of HIV-
education and information and other HIV-prevention strategies that form part of the research 
process, Research Centre X creates a transformative social context that supports and 
motivates individuals to practice health promoting behaviours and engage in personal health 
surveillance in between visits to the research Centre.   
CAB members, by contrast, report that the material context of community 
engagement at Research Centre X in which they operate stymies their efforts to act as 
representatives of the community, and creates feelings of disempowerment. They report that 
they lack access to resource-based agency in the form of financial and structural resources. 
Access to resources also serves as markers of symbolic recognition and esteem (Campbell & 
Cornish, 2010, 2011), the absence of which may impact their levels of confidence and 
competency. In addition, their expressed lack of adequate research competency also creates 
dilemmas for CAB members and impacts their ability to provide authentic, meaningful and 
impartial input into study documentation and perform their role in disseminating HIV vaccine 
information to community members who they represent. This dilemma that CABs face is 
explained by Reddy et al. (2010) as a function of their dependence on HVT sites, inhibiting 
their ability to form independent opinions on study-related aspects. While CAB members 
have been afforded a central, crucial linking role, role in the community engagement process, 
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they lack access to the resource- and experience-based agency that facilitates empowerment 
(Campbell & Cornish, 2010, 2011). This, they report, impacts their feelings of competence 
and integrity in executing their role within the process.  
In contrast to findings in the symbolic and relational contexts of community 
engagement at Research Centre X that document the factors that inhibit meaningful 
community engagement in HIV vaccine research in this setting, the findings on the material 
context form basis upon which community engagement in HIV vaccine research at Research 
Centre X may be transformed into health enabling environments. The material context, as 
constructed in the accounts of community members who participate in the research being 
conducted at Research Centre X, provides direct, immediate benefits to these individuals, 
allowing them to access health promoting resources and bridging social capital that facilitate 
their empowerment and equip them to address threats to their health and well-being. From the 
perspectives provided in reports on the material context, therefore, HIV vaccine research at 
Research Centre X is a social good for this group of research participants that uses trial-
related resources to create a health enabling context (Campbell, 2003), that leaves them better 
off by virtue of their involvement in the process. This process of empowerment and the 
supportive context that has been created may serve as the foundation for expanding the role 
of those who participate in the research in the community engagement process, and involving 
them as co-owners and active participants in the process (Green & Mercer, 2001). Such an 
expansion will permit the integration of the agendas of the HIV vaccine research enterprise, 
i.e., developing a safe and efficacious HIV vaccine; with the agenda of the local community, 
i.e., access to resources that build their capacity and facilitate their empowerment, enabling 
them to address threats to their health and well-being.  
Stellenbosch University  https://scholar.sun.ac.za
188 
 
Chapter 7: Concluding comments 
7.1. Introduction  
My research focussed on the local community level of community engagement (Slevin et al., 
2008) in HIV vaccine research and examined the process of community engagement in HIV 
vaccine research at Research Centre X from the perspective of those stakeholders involved in 
the process. In Chapter 3, I discussed what I consider to be success in the HIV vaccine 
enterprise. In my view, successful HIV vaccine research integrates the goals of HIV vaccine 
science with those of the local communities that host the research. Integrating the goals of these 
respective parties, involves investing as much in developing the ‘’social’’, as is invested into 
the process of scientific experimentation. An integration approach uses the HIV-prevention and 
the other resources that accompany HIV vaccine research to create clinical trial contexts that 
generate mutual benefit for all stakeholders involved in the process. The analysis of my data 
was guided by a community mobilisation approach. I interpreted the perspectives of 
stakeholders in the community engagement process at Research Centre X using Campbell & 
Cornish’s (2010, 2011) framework that incorporates the symbolic, relational and material 
contexts that support or undermine community mobilisation.  
In this concluding chapter I comment on a few key aspects of my research. Firstly, I 
sketch a few aspects of my conceptualisation of successful HIV vaccine research that I outlined 
in Chapter 3 to frame my conclusions on the current practice of community engagement at 
Research Centre X. Secondly, I comment on my research findings and the conclusions that 
using a community mobilisation approach to examining community engagement at Research 
Centre X has generated. I reflect on how using the community mobilisation approach may act 
as a starting point for viewing HIV vaccine research in resource-poor contexts as health 
enabling environments that offer immediate, direct benefits to local community members who 
participate in the research.  I also outline key recommendations for creating a health enabling 
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context for community engagement in HIV vaccine research at Research Centre X in the 
symbolic, relational and material contexts. Finally, I outline the limitations and strengths of my 
research on community engagement in HIV vaccine research at Research Centre X.  
7.2. Reframing Success in the HIV vaccine Research Enterprise     
As I have highlighted throughout this thesis, the participation of local communities is believed 
to be crucial to developing a safe and efficacious HIV vaccine (Wakefield, 2005). 
Implementing HIV vaccine research in community settings is political, personal and deeply 
embedded in the local social and historical contexts in which HVTs are conducted (Nowotny 
et al., 2001). HIV vaccine research occupies a position at the intersection between the complex 
global and local relationships between science, society and the social context of the HIV/AIDS 
pandemic. The relationship between scientists and local community members who host such 
research is plagued by histories of mistrust, abuses of power, and violations of the ethical and 
human rights of vulnerable, marginalised populations (MacQueen, 2011; Newman et al., 2015). 
In addition, the features of local communities in which HIV vaccine research is conducted 
includes high levels of HIV/AIDS-related stigma and lack of access to resources, which fuel 
the spread of the virus and complicate efforts to involve communities in the research process. 
The findings of my research highlight the fact that, while efforts to engage the local community 
in the scientific process are complex and challenging, they are also experienced as empowering 
by those who participate in the research. Participants report that they experience their 
participation in HIV vaccine research as empowering and beneficial in equipping them to 
address threats to their health and well-being. This finding is promising and highlights the 
potential for integrating the agendas of the global HIV vaccine enterprise with those of the 
local communities who host the research.  
The community engagement process is an integral component of successful HIV vaccine 
development. It focusses on developing community-researcher partnerships to support HVT 
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implementation and promoting the participation of the local community in the research process 
(Emanuel et al., 2004; UNAIDS-AVAC, 2011). In Chapter 3 I suggested that successful HIV 
vaccine research integrates ethical, operational and community capacity-building goals and 
uses the community engagement process to transform HIV vaccine research into a health-
enabling context (Campbell, 2003). Transforming HIV vaccine research in resource-poor 
environments into health-enabling contexts starts with a commitment by those who design, 
implement and fund such research to move beyond the best practice guidelines and the focus 
on the ethical, scientific and operational vaccine development, to a position that incorporates 
community capacity-building as an integral part of HIV vaccine research. A health-enabling 
HIV vaccine research context position the research as a social good and incorporates three key 
components to promote the empowerment of local community members. Firstly, it generates 
mutual and immediate benefit for the local communities who host the research. Secondly, it 
provides local community members who participate in the research process with access to 
power and health promoting resources that enable them to address threats to their health and 
well-being in the resource-poor environments that they reside in (Campbell & Murray, 2004; 
Campbell & Cornish, 2010).Thirdly, it builds community-researcher partnerships (UNAIDS-
AVAC, 2011) that offer local community members an active role in the research process and 
moves their participation beyond the level of tokens or subjects of research.   
7.3. Creating a Health-enabling Community Context for HIV Vaccine Research at 
Research Centre X: Key Findings and Recommendations   
In this section I comment on my research findings and the extent to which the three key 
components of facilitating local community members’ empowerment via their participation 
highlighted above are reflected in my interpretation of the symbolic, relational and material 
contexts of community engagement of HIV vaccine research at Research Centre X. I also 
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provide recommendations for transforming the symbolic, relational and material contexts of 
HIV vaccine research in this setting.  
7.3.1. On the symbolic context of community engagement in HIV vaccine research 
at Research Centre X 
The findings on the symbolic context of community engagement at Research Centre X 
highlight a community dialogue about HIV/AIDS and anything associated with it that inhibits 
willingness to be involved in HIV vaccine research at Research Centre X. The inhibiting factors 
reported by the research participants in my study mirror those found in other studies examining 
the correlates of WTP (e.g., Dhalla & Poole, 2011; Lesch et al., 2006; Nyblade et al., 2011) 
and include fear, avoidance, judgement and rejection of HIV/AIDS and anything associated 
with it. These features of the community dialogue about HIV/AIDS inhibit the potential for 
transforming the symbolic context of HIV vaccine research at Research Centre X into a health-
enabling context. It also inhibits local community members’ access to the three key 
components that may promote their empowerment via their participation in the research 
process.  
Participating in the HIV vaccine research and community engagement activities at 
Research Centre X carries risks for those who participate. Local community members risk 
being stigmatised and discriminated against due to being mistakenly presumed to be HIV 
positive by association with Research Centre X. The community surveillance system that 
serves as an HIV prevention strategy by which community members’ bodies and movements 
within the community are scrutinised for signs of HIV infection, contributes to this risk, and 
the stigma, discrimination and rejection that may accompany participation in the research. 
Local community members, therefore, must overcome these barriers in order to openly 
participate in the HIV vaccine research and community engagement activities at Research 
Centre X. The narrative of harm about Research Centre X that labels it as a place where people 
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are injected with HIV and are ‘’coming to fetch AIDS’’ also inhibits the transformation of the 
symbolic context of HIV vaccine research. The narrative of harm directly impedes attempts to 
position the research being conducted as social good from which local community members 
may derive benefits and through which they may access resources. The features of the symbolic 
context of community engagement in HIV vaccine research at Research Centre X, therefore, 
represent the most significant barrier to transforming the research into a health-enabling 
context and generating a supportive context for community participation in the research and 
community engagement processes that take place in the local community.  
7.3.1.1. Recommendations for transforming the symbolic context of community 
engagement at Research Centre X 
Initiating dialogue about HIV/AIDS at the community level is integral to addressing the 
HIV/AIDS stigma and discrimination in the study community where participants report that 
HIV is salient but not discussed. The findings highlight the fact that in the research context, 
where HIV/AIDS is cloaked in secrecy, fear and avoidance and accompanied by surveillance, 
rejection and judgement, community members lack access to safe social spaces in which to 
discuss the disease and their fears about it. Creating safe social spaces (Campbell et al., 2007; 
Esma’el et al., 2015) in which the local community can have open community conversations 
about HIV/AIDS is crucial to transforming the current community dialogue and atmosphere 
about HIV/AIDS in this setting. In the research setting, creating safe social spaces for open 
community conversations about HIV/AIDS may also assist with reducing the stigma that 
inhibits engagement with HIV/AIDS and anything associated with it, as has been shown in 
other settings (Esma’el et al., 2015).Without it, attempts to transform the research being 
conducted at Research Centre X into a health-enabling environment based on community-
researcher partnerships and active participation that mediates community members’ access to 
the HIV prevention resources embedded in the research, is unlikely to succeed.    
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Creating safe social spaces for community conversation and dialogue about HIV/AIDS 
and the research being conducted at Research Centre X is, therefore, the foundation upon which 
the research being conducted may be transformed into a health-enabling context. In these safe 
social spaces, community members can share their HIV/AIDS knowledge, challenge different 
perspectives on HIV/AIDS and research and collectively construct their understanding of 
HIV/AIDS and the HIV vaccine research in their community. They can also explore how they 
may participate in the research in ways that are meaningful within their own personal contexts. 
Engaging community members in discussions about HIV/AIDS would rest on overcoming 
their fears and avoidance of HIV/AIDS.  
There are two potential strategies that may be used to initiate community dialogue about 
HIV/AIDS. Firstly, local community members who participated in my research suggested that 
initially, information should be provided in what community members may perceive as a non-
threatening environment. Providing information about HIV/AIDS may be integrated into 
community health events that deal with less stigmatised and less threatening illnesses, e.g., 
screening for diabetes and hypertension, TB, and providing information on adopting health-
promoting behaviours that address the threat of these illnesses. Secondly, building on this 
strategy, community outreach workers who participated in my research reported the importance 
of taking the message about HIV/AIDS, HIV vaccines and the research into any setting where 
community members congregate, e.g., taxi ranks, clinics. They also reported how they utilise 
lay community members as a relational resource to access members of their social networks, 
conducting HIV vaccine education and awareness-raising sessions in these community 
members’ homes. The opportunities created for dialogue through this strategy may also be used 
to create safe social spaces for dialoguing about HIV/AIDS in micro-settings in the community, 
i.e., community members’ homes. Given the current climate and dialogue about HIV/AIDS in 
the community, starting the dialogue in micro-settings may be a usual starting point, 
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destigmatising discussion of HIV/AIDS and acting as a conduit for moving such conversations 
into larger settings in the community. This may include Research Centre X, which current 
research participants describe as a safe and supportive space in which they access health 
promoting resources and the input of experts.  
7.3.2. On the relational context of community engagement in HIV vaccine research 
at Research Centre X 
Given the purpose of my research, that sought to examine the current process of community 
engagement at Research Centre X, the findings that my research generated on the relational 
context are unique. In the relational context, my findings provide insight into the understanding 
and practice of, and the networks of social relationships that support the community 
engagement process. These findings are new in the available social science research on HIV 
vaccines, where examinations of community engagement have tended to mirror the focus of 
research on the correlates of WTP, i.e., focussing on identifying the factors that impact 
community participation and stakeholder engagement (e.g., Frew et al., 2011; Newman et al., 
2015).  
The success of HIV vaccine research rests on the networks of relationships between the 
stakeholders involved (MacQueen, 2011). Findings in the relational context highlight the fact 
that, when clinical trials move out of laboratories and are transplanted into community settings, 
they become an integral part of the local community and the networks of social relationships 
in the HIV vaccine research setting. These relationships serve as the foundation for the 
development of the third key component of successful HIV vaccine research, namely, 
community-researcher partnerships. Community-researcher partnerships that promote active 
participation and meaningful community engagement of community members in the research 
are instrumental in developing community capacity in HIV vaccine research contexts.  
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There are key features of the relational context of community engagement that act as 
barriers to the task of transforming HIV vaccine research at Research Centre X into a health 
enabling environment that require interrogation. Community outreach workers report that, in 
their daily practice, they face the ongoing challenge of navigating the tension between 
community engagement and trial implementation goals. Pursuing trial implementation goals 
and pressures to meet recruitment targets are imposed on them by clinical trial researchers and 
funders. Navigating these tensions impact their community engagement practices on two 
levels. Firstly, it impacts how they operate to build a relational network through which they 
can recruit community members to fulfil the recruitment targets set by funders. They develop 
three relational resources to assist them in fulfilling recruitment targets: partnerships with lay 
community members, community organisations and the CAB. These partnerships serve as a 
source of bonding social capital and within-community solidarity (Campbell et al., 
2007;Saegert et al., 2001) on which community outreach workers draw to achieve their 
recruitment goals. The roles that they offer their partners in the community engagement 
process, denies their partners an active role in the process and limits their access to the social 
capital available through the partnership. The within-community solidarity or bonding social 
capital (Campbell et al., 2007; Saegert et al., 2001), therefore, exists simply as a resource for 
community outreach workers and does not promote the empowerment of community members 
and CAB members. In this scenario, the research is not mutually beneficial and solely serves 
the HIV vaccine research agenda. This is deeply problematic given the context in which the 
research is conducted.  
Secondly, given their limited access to agency and power in executing their community 
engagement role, community outreach workers engage in a very narrow set of activities that 
centre around ‘’spreading the word’’. This narrow set of awareness-raising and educational 
activities that focus on recruitment has come to represent the community engagement process 
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at Research Centre X.  In their descriptions of their community engagement activities, 
community outreach workers draw on the language and terminology of the best practice 
guidelines, referring to the activities that they engage in to promote community participation 
in the research as building partnerships, liaising and collaborating with stakeholders and 
promoting dialogue about the research in communities (e.g., HANC, 2014; Slevin et al., 2008; 
UNAIDS-AVAC, 2011). The application of this language to a community engagement process 
that focusses on education, awareness-raising and recruitment is contradictory and may not be 
appropriate in this context given the focus of the community engagement process and the 
current consultation roles and levels of participation offered to lay community members and 
CABs in the research. It ignores the contextual complexities that impact community 
engagement and the extent to which the goals of best practices are achievable, and/or relevant 
within the social constraints of local clinical trials contexts. 
7.3.2.1. Recommendations for transforming the relational context of community 
engagement at Research Centre X 
There are four areas that require intervention to facilitate the task of transforming the relational 
context of community engagement in HIV vaccine research at Research Centre X into a health 
enabling context. Firstly, given the tensions that community outreach workers navigate and 
their frustrations with the challenges that they encounter in executing their role, the 
development of a fourth relational resource in the form of supportive relationships to address 
their experience that: It always ends up being top down because our top is in the States. We’re 
not at the top of the food chain here. Such relationships will connect community outreach 
workers on both global and local levels of the research that impact their daily practices and the 
challenges that they face. Supportive relationships with community outreach workers will 
create a space for open and ongoing dialogue between community outreach workers and those 
who set recruitment targets that draw on their input as experts with socio-cultural competence 
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(UNAIDS-AVAC, 2011) about the local community. Community outreach workers’ input, 
rather than clinical research operational timelines should, therefore, frame recruitment targets 
and timelines to bring these into closer alignment with the realities of recruitment in the local 
community context. Targets and timelines, rather than being imposed from the outside, can be 
developed in collaboration with those who implement the research in the local community 
context, with closer attention to the barriers to recruitment that they encounter.  
Secondly, given the narrow set of activities and the strong recruitment focus that has 
come to represent the community engagement process at Research Centre X, the notion of 
community engagement must be refocussed to its core function, i.e., building sustained, 
collaborative partnerships with multiple levels of stakeholders who may participate in, be 
affected by or influence the conduct of the research in the local community context (Frew et 
al., 2008; HPTN, n.d.; UNAIDS, 2007; UNAIDS-AVAC, 2011). Refocussing the process will 
generate the various components suggested for promoting meaningful community engagement 
in the research, and gaining community support for the research. For example, relieved from 
the pressures of meeting recruitment targets, community outreach workers could engage in 
rigorous formative research in the local community context to inform their community 
engagement strategy. Formative research will initiate an ongoing dialogue with community 
members that allows community outreach workers to access the myths, misconceptions and 
stories about HIV/AIDS, HIV vaccine research and Research Centre X, that act as barriers to 
participation in this context. It will illuminate the social networks within the community and 
how they operate as the basis on which outreach workers may expand their community 
engagement activities into multiple layers of the community, including hard-to-reach groups. 
It will also create a platform for creating community-researcher partnerships that allow local 
community members and CABs to provide input into the implementation of the research, and 
articulate their preferences, needs and goals. While not directly focussing on the meeting 
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recruitment objective, such community engagement activities promote recruitment by creating 
a supportive local community context for the research participation.  
A third strategy, related to the refocussing of the community engagement strategy, relates 
to ongoing training and development to build community outreach workers’ capacity. In my 
research community outreach workers indicated that they often engaged in ad hoc strategies to 
recruit community members into the research, e.g., using existing participants’ social networks 
and using any setting in the community as an opportunity for ‘’spreading the word’’ about 
Research Centre X. Ongoing training and development facilitate the development of 
community outreach workers’ skills to access the dynamics of the local social contexts, the 
personal, family, community and broader social contexts that may impact decisions about 
participation in HIV vaccine research. Such training will also focus on introducing community 
outreach workers to a range of strategies and techniques for promoting community involvement 
in the research, e.g., initiating community dialogue about HIV/AIDS in safe social spaces 
(Campbell et al., 2007), creating interactive learning spaces that facilitate deep learning 
(Marton & Saljo (1984) of HIV/AIDS, HIV vaccine, research knowledge and promote the 
development of participatory competence (Radebe, 2012). Expanding on the range of strategies 
currently being utilised expands opportunities for providing community members’ access to 
resource- and experience-based agency (Campbell & Cornish, 2010, 2011), and empowering 
them through their participation in the research.  
Finally, given the rigid methodologies that govern randomised controlled clinical trials, 
it is unlikely that community members will participate fully in all stages of the HIV vaccine 
development process. In addition, there are power inequalities between the various levels of 
stakeholders involved in the HIV vaccine research process at the global and local levels that 
challenge the notion of equal partnership. The focus for development of this area is, therefore, 
providing community members with more meaningful roles in the process that moves their 
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level of participation further up the ladder of participation (SAAVI, n.d.). Given the nature of 
clinical research, that is researcher initiated, local communities will not move to the upper level 
of the ladder of participation. Their involvement can, however, be moved to the level where 
they share decision-making with researchers about key aspects of the process and 
implementation of research in the community. They can, e.g., provide input into how to tailor 
the research to the local community so that it promotes participation in the research. While not 
making communities co-owners (Green & Mercer, 2001) of the process, this does make them 
co-producers (Callon, 1999) of meaningful local knowledge. In addition, models of peer 
education, mentorship, and opinion leader models may be used to provide community members 
more active roles in the research, empowering them through giving them the opportunity to 
build experience-based agency (Campbell & Cornish, 2010, 2011) as they ‘’lead the way into 
the community’’.   
7.3.3. On the material context of community engagement in HIV vaccine research 
at Research Centre X 
Mutually beneficial community-researcher partnerships and access to resources that promote 
health and well-being are crucial components of health enabling HIV vaccine research in 
resource-poor contexts. As highlighted above, HIV vaccine research is a form of combination 
HIV prevention and brings resources into communities that host the research. These resources 
include: HIV/AIDS education and awareness-raising, confidential VCT services, health 
screening procedures, sexual risk monitoring and financial incentives (Lesch et al., 2006, 
Newman et al., 2006; Voytek et al., 2011). Participation in HIV vaccine research mediates 
community members’ access to the resources that accompany HIV vaccine research. Through 
participation, the needs, goals and agendas of the local community may be integrated into the 
research process.  
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Alongside the challenges associated with promoting community engagement in HIV 
vaccine research highlighted in the symbolic and relational contexts, the strongest evidence of 
the potential of HIV vaccine research to be transformed into a health-enabling context 
(Campbell, 2003) comes from the results generated in the material context of community 
engagement at Research Centre X. In contexts where HIV/AIDS is salient and levels of access 
to resources are low, HIV vaccine research brings a range of valuable resources into the 
communities that host the research (Lesch et al., 2006). These resources shape the material 
context of community engagement in HIV vaccine research. Participants in my research report 
that they derive benefits, in the form of access to HIV/AIDS education and health promoting 
information, quality screening and healthcare and supportive relationships with expert staff 
members, from their participation in the research. These resources represent resource- and 
experience-based agency that facilitate participants’ feelings of empowerment to deal with the 
threat of HIV/AIDS in their community (Campbell & Cornish, 2010, 2011). Through their 
access to the trial-related resources, participants report that they feel empowered to actively 
engage with their health and adopt health protective behavioural practices. Participants also 
report that their participation allows them to access bridging social capital (Campbell & 
Cornish, 2010, 2011) through the supportive relationships that they have access to with expert 
staff at Research Centre X. These relationships represent an important resource and stand in 
stark contrast to their interactions with healthcare staff in the overburdened public healthcare 
system. Both these aspects generate mutual benefit for the HIV vaccine enterprise and the 
community members who participate in the research.   
In contrast to community members who participate in the research, CAB members 
involved in the activities at Research Centre X report that they lack access to the resource- and 
experience-based agency that facilitates empowerment (Campbell & Cornish, 2010, 2011). 
They report that they lack access to resources, power and control over their role in liaising with 
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the community, linking the community to the research centre and providing authentic input 
into research-related activities. This has an impact on their feelings of competence and in their 
confidence in executing their role within the process. The material context of community 
engagement, therefore, leaves CAB members feeling frustrated and disempowered.   
7.3.3.1. Recommendations for transforming the material context of community 
engagement at Research Centre X 
Access to HIV/AIDS education and information at Research Centre X is highlighted as a key 
resource that promotes the development of resource- and experience-based agency (Campbell 
& Cornish, 2010, 2011) amongst research participants. This information is provided in the 
context of the narrow set of practices that community outreach workers engage in to encourage 
community members to participate in the research being conducted at Research Centre X. 
Information is provided in various community settings, and in HIV vaccine discussion groups 
held at Research Centre X. The strategy of ‘’spreading the word’’ is believed to be instrumental 
to increasing the numbers of community members willing to participate in the research, as 
emphasised by all stakeholders who participated in my research. This perspective, that focusses 
on information as the key facilitator to participation is problematic. It highlights the simplistic 
assumption that information is the key success factor to increasing community participation in 
the HIV vaccine research being conducted at Research Centre X. Participants articulated this 
assumption through their beliefs that “pour us some more and more and more information” 
and “education to open people’s minds and eyes” is the key to dealing with HIV/AIDS stigma, 
fears and avoidance and myths and misconceptions about HIV/AIDS in the community. This 
emphasis on lack of knowledge is reminiscent of the ‘’first generation approaches’’ to HIV 
prevention outlined by Campbell & Cornish (2010, p. 1571) that focus on raising awareness as 
the foundation of behaviour change and use the chalk and talk, didactic approaches conjured 
by expressions such as “pour us some more and more and more information”. Articulating the 
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challenge in this manner is limiting and fails to consider the dynamics of social contexts that 
impact people’s views about HIV/AIDS, scientific research, and their participation in it. It also 
perpetuates static notions of community members as subjects in the research process and 
vessels for information to be transmitted to, rather than co-creators of their own understanding 
and use of information. Building community capacity and empowering community members 
is not solely a function of information provision, it also involves providing people with 
supportive environments in which to process and discuss the information and work out how 
and if it will be useful to them. The notion that lack of information is the key barrier to 
participation, as well as strategies and methods that use passive, didactic methods of 
information transfer to educate communities about HIV/AIDS and HIV vaccine research 
require transformation and innovation.  
A first step in the process involves incorporating and assessment of the levels of 
knowledge about HIV/AIDS, HIV vaccines and scientific research that community members 
have into the formative research process. This includes identifying myths and misconceptions 
about HIV/AIDS, HIV vaccines, HIV vaccine research and Research Centre X. The vignette 
and narrative methods for assessing understanding of key HIV vaccine research concepts 
developed by Lindegger et al. (2006) may be useful in this regard. Secondly, community 
outreach workers must transform their approach to information provision. This involves both 
the content and language used, as well as the method of delivery. Using transformational, 
dialogical and interactive approaches to engaging with lay community members in group 
settings will facilitate this process.  
The CAB can partner with community outreach workers and play an instrumental role in 
transforming the way in which information about HIV/AIDS, HIV vaccines and scientific 
research is shared with community members. Involving them in this aspect of the process may 
act as one way of alleviating CAB members’ feelings of disempowerment in the process. CAB 
Stellenbosch University  https://scholar.sun.ac.za
203 
 
members and lay community members can also partner with community outreach workers in 
the process of creating community dialogue about HIV/AIDS and the research being conducted 
at Research Centre X, generating mutual benefit for all involved in the process as they serve as 
a supportive network and resource to each other. Through this, supportive network bonding 
and bridging social capital (Campbell & Cornish, 2010) may be built that serves as a source of 
support to all stakeholders involved in the process. In addition, lay community members who 
participate in the research at Research Centre X have reported feeling a psychological sense of 
control and agency that equips them to stay HIV-free. Involving them in the process of 
community dialogue about HIV/AIDS, further develops community-researcher partnerships 
and offers them an active role in the process, expanding their levels of resource- and 
experience-based agency (Campbell & Cornish, 2010, 2011).  Evidence-based strategies that 
have been used in community-based health interventions and HIV prevention interventions, 
such as peer education, mentor and opinion leader models can be evaluated to assess which 
strategy offers the best-fit in this context.  
Finally, the feelings of disempowerment experience by the CAB members require 
attention. At present the relationship between the CAB, Research Centre X and the community 
outreach workers is perceived as one-directional. Linking the CAB with the Principal 
Investigators and funders at the research centre to voice their concerns and collectively generate 
solutions is an important first step. While it may simply fulfil a symbolic function, it will ensure 
that CAB members feel that they are being heard, and ensure that those who hold power in the 
research process have clear information about CAB members’ expectations. Such 
conversations may also include developing strategies and timelines that allow the CAB to fulfil 
on their community consultation function. Providing additional training to CAB members that 
develop their participatory competence (Radebe, 2012) in executing their role is also important 
in this regard. Finally, CAB members reported that they lack access to financial resources to 
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host community engagement activities. This suggests that clarification of the role of the CAB 
in the research process is required. Providing CAB members with more active roles in the 
community engagement process, whereby they work closely with community outreach workers 
in the execution of their activities, may address their desire to be involved in community 
engagement activities, rather than being limited to providing input into research-related 
documents and clinical trial implementation aspects.  
7.4. Limitations and Strengths of the Research 
In the section below I highlight the key limitations and strengths of my research.  
My research focussed on the community engagement activities being conducted at one 
research centre and presents the perspectives of stakeholder parties involved in community 
engagement activities that are tied to the local community context. This may limit the 
applicability of my research findings to other settings. However, aspects of my findings may 
have relevance to other research centres who share characteristics with my ‘’typical case’’ 
selection of Research Centre X.  
My research and its findings are also limited by the conceptualisation of community 
used. By adopting the conceptualisation of community utilised by Research Centre X, i.e., the 
high HIV-risk, geographical location in which the research is located, I achieved my goal of 
examining the current practice of community engagement in the research setting by gathering 
the perspectives of a sample of ‘typical’ HIV vaccine research local community stakeholders. 
These research participants display agency in terms of knowing where to access resources in 
an environment in which resources are limited. In my research, they served as the proxy for the 
broader community, sharing community perspectives and beliefs about HIV/AIDS, whilst 
simultaneously distinguishing themselves from others in their community. However, this 
conceptualisation limited the perspectives on community engagement that I accessed. 
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Stakeholder based conceptualisations of community promoted by MacQueen et al. (2001) and 
UNAIDS-AVAC (2011) allow for conceptualisations of community as multi-dimensional. 
Such definitions consider the fact that communities may not be pre-existing and homogeneous 
entities as implied by, e.g., geographical and risk sub-group definitions, but may take shape in 
response to specific issues of common concern and interest (Lavery et al., 2010). Stakeholder 
based definitions may be incorporated into the current conceptualisation of community in the 
research context to add nuance and access broader perspectives on the HIV/AIDS, the research 
and the community engagement process. Applying such definitions may also permit 
researchers and community outreach workers to access broader levels of community than they 
are currently accessing. Due to pressures to meet recruitment targets, community outreach 
workers take an ad hoc approach to targeting community members for their participation in the 
research process. The result is that the perspectives of multiple layers of the local community 
remain absent from the research.  
Due to challenges associated with recruiting community members to participate in 
HIV/AIDS-related research in the research setting, I opted to use the existing recruitment 
system at Research Centre X. I was assisted by two staff members at Research Centre X who 
extended invitations to research participants to volunteer for my research. In taking on this role, 
these staff members may have unwittingly invited volunteers who they believed would present 
a favourable view of the research being conducted at Research Centre X.  
In documenting the current practice of community engagement in HIV vaccine research 
at Research Centre X, I accessed the descriptions of the process through interviewing 
community outreach workers and CAB members. I only have access to their reports of 
community engagement practice and have no way of verifying the extent to which their 
descriptions match actual practices. Ethnographic observations of community engagement 
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activities may have served to illuminate the extent to which descriptions and rhetoric match 
practice.  
My research design, data collection and interpretation represents one possible way of 
interpreting the data. There is much about the dynamics of community engagement in HIV 
vaccine research at Research Centre X that remains unexplored in data that I collected that may 
be illuminated through future analysis using different data collection and analytic techniques 
and theoretical lenses. My research points to a need to explicitly connect the global to the local 
level of community engagement in HIV vaccine research, to further explore the relational 
networks and power relationships that regulate the interactions between stakeholders in this 
context and to formulate new questions to address the issues that plague HIV vaccine research 
in local community contexts. Such questions will move beyond a focus on description to in-
depth evaluations of the dynamics of HIV vaccine research as a complex social process.  
As mentioned in Chapter 3, in executing my research I chose the position of conducting 
critical research that amplies, reveals and makes sense of the community engagement process 
at Research Centre X. A key strength of my research lies in the contribution that it makes to 
the social science literature on HIV vaccine research. Within this body of literature, community 
engagement is framed as a key clinical trial process that facilitates successful trial 
implementation. My research is, to my knowledge, the first study that examines the local 
context of community engagement, documenting the activities, roles, responsibilities, and 
relationships between stakeholders in an HIV vaccine research setting in the South African 
context. In addition, my research departs from the accepted practice of community engagement 
guidelines as the foundation for community engagement activities, and highlights the limits of 
such guidelines to examining dynamics of the local context in which HIV vaccine research is 
conducted. It positions HIV vaccine research as a social process, and questions the current 
ways in which local communities, who are considered to be crucial to HIV vaccine 
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development, are involved in the research process. It also reflects on how such research may 
become mutually beneficial and provide immediate benefits to community members in the 
resource-poor communities that host the research.  
My research is also unique in that it is the first HIV vaccine research study to depart 
from community engagement frameworks, adopting a community mobilisation framework to 
respond to questions about how the research may become a social good that leaves 
communities better off as a function of their participation in the research process (Swartz & 
Kagee, 2006). In this regard, it provides a nuanced and systematic impression of the community 
engagement process at Research Centre X, the social context in which it is implemented and 
those who participate in it. In acknowledging that the goals of the HIV vaccine enterprise and 
local communities are not mutually exclusive, my research reframes the definition of success 
adopted by the HIV vaccine research enterprise, i.e., the development of a safe and efficacious 
HIV vaccine. It highlights how the project of integrating the goals of the HIV vaccine enterprise 
and local communities may be achieved by transforming HIV vaccine research into a health-
enabling context (Campbell, 2003). 
There are limits to my application of the community mobilisation approach to the HIV 
vaccine research context. For example, collective action and active participation are key 
components of community mobilisation approaches (Campbell & Murray, 2004). Due to the 
rigid clinical trial methodologies that are the architecture of HVTs, it is unlikely that either of 
these components will become part of the community engagement process that supports HIV 
vaccine research. While local communities may not contribute to the scientific agenda of the 
research, they can contribute to the social process that such research is transformed into when 
it enters community contexts.  Through their involvement and participation in the social 
process of HVTs they can access trial-related resources that accrue immediate, short-term 
benefits to them and others in their community. This is crucial in HIV vaccine research contexts 
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where HIV risk is high, and access to resources is low. The far-off benefit of a safe and 
efficacious HIV vaccine offers cold comfort to local communities in such environments. 
Adopting a community mobilisation approach to community engagement in HIV vaccine 
research, moves community engagement beyond ‘’spreading the word” towards a more 
meaningful process that is mutually beneficial, promotes access to health-promoting resources 
and facilitates the empowerment of local community members. In such community 
engagement processes, local community members become partners and (more) active 
participants in the process, rather than remaining bodies in and subjects of scientific 
experimentation.  
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APPENDIX 1: Focus Group Discussion Schedule 
  
(Participant sample: community members who have attended HIV vaccine education 
activities conducted at the trial site).  
The focus group discussions covered three areas.  
1. What kinds of HIV vaccine education activities have you participated in at the trial site?  
2. What are some of the beliefs in your community about HIV/AIDS, HIV treatment, 
vaccines and research? How do you think this may influence efforts to educate the 
community about HIV vaccines?  
3. How do people in your community get information about HIV vaccines?  
Probe for:  
o Who can they talk to?  
o Where can they go to get information about HIV vaccines?  
o How do people share information that they get about HIV vaccines with each other?  
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APPENDIX 2: English Informed Consent Form 
INFORMED CONSENT – FOCUS GROUP DISCUSSION 
 
PARTICIPANT INFORMATION LEAFLET AND 
CONSENT FORM 
 
TITLE OF THE RESEARCH PROJECT: 
 
Building scientific literacy: A case study of community participation in HIV vaccine research 
REFERENCE NUMBER: N10/11/366 
PRINCIPAL INVESTIGATOR: Ms Anthea Lesch  
ADDRESS: Department of Psychology, Stellenbosch University, Matieland 7602 
CONTACT NUMBER: (021) 8083456 
You are being invited to take part in a research project.  Please take some time to read the 
information presented here, which will explain the details of this project.  Please ask the 
researcher any questions about any part of this project that you do not fully understand.  It is 
very important that you are fully satisfied that you clearly understand what this research 
entails and how you could be involved.  Also, your participation is entirely voluntary and 
you are free to decline to participate.  If you say no, this will not affect you negatively in any 
way whatsoever.  You are also free to withdraw from the study at any point, even if you do 
agree to take part. 
This study has been approved by the Health Research Ethics Committee at 
Stellenbosch University and will be conducted according to the ethical guidelines and 
principles of the international Declaration of Helsinki, South African Guidelines for 
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What is this research study all about? 
The study will be conducted at the HIV vaccine trial site of which you are a community 
member, HIV vaccine trial site researcher, HIV vaccine educator, HIV vaccine recruiter or 
community advisory board member in the Western Cape, South Africa. Approximately 110 
participants will be recruited to participate in this study.  
The aim of this study is to find out about the HIV vaccine education activities that have been 
taking place at your trial site and to learn more about how community members participate in 
the HIV vaccine education activities that have been held at your trial site. The information 
collected from the study will be used to develop a model for teaching members of your 
community about research and HIV vaccines. The researcher will work with community 
members, HIV vaccine researchers, HIV vaccine educators and recruiters and community 
advisory board members at your trial site to develop this model.  
Data for the study will be collected using interviews, focus groups, observations, 
questionnaires and trial site documents.  
Why have you been invited to participate? 
You have been invited to participate in this study because you have attended HIV vaccine 
education workshops or other education events conducted at the HIV vaccine trial site.  
What will your responsibilities be? 
You will be asked to participate in a focus group discussion which will be conducted by the 
researcher and an interpreter. You will be asked questions regarding the community 
education activities that you participated in at the HIV vaccine trial site. The focus group 
discussion will last approximately 90 minutes.  
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Will you benefit from taking part in this research? 
There are no personal benefits associated with your participation in this research. The 
data collected from this study will be used to collaborate with stakeholders at your trial site to 
design a community-based education model to promote understanding of research and HIV 
vaccines in the trial site community.   
Are there in risks involved in your taking part in this research? 
There are no risks associated with your participation in this research study.  
Who will have access to your personal information? 
All information collected as part of this study will be treated as confidential and protected. If 
information is used in a publication or research thesis, your identity will remain anonymous. 
All documentation containing identifying information and other confidential documentation 
collected will be stored in locked cabinets and only the researcher will access these records. 
The focus groups will be tape-recorded. The recordings will be stored in locked cabinets and 
only the researcher will have access to the recordings. The recordings will remain in locked 
storage at the completion of the study. 
Will you be paid to take part in this study and are there any costs involved? 
No you will not be paid to take part in the study but your transport and meal costs will be 
covered for your study visit.  There will be no costs involved for you, if you do take part. 
Is there anything else that you should know or do? 
You can contact the Health Research Ethics Committee at 021-938 9207 if you have any 
concerns or complaints that have not been adequately addressed by the researcher.  
You will receive a copy of this information and consent form for your own records. 
Declaration by participant 




By signing below, I …………………………………..…………. agree to take part in a 
research study entitled Building scientific literacy: A case study of community participation 
in HIV vaccine research. 
I declare that: 
 
• I have read or had read to me this information and consent form and it is written in a 
language with which I am fluent and comfortable. 
• I have had a chance to ask questions and all my questions have been adequately 
answered. 
• I understand that taking part in this study is voluntary and I have not been 
pressurized to take part. 
• I may choose to leave the study at any time and will not be penalized or prejudiced in 
any way. 
• I may be asked to leave the study before it has finished, if the study doctor or 
researcher feels it is in my best interests, or if I do not follow the study plan, as agreed 
to. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2011. 
   
Signature of participant Signature of witness 
 
Declaration by investigator 
I (name) ……………………………………………..……… declare that: 
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• I explained the information in this document to ………………………………….. 
• I encouraged him/her to ask questions and took adequate time to answer them. 
• I am satisfied that he/she adequately understands all aspects of the research, as 
discussed above 
• I did/did not use an interpreter.  (If an interpreter is used then the interpreter must sign 
the declaration below. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2011. 
    
Signature of investigator Signature of witness 
 
Declaration by interpreter 
I (name) ……………………………………………..……… declare that: 
 
• I assisted the investigator (name) ………………………………………. to explain the 
information in this document to (name of 
participant) ……………..…………………………….. using the language medium of 
Afrikaans/Xhosa. 
• We encouraged him/her to ask questions and took adequate time to answer them. 
• I conveyed a factually correct version of what was related to me. 
• I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her question satisfactorily answered. 
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Signed at (place) ......................…........…………….. on (date) …………....……………….. 
   
Signature of interpreter Signature of witness 
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APPENDIX 3: Xhosa Informed Consent Form 
INCWADANA ENGOLWAZI NGOMTHATHI-NXAXHEBA KUNYE NEFOMU 
YEMVUMELWANO 
ISIHLOKO SEPROJEKTHI YOPHANDO: Building scientific literacy: A case study of 
community participation in HIV vaccine research 
INOMBOLO YONXULUMANO: N10/11/366 
UMPHANDI OYINTLOKO: Ms Anthea Lesch 
IDILESI: Department of Psychology, Stellenbosch University, Matieland 7602 
INOMBOLO YOQHAKAMSHELWANO: (021) 808 3456 
Uyamenywa ukuba uthathe inxaxheba kule projekthi. Nceda uthathe ixesha lakho ekufundeni 
iinkcukacha nolwazi oluqulethwe kolu xwebhu, noluphathelene nesi sifundo sophando. 
Ukhululekile ukuba ubuze nayo nayiphi na imibuzo malunga naliphi na icandelo lesi sifundo 
sophando, okanye ubuze nayiphi na into ethe yangakucaceli ngesi sifundo sophando. 
Kubalulekile ukuba woneliseke ukuba uziqonda ngokupheleleyo zonke iinkcukacha 
eziphathelene nesi sifundo sophando, kwanendima ozakuthi uyidlale kuso. Ngaphezu koko, 
ukuthabatha kwakho inxaxheba kwesi sifundo sophando ukwenza ngokukhululekileyo, yaye 
unganyanzeliswanga (ukwakhululekile ukuba ungavumi ukuthabatha inxaxheba xa uthe 
wangathandi). Ukuba awuvumi ukuthabatha inxaxheba, loo nto ayizi kukuchaphazela 
nangayiphi na indlela. Ukwakhululekile ukuba urhoxe kwisifundo sophando nangaliphi na 
ithuba, nditsho nokuba ubuvumile ukuthabatha inxaxheba.   
Esi sifundo sophando siphunyezwe yiKomiti Ejongene Nemigaqo Yezifundo Zophando 
kwiYunivesithi yaseStellenbosch, yaye siza kuqhutywa ngokwemigaqo ephathelene 
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nezophando kwizifundo zophando-zifundo ze-Helsinki, South African Guidelines for Good 
Clinical Practice kwakunye ne-Medical Research Council (MRC) Ethical Guidelines. 
Simalunga nantoni esi sifundo sophando?  
Esi sifundo sophando siza kuqhutywa kwicandelo lovavanyo-machiza oluhlola 
intsholongwane ye-HIV kwingingqi yakho yasekuhlaleni, nalapho ungumphandi wesifundo 
saloo ndawo, okanye ufundisa ngentsholongwane ye-HIV, okanye usenza izimemelelo 
zokuhlola ngentsholongwane ye-HIV, okanye ulilungu elikwibhunga elinika ngeengcebiso 
kwiPhondo laseNtshona Koloni, eMzantsi Afrika. Ngokomlinganiselo, bangama-110 
abathabathi-nxaxheba abazakuthi bamenyelelwe ukuthabatha inxaxheba kwesi sifundo 
sophando. 
Injongo yesi sifundo sophando kukufumanisa ngokubanzi malunga nemfundiso 
ngentsholongwane yamachiza e-HIV, mfundiso leyo esele ilithuba iqhuba kwingingqi leyo 
omiselwe kuyo, kwanokufunda ngokubanzi ngeendlela abathi abantu basekuhlaleni 
bathabathe ngayo inxaxheba kwiinkqubo zokufundisa ngentsholongwane ye-HIV 
ebeziqhutywa kuloo ngingqi yakho yovavanyo-machiza. Ulwazi oluqokelelwe kwesi sifundo 
sophando luza kusetyenziswa ukuphuhlisa indlela yokufundisa kwanokuxhobisa abantu 
basekuhlaleni kwingingqi yakho ngokuphathelene nophando lwesifundo kwanamachiza e-
HIV. Umphandi uza kusebenza namalungu okanye abantu basekuhlaleni, nabaphandi 
bamachiza, abafundisa ngamachiza, kwanabo bamemelela abantu ekuvavanyeni amachiza e-
HIV, kwakunye namalungu akwibhunga elinika ngeengcebiso kwingingqi leyo yokuvavanya 
omiselwe kuyo, ngeenjongo zokuphuhlisa le ndlela isetyenziswayo yokufundisa 
ngentsholongwane ye-HIV. 
Iingqokelela zolwazi oluthe lwaphuhliswa nolukwavezwe sesi sifundo sophando, ziza 
kuqokelelwa ngokuthi kusetyenziswe udliwano-ndlebe (okanye uluhlu lwemibuzo), 
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neengxoxo ezenziwa ukuxovulula imiba ethile ebuziweyo, nokubeka iliso kukwajongwa abo 
bathabatha inxaxheba, noluhlu lwemibuzo oluqulethwe kwiphepha-mibuzo, kwanamaxwebhu 
axela imo yengingqi leyo yovavanyo-machiza. 
Ingaba kutheni umenywa ukuba uthabathe inxaxheba kwesi sifundo sophando?  
Umenyiwe ukuba uthabathe inxaxheba kwesi sifundo sophando kuba sele ukhe wangomnye 
wabo bantu bathe bafumana imfundiso yovavanyo lwamachiza e-HIV okanye ezinye 
iimfundiso ebeziqhutyelwe kuloo ngingqi yovavanyo lwamachiza e-HIV.  
Ingaba yintoni omelwe kukuyenza xa uthabatha inxaxheba kwesi sifundo sophando? 
Uza kucelwa ukuba uthathe inxaxheba kwingxoxo egqalileyo yeqela eza kuqhutywa 
ngumphandi netoliki. Uza kubuzwa imibuzo mayela neenkqubo zemfundo zasekuhlaleni 
okhe wanenxaxheba kuzo kwindawo yolingo lwesitofu se- HIV. Ingxoxo egqalileyo yeqela 
izakushicilelwa kwaye iza kuthatha malunga nemizuzu engamashumi alithoba (90). 
Ingaba uza kuxhamla (okanye wenze inzuzo) ngokuthabatha kwakho inxaxheba kwesi 
sifundo sophando?  
Akukho nzuzo ozakuyifumana ngokuthi uthabathe inxaxheba kwesi sifundo sophando. 
Ulwazi oluqokelelwe kwesi sifundo sophando luza kusetyenziswa ukubambisana phakathi 
kwabo basebenzela loo ngingqi omiselwe kuyo, khon’ukuze kusekwe eyona ndlela eyiyo 
yokufundisa abantu basekuhlaleni ukuphuhlisa indlela ebhetele yokusiqonda kakuhle isiseko 
sophando lwesifundo ngamachiza e-HIV kwingingqi leyo yovavanyo yasekuhlaleni. 
Ingaba bukhona ubungozi obukhoyo ekuthabatheni inxaxheba kwesi sifundo sophando?  
Akukho bungozi bayanyaniswa nokuthabatha kwakho inxaxheba kwesi sifundo sophando. 
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Ngubani ozakuthi afikelele kwinkcukacha zakho (nothe wazinika ngokuphendula kwakho 
imibuzo)?  
Lonke ulwazi oluqokelelwe kwesi sifundo sophando lulwazi lwabucala, noluza kuthatyathwa 
njengolungafikelelwa nangubani na, yaye aluzi kuxelwa komnye umtu.  Ukuba iziphumo zesi 
sifundo sophando ziyapapashwa kumaphepha ashicilela iziphumo zophando lwesifundo, 
ulwazi oluphathelene nawe (kwanegama lakho, nendawo ohlala kuyo) aluzi kwaziswa xa 
kushicilelwa olo lwazi. Wonke amaxwebhu aqulethe ulwazi olungasingisela lula kuwe, nazo 
zonke ezinye iinkcukacha zabucala malunga nawe, ziza kutshixelwa kwiindawo zokugcina 
ulwazi lwabucala, yaye ngumphandi oyintloko kuphela oza kufikelela kolo lwazi.  
Ingaba uza kubhatalwa (uhlawulwe) ngokuthabatha kwakho inxaxheba kwesi sifundo 
sophando? Ingaba kukhona ezinye iilahleko ozakuthi ujongane nazo ngokuthabatha kwakho 
inxaxheba?  
Hayi, awuzi kubhatalwa (awuzi kuhlawulwa) ngokuthabatha kwakho inxaxheba kwesi 
sifundo sophando, kodwa uza kubuyekezwa ngeendleko zokuqabela kwakho imoto, i-taxi 
okanye uloliwe (kwaneendleko zokufumana into etyiwayo) xa usiya kwindawo yesifundo 
sophando. Awuzi kuba nazilahleko ngokuthabatha kwakho inxaxheba kwesi sifundo 
sophando.  
Ingaba ikhona enye into ongathanda ukuyazi okanye ukuyenza? 
Ungaqhakamshelana necandelo le-Health Research Ethics Committee kwiSebe 
lwezobuNzulu-lwazi kwezeMpilo, kwiYunivesithi yaseStellenbosch, ngokuthi utsalele le 
nombolo yomnxeba ethi: 021-938 9207, ukuba unazo naziphi na izinto ongathanda ukuzibuza 
okanye othe wangaziqondi, okanye mhlawumbi othe wanezikhalazo ezithe azasiwa so (zaze 
zangahoywa ngendlela eyanelisekayo) ngumphandi.  
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Khon’ukuze ukwazi ukumana uzijongela (kwanokuzigcinela ngokwakho ulwazi 
oluphathelene nesi sifundo sophando), uza kufumana uxwebhu olukwafana nolu luqulethwe 
kule mvumelwano uyifundayo kungoku nje.  
Isifungo somthathi-nxaxheba 
Ngokuytyikitya ngezantsi, Mna …………………………………..…………. ndiyavuma 




• Ndilufundile okanye ndalufunda olu lwazi kunye nefomu yemvumelwano kwaye 
ibhalwe ngolwimi endiliciko nendikhululekileyo kulo  
• Bendinalo ithuba lokuba ndibuze imibuzo kwaye yonke imibuzo yam iphendulwe 
ngokwanelisayo. 
• Ndiyakuqonda ukuba ukuthatha inxaxheba kolu phando kube kukuzithandela kwam 
kwaye andikhange ndinyanzelwe ukuba ndithathe inxaxheba. 
• Ndingakhetha ukusishiya isifundo naninina kwaye andisayi kohlwaywa okanye uqal’ 
ugwetywe nangayiphi indlela. 
• Usenokucelwa ukuba usishiye isifundo phambi kokuba siphele, ukuba ugqirha 
wesifundo okanye umphandi ukubona kuyinzuzo kuwe, okanye ukuba andisilandeli 
isicwangciso sesifundo, ekuvunyelenwe ngaso. 
 
Kutyikitywe e-(indawo) .........…........…………….. ngo-(usuku) ………....……….. 2011. 
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Umtyikityo womthathi-nxaxheba   Umtyikityo wengqina 
Isifungo somphandi 
 
Mna (igama) ………………………………………………… ndiyafunga ukuba: 
• Ndilucacisile ulwazi olu kweli xwebhu ku-…………………..……………... 
• Ndimkhuthazile ukuba abuze imibuzo kwaye athathe ixesha elifanelekileyo ukuba 
ayiphendule. 
• Ndiyaneliseka kukuba uyakuqonda ngokwanelisayo konke okumalunga nophando 
okuxoxwe ngasentla. 
• Ndisebenzise/andisebenzisanga toliki.  (Ukuba itoliki isetyenzisiwe kumele ityikitye 
isaziso ngezantsi. 
 
Kutyikitywe e-(indawo) .........…........…………….. ngo-(usuku) ………....……….. 2011. 
 
    




Mna (igama) .............................................................................. ndigunyazisa ukuba:  
• Ndimncedisile umphandi (igama) ................................................................. 
ekucaciseni  
•  
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• iinkcukacha zalo mqulu ku(igama lalowo uthatha 
inxaxheba) ............................................... 
•  
• Ndisebenzisa ulwimi lwesi-Afrikansi /IsiXhosa njengonxibelelwano . 
•  
• Simkhuthazile ukuba abuze imibuzo athathe nexesha eloneleyo ekuphenduleni 
imibuzo. 
•  
• Ndidlulise inguqulelo eyiyo njengoko bendiyichazelwe. 
•  
• Ndonelisekile ukuba umthathi-nxaxheba ukuve ngokupheleleyo konke okuqulathwe  
•  
• loluxwebhu lwephepha-mvume kwaye nemibuzo yakhe yonke iphenduleke  
•  
• ngokwanelisekayo.  
•  
•  
Ityikitywe e (indawo) ................................................... ngomhla .................................2011 
 
......................................................................                             .............................................. 
Utyikityo lwetoliki                                                Utyikityo lwengqina 
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APPENDIX 4: Demographic Information 
 
DEMOGRAPHIC INFORMATION  
 
 
PARTICIPANT ID   
DATE   
INTERVIEWER NAME  
Interviewer administered:  Please complete the following by circling the appropriate 
answer or filling in the appropriate details: 


















3 Level of education: None Grade1-7 Grade 8-11 Matric 
Tertiary Honours Masters PhD 
Other (Specify)  
4 Are you employed?   
YES / NO 
5 If yes, what is your 
occupation? 
 
6 Home Language:  
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7 Marital status: Married Permanent partner Single  
Casual relationships Other (Specify) 
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8a We understand that there is a long process people go through to enrol in trials. Please list 







8b Have you attended a vaccine information/discussion group?  Yes No 
If yes, how many sessions have you attended? 
 
8c Have you attended sessions with an individual counsellor? Yes No 
 
If yes, how many individual sessions have you attended? 
8d Have you received any written material on the vaccine 
trials? 
Yes No 
If yes, what material were you given?  
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8e Have you undergone screening for a vaccine trial? 
 
Yes No 
8h Are you enrolled in an HIV vaccine trial? 
 
Yes No 
8i If yes, which vaccine trial? 
 
8j Have you received any other education material? Yes No 
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APPENDIX 5: Key Informant Interview Schedule 
 
OPENING QUESTIONS 
What is your role at the HIV vaccine trial site?  
How would you describe your role and responsibilities?  
What activities do you perform in your role?  
AREA 1: Role of the CAB 
What is you role in the activities of Research Centre X?  
What is your role in your community? Who is the community that you serve?  
How did you become a part of the CAB at Research Centre X?  
As a CAB member, what do you think your goal is in the activities that you conduct in that 
capacity?  
In your capacity as CAB member, whose interests do you represent? How do you 
communicate with your constituents and the CE team at the research centre? How often?  
What activities do you engage in to achieve the above objectives?  
What are some of the local norms, beliefs, views and concerns about HIV, and HIV vaccines 
that you have encountered in your community? How do you respond to these?  
What kinds of issues/information have you assisted the research centre with? (translation of 
information in that which is digestible to the community) 
What training have you received to execute your role? Do you feel that this training is 
adequate?  
Stellenbosch University  https://scholar.sun.ac.za
249 
 
What role do you think you could play? Recommendations for expanding the involvement of 
CAB members in trial site activities.  
AREA 2: DISCUSSING COMMUNITY EDUCATION ABOUT HIV VACCINES  
Describe the community education strategy in place at your trial site. 
Probe for:  
o Which sectors of the trial site community is it targeted at? 
o What is the broad community education strategy of the trial site?  
o What are the community education activities currently undertaken at your trial 
site?  
o What materials and didactic techniques, disseminations strategies are used in 
your community education strategy?  
 
CLOSING QUESTIONS  
o How do you understand the relationship between community participation and 
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Appendix 6: Informed Consent Form for Key Informant Interviews 




TITLE OF THE RESEARCH PROJECT: 
 
Building scientific literacy: A case study of community participation in HIV vaccine research 
REFERENCE NUMBER: N10/11/366 
PRINCIPAL INVESTIGATOR: Ms Anthea Lesch  
ADDRESS: Department of Psychology, Stellenbosch University, Matieland 7602 
CONTACT NUMBER: (021) 8083456 
You are being invited to take part in a research project.  Please take some time to read the 
information presented here, which will explain the details of this project.  Please ask the 
researcher any questions about any part of this project that you do not fully understand.  It is 
very important that you are fully satisfied that you clearly understand what this research 
entails and how you could be involved.  Also, your participation is entirely voluntary and 
you are free to decline to participate.  If you say no, this will not affect you negatively in any 
way whatsoever.  You are also free to withdraw from the study at any point, even if you do 
agree to take part. 
This study has been approved by the Health Research Ethics Committee at 
Stellenbosch University and will be conducted according to the ethical guidelines and 
principles of the international Declaration of Helsinki, South African Guidelines for 
Good Clinical Practice and the Medical Research Council (MRC) Ethical Guidelines for 
Research. 
 
What is this research study all about? 
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The study will be conducted at the HIV vaccine trial site of which you are a community 
member, HIV vaccine trial site researcher, HIV vaccine educator, HIV vaccine recruiter or 
community advisory board member in the Western Cape, South Africa. Approximately 110 
participants will be recruited to participate in this study.  
The aim of this study is to find out about the HIV vaccine education activities that have been 
taking place at your trial site and to learn more about how community members participate in 
the HIV vaccine education activities that have been held at your trial site. The information 
collected from the study will be used to develop a model for teaching members of your 
community about research and HIV vaccines. The researcher will work with community 
members, HIV vaccine researchers, HIV vaccine educators and recruiters and community 
advisory board members at your trial site to develop this model. 
Data for the study will be collected using interviews, focus groups, observations, 
questionnaires and trial site documents.  
Why have you been invited to participate? 
You have been invited to participate in this study because you are a community advisory 
board member at the HIV vaccine trial site.  
What will your responsibilities be? 
You will be asked to participate in a focus group discussion which will be conducted by the 
researcher. You will be asked questions related to your involvement in community 
participation and community education activities at the HIV vaccine trial site. The interview 
will last approximately 90 minutes.  
Will you benefit from taking part in this research? 
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There are no personal benefits associated with your participation in this research. The 
data collected from this study will be used to collaborate with stakeholders at your trial site to 
design a community-based education model to promote understanding of research and HIV 
vaccines in the trial site community.   
Are there in risks involved in your taking part in this research? 
There are no risks associated with your participation in this research study.  
Who will have access to your personal information? 
All information collected as part of this study will be treated as confidential and protected. If 
information is used in a publication or research thesis, your identity will remain anonymous. 
All documentation containing identifying information and other confidential documentation 
collected will be stored in locked cabinets and only the researcher will access these records. 
All interviews, focus groups and workshops will be tape-recorded. The recordings will be 
stored in locked cabinets and only the researcher will have access to the recordings. The 
recordings will remain in locked storage at the completion of the study. 
Will you be paid to take part in this study and are there any costs involved? 
No you will not be paid to take part in the study.  You will receive a reimbursement for your 
travels costs. There will be no costs involved for you, if you do take part in the study.  
Is there anything else that you should know or do? 
You can contact the Health Research Ethics Committee at 021-938 9207 if you have any 
concerns or complaints that have not been adequately addressed by the researcher.  
You will receive a copy of this information and consent form for your own records. 
 
Declaration by participant 
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By signing below, I …………………………………..…………. agree to take part in a 
research study entitled Building scientific literacy: A case study of community participation 
in HIV vaccine research. 
I declare that: 
 
• I have read or had read to me this information and consent form and it is written in a 
language with which I am fluent and comfortable. 
• I have had a chance to ask questions and all my questions have been adequately 
answered. 
• I understand that taking part in this study is voluntary and I have not been 
pressurized to take part. 
• I may choose to leave the study at any time and will not be penalized or prejudiced in 
any way. 
• I may be asked to leave the study before it has finished, if the study doctor or 




Signed at (place) ......................…........…………….. on (date) …………....……….. 2011. 
 
 
    
Signature of participant Signature of witness 
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Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 
• I explained the information in this document to ………………………………….. 
• I encouraged him/her to ask questions and took adequate time to answer them. 
• I am satisfied that he/she adequately understands all aspects of the research, as 
discussed above 
• I did/did not use an interpreter.  (If an interpreter is used then the interpreter must sign 
the declaration below. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2011. 
 
    
Signature of investigator Signature of witness 
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Appendix 7: University of Stellenbosch Ethical Approval 
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Appendix 8: University of Cape Town Ethical Approval 
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